Disease on EC 5.3.2.1 - phenylpyruvate tautomerase
Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Acquired Immunodeficiency Syndrome
Red blood cells: The primary reservoir of macrophage migration inhibitory factor in whole blood.
ACTH-Secreting Pituitary Adenoma
Immunocytochemical localization of macrophage migration inhibitory factor in human hypophysis and pituitary adenomas.
Acute Coronary Syndrome
Association between the -794 (CATT)5-8??MIF gene polymorphism and susceptibility to acute coronary syndrome in a western Mexican population.
Acute Coronary Syndrome
High Plasma Levels of Gremlin-1 and Macrophage Migration Inhibitory Factor, but Not Their Ratio, Indicate an Increased Risk for Acute Coronary Syndrome in Patients With Type 2 Diabetes Mellitus.
Acute Coronary Syndrome
Increased circulating macrophage migration inhibitory factor levels are associated with coronary artery disease.
Acute Coronary Syndrome
Macrophage migration inhibitory factor is enhanced in acute coronary syndromes and is associated with the inflammatory response.
Acute Coronary Syndrome
Platelets as a novel source of Gremlin-1: Implications for thromboinflammation.
Acute Kidney Injury
Blocking Macrophage Migration Inhibitory Factor Protects Against Cisplatin-Induced Acute Kidney Injury in Mice.
Acute Kidney Injury
Comparison of macrophage migration inhibitory factor and neutrophil gelatinase-associated lipocalin-2 to predict acute kidney injury after liver transplantation: An observational pilot study.
Acute Kidney Injury
Renoprotective effect of long acting thioredoxin by modulating oxidative stress and macrophage migration inhibitory factor against rhabdomyolysis-associated acute kidney injury.
Acute Kidney Injury
The Macrophage Migration Inhibitory Factor (MIF) Promoter Polymorphisms (rs3063368, rs755622) Predict Acute Kidney Injury and Death after Cardiac Surgery.
Acute Kidney Injury
The protective role of macrophage migration inhibitory factor in acute kidney injury after cardiac surgery.
Acute Kidney Injury
Urinary macrophage migration inhibitory factor serves as a potential biomarker for acute kidney injury in patients with acute pyelonephritis.
Acute Kidney Injury
Uropathogenic Escherichia coli causes cortical tubular necrotic cell death and the release of macrophage migration inhibitory factor.
Acute Lung Injury
Age-dependent alterations in the inflammatory response to pulmonary challenge.
Acute Lung Injury
Circulating levels of macrophage migration inhibitory factor are associated with mild pulmonary dysfunction after cardiopulmonary bypass.
Acute Lung Injury
Heme oxygenase-1 upregulation improves lipopolysaccharide-induced acute lung injury involving suppression of macrophage migration inhibitory factor.
Acute Lung Injury
Macrophage migration inhibitory factor in acute lung injury: expression, biomarker, and associations.
Acute Lung Injury
Relationship between elevated soluble CD74 and severity of experimental and clinical ALI/ARDS.
Acute Lung Injury
Role of macrophage migration inhibitory factor in acute lung injury in mice with acute pancreatitis complicated by endotoxemia.
Acute Lung Injury
Surface expression of CD74 by type II alveolar epithelial cells: a potential mechanism for macrophage migration inhibitory factor-induced epithelial repair.
Acute Lung Injury
Tanshinone IIA attenuates seawater aspiration-induced lung injury by inhibiting macrophage migration inhibitory factor.
Adenocarcinoma
D-dopachrome tautomerase is over-expressed in pancreatic ductal adenocarcinoma and acts cooperatively with macrophage migration inhibitory factor to promote cancer growth.
Adenocarcinoma
Enhanced expression of macrophage migration inhibitory factor in prostatic adenocarcinoma metastases.
Adenocarcinoma
Inhibition of macrophage migration inhibitory factor decreases proliferation and cytokine expression in bladder cancer cells.
Adenocarcinoma
Intracellular distribution of macrophage migration inhibitory factor predicts the prognosis of patients with adenocarcinoma of the lung.
Adenocarcinoma
Macrophage immigration inhibitory factor promotes cell proliferation and inhibits apoptosis of cervical adenocarcinoma.
Adenocarcinoma
Macrophage migration inhibitory factor - a therapeutic target in gallbladder cancer.
Adenocarcinoma
Macrophage migration inhibitory factor in prostatic adenocarcinoma: correlation with tumor grading and combination endocrine treatment-related changes.
Adenocarcinoma
Macrophage migration inhibitory factor induces epithelial to mesenchymal transition, enhances tumor aggressiveness and predicts clinical outcome in resected pancreatic ductal adenocarcinoma.
Adenocarcinoma
Macrophage migration inhibitory factor up-regulates alpha(v)beta(3) integrin and vascular endothelial growth factor expression in endometrial adenocarcinoma cell line Ishikawa.
Adenocarcinoma
Upregulation of macrophage migration inhibitory factor promotes tumor metastasis and correlates with poor prognosis of pancreatic ductal adenocarcinoma.
Adenocarcinoma of Lung
Astragalus Polysaccharide (PG2) Suppresses Macrophage Migration Inhibitory Factor and Aggressiveness of Lung Adenocarcinoma Cells.
Adenocarcinoma of Lung
Elevated expression of transforming growth factor betas and the tumor necrosis factor family in lung adenocarcinomas induced by N-nitrosobis(2-hydroxypropyl)amine in rats.
Adenocarcinoma of Lung
MIF family members cooperatively inhibit p53 expression and activity.
Adenocarcinoma of Lung
Regulation of human lung adenocarcinoma cell migration and invasion by macrophage migration inhibitory factor.
Adenoma
Immunocytochemical localization of macrophage migration inhibitory factor in human hypophysis and pituitary adenomas.
Alopecia Areata
Evaluation of macrophage migration inhibitory factor (MIF) levels in serum and lesional skin of patients with alopecia areata.
Alopecia Areata
Increased macrophage migration inhibitory factor (MIF) in the sera of patients with extensive alopecia areata.
Alopecia Areata
Macrophage Migration Inhibitory Factor in Alopecia Areata and Vitiligo: A Case-Controlled Serological Study.
Alopecia Areata
Macrophage migration inhibitory factor polymorphism (rs755622) in alopecia areata: a possible role in disease prevention.
Alopecia Areata
Promoter region polymorphism of macrophage migration inhibitory factor is strong risk factor for young onset of extensive alopecia areata.
Alopecia Areata
Serum Level of Macrophage Migration Inhibitory Factor (MIF) in Egyptians With Alopecia Areata and Its Relation to the Clinical Severity of the Disease.
Alphavirus Infections
Macrophage Migration Inhibitory Factor Receptor CD74 Mediates Alphavirus-Induced Arthritis and Myositis in Murine Models of Alphavirus Infection.
Alveolar Bone Loss
MIF induces osteoclast differentiation and contributes to progression of periodontal disease in mice.
Alzheimer Disease
Bioplex analysis of plasma cytokines in Alzheimer's disease and mild cognitive impairment.
Alzheimer Disease
Corrigendum: Macrophage Migration Inhibitory Factor is subjected to glucose modification and oxidation in Alzheimer's Disease.
Alzheimer Disease
Deficiency of macrophage migration inhibitory factor attenuates tau hyperphosphorylation in mouse models of Alzheimer's disease.
Alzheimer Disease
Glutamine synthetase, hemoglobin alpha-chain, and macrophage migration inhibitory factor binding to amyloid beta-protein: their identification in rat brain by a novel affinity chromatography and in Alzheimer's disease brain by immunoprecipitation.
Alzheimer Disease
Macrophage migration inhibitory factor in mild cognitive impairment and Alzheimer's disease.
Alzheimer Disease
Macrophage Migration Inhibitory Factor is Associated with Biomarkers of Alzheimer's Disease Pathology and Predicts Cognitive Decline in Mild Cognitive Impairment and Mild Dementia.
Alzheimer Disease
Macrophage Migration Inhibitory Factor is subjected to glucose modification and oxidation in Alzheimer's Disease.
Alzheimer Disease
Profile of MIF in Developing Hippocampus: Association With Cell Proliferation and Neurite Outgrowth.
Alzheimer Disease
The role of macrophage migration inhibitory factor in Alzheimer's disease.
Alzheimer Disease
The Role of Macrophage Migration Inhibitory Factor in Alzheimer's Disease: Conventionally Pathogenetic or Unconventionally Protective?
Anemia
A critical role for the host mediator macrophage migration inhibitory factor in the pathogenesis of malarial anemia.
Anemia
A decrease of plasma macrophage migration inhibitory factor concentration is associated with lower numbers of circulating lymphocytes in experimental Plasmodium falciparum malaria.
Anemia
African Trypanosomiasis-Associated Anemia: The Contribution of the Interplay between Parasites and the Mononuclear Phagocyte System.
Anemia
Expression of erythropoietic cytokines in ?-tocopherol transfer protein knockout mice with murine malaria infection.
Anemia
Macrophage migration inhibitory factor release by macrophages after ingestion of Plasmodium chabaudi-infected erythrocytes: possible role in the pathogenesis of malarial anemia.
Anemia
Role of monocyte-acquired hemozoin in suppression of macrophage migration inhibitory factor in children with severe malarial anemia.
Anemia
Structural and functional comparison of MIF ortholog from Plasmodium yoelii with MIF from its rodent host.
Anemia
T cell and monocyte/macrophage activation markers associate with adverse outcome, but give limited prognostic value in anemic patients with heart failure: results from RED-HF.
Angina Pectoris
[The research of establishing discriminant function for patients with angina pectoris by stepwise analysis based on serum inflammatory factors].
Angina, Stable
[The research of establishing discriminant function for patients with angina pectoris by stepwise analysis based on serum inflammatory factors].
Angina, Unstable
[The research of establishing discriminant function for patients with angina pectoris by stepwise analysis based on serum inflammatory factors].
Arteriosclerosis
Prevention of chronic deterioration of heart allograft by recombinant adeno-associated virus-mediated heme oxygenase-1 gene transfer.
Arteriovenous Malformations
Macrophage migration inhibitory factor reduces apoptosis in cerebral arteriovenous malformations.
Arteritis
Lack of association between macrophage migration inhibitory factor gene polymorphism and giant cell arteritis.
Arthralgia
Association of CD14 and macrophage migration inhibitory factor gene polymorphisms with inflammatory microRNAs expression levels in ankylosing spondylitis and polyarthralgia.
Arthritis
A functional promoter haplotype of macrophage migration inhibitory factor is linked and associated with juvenile idiopathic arthritis.
Arthritis
A novel 5'-flanking region polymorphism of macrophage migration inhibitory factor is associated with systemic-onset juvenile idiopathic arthritis.
Arthritis
A novel DNA vaccine targeting macrophage migration inhibitory factor protects joints from inflammation and destruction in murine models of arthritis.
Arthritis
Critical role for macrophage migration inhibitory factor (MIF) in Ross River virus-induced arthritis and myositis.
Arthritis
Functional and prognostic relevance of the -173 polymorphism of the macrophage migration inhibitory factor gene in systemic-onset juvenile idiopathic arthritis.
Arthritis
Inhibition of joint inflammation and destruction induced by anti-type II collagen antibody/lipopolysaccharide (LPS)-induced arthritis in mice due to deletion of macrophage migration inhibitory factor (MIF).
Arthritis
Inhibition of macrophage migration inhibitory factor (MIF) tautomerase and biological activities by acetaminophen metabolites.
Arthritis
Macrophage migration inhibitory factor (MIF) and oligoarticular juvenile idiopathic arthritis (o-JIA): association of MIF promoter polymorphisms with response to intra-articular glucocorticoids.
Arthritis
Macrophage migration inhibitory factor (MIF) gene polymorphism is associated with susceptibility to but not severity of inflammatory polyarthritis.
Arthritis
Macrophage migration inhibitory factor (MIF) inhibitor, Z-590 suppresses cartilage destruction in adjuvant-induced arthritis via inhibition of macrophage inflammatory activation.
Arthritis
Macrophage migration inhibitory factor and its genetic association with arthritis: a work in progress.
Arthritis
Macrophage migration inhibitory factor exhibits a pronounced circadian rhythm relevant to its role as a glucocorticoid counter-regulator.
Arthritis
Macrophage migration inhibitory factor in patients with juvenile idiopathic arthritis.
Arthritis
Macrophage migration inhibitory factor is essential for osteoclastogenic mechanisms in vitro and in vivo mouse model of arthritis.
Arthritis
Macrophage migration inhibitory factor is involved in the pathogenesis of collagen type II-induced arthritis in mice.
Arthritis
Macrophage Migration Inhibitory Factor Receptor CD74 Mediates Alphavirus-Induced Arthritis and Myositis in Murine Models of Alphavirus Infection.
Arthritis
Macrophage migration inhibitory factor regulates neutrophil chemotactic responses in inflammatory arthritis in mice.
Arthritis
Macrophage-derived, macrophage migration inhibitory factor (MIF) is necessary to induce disease in the K/BxN serum-induced model of arthritis.
Arthritis
Mutation screening of the macrophage migration inhibitory factor gene: positive association of a functional polymorphism of macrophage migration inhibitory factor with juvenile idiopathic arthritis.
Arthritis
Natural killer T cells ameliorate antibody-induced arthritis in macrophage migration inhibitory factor transgenic mice.
Arthritis
Novel arylazoarylmethane as potential inhibitor of macrophage migration inhibitory factor.
Arthritis
Production of a macrophage migration inhibitory factor in rabbits with experimental arthritis.
Arthritis
Regulation of macrophage migration inhibitory factor by endogenous glucocorticoids in rat adjuvant-induced arthritis.
Arthritis
Regulation of p53 by macrophage migration inhibitory factor in inflammatory arthritis.
Arthritis
Role of macrophage migration inhibitory factor (MIF) in murine antigen-induced arthritis: interaction with glucocorticoids.
Arthritis
The association between the functional PTPN22 1858 C/T and MIF -173 C/G polymorphisms and juvenile idiopathic arthritis: a meta-analysis.
Arthritis, Experimental
A novel DNA vaccine targeting macrophage migration inhibitory factor protects joints from inflammation and destruction in murine models of arthritis.
Arthritis, Experimental
Inhibition of joint inflammation and destruction induced by anti-type II collagen antibody/lipopolysaccharide (LPS)-induced arthritis in mice due to deletion of macrophage migration inhibitory factor (MIF).
Arthritis, Experimental
Involvement of macrophage migration inhibitory factor in the evolution of rat adjuvant arthritis.
Arthritis, Juvenile
A functional promoter haplotype of macrophage migration inhibitory factor is linked and associated with juvenile idiopathic arthritis.
Arthritis, Juvenile
A novel 5'-flanking region polymorphism of macrophage migration inhibitory factor is associated with systemic-onset juvenile idiopathic arthritis.
Arthritis, Juvenile
Association of macrophage migration inhibitory factor gene -173 G/C polymorphism with prognosis in turkish children with juvenile rheumatoid arthritis.
Arthritis, Juvenile
Functional and prognostic relevance of the -173 polymorphism of the macrophage migration inhibitory factor gene in systemic-onset juvenile idiopathic arthritis.
Arthritis, Juvenile
Macrophage migration inhibitory factor (MIF) and oligoarticular juvenile idiopathic arthritis (o-JIA): association of MIF promoter polymorphisms with response to intra-articular glucocorticoids.
Arthritis, Juvenile
Macrophage migration inhibitory factor in patients with juvenile idiopathic arthritis.
Arthritis, Juvenile
Mutation screening of the macrophage migration inhibitory factor gene: positive association of a functional polymorphism of macrophage migration inhibitory factor with juvenile idiopathic arthritis.
Arthritis, Juvenile
The association between the functional PTPN22 1858 C/T and MIF -173 C/G polymorphisms and juvenile idiopathic arthritis: a meta-analysis.
Arthritis, Psoriatic
Macrophage migration inhibitory factor (MIF) promoter polymorphisms (-794 CATT5-8 and -173 G>C): association with MIF and TNF? in psoriatic arthritis.
Arthritis, Psoriatic
MIF functional polymorphisms (-794 CATT5-8 and -173 G>C) are associated with MIF serum levels, severity and progression in male multiple sclerosis from western Mexican population.
Arthritis, Psoriatic
The Frequency of anti-CCP antibodies in patients with rheumatoid arthritis and psoriatic arthritis and their relationship with clinical features and parameters of angiogenesis: A comparative study.
Arthritis, Rheumatoid
A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis.
Arthritis, Rheumatoid
Activation of synovial cell p38 MAP kinase by macrophage migration inhibitory factor.
Arthritis, Rheumatoid
Association of MIF-173G/C and MBL2 codon 54 gene polymorphisms with rheumatoid arthritis: A meta-analysis.
Arthritis, Rheumatoid
Associations between circulating macrophage migration inhibitory factor (MIF) levels and rheumatoid arthritis, and between MIF gene polymorphisms and disease susceptibility: a meta-analysis.
Arthritis, Rheumatoid
Correlation of rheumatoid arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factor.
Arthritis, Rheumatoid
Critical role for macrophage migration inhibitory factor (MIF) in Ross River virus-induced arthritis and myositis.
Arthritis, Rheumatoid
Deletion of macrophage migration inhibitory factor ameliorates inflammation in mice model severe acute pancreatitis.
Arthritis, Rheumatoid
Detection of sarcolectin-specific receptors like the cytokine macrophage migration inhibitory factor in rheumatoid nodules.
Arthritis, Rheumatoid
Development of a novel method to measure macrophage migration inhibitory factor (MIF) in sera of patients with rheumatoid arthritis by combined electrochemical immunosensor.
Arthritis, Rheumatoid
Direct link between cytokine activity and a catalytic site for macrophage migration inhibitory factor.
Arthritis, Rheumatoid
Elevated serum levels of macrophage migration inhibitory factor and their significant correlation with rheumatoid vasculitis disease activity.
Arthritis, Rheumatoid
Functional MIF promoter haplotypes modulate Th17-related cytokine expression in peripheral blood mononuclear cells from control subjects and rheumatoid arthritis patients.
Arthritis, Rheumatoid
Functional variants of the macrophage migration inhibitory factor do not infer risk of cardiovascular disease in rheumatoid arthritis.
Arthritis, Rheumatoid
Hypoxia and glucocorticoid signaling converge to regulate macrophage migration inhibitory factor gene expression.
Arthritis, Rheumatoid
Induction of macrophage migration inhibitory factor in ConA-stimulated rheumatoid arthritis synovial fibroblasts through the P38 map kinase-dependent signaling pathway.
Arthritis, Rheumatoid
Lack of association between macrophage migration inhibitory factor-173 gene polymorphism with disease susceptibility and cardiovascular risk in rheumatoid arthritis patients from northwestern Spain.
Arthritis, Rheumatoid
Macrophage migration inhibitory factor (MIF) as a therapeutic target for rheumatoid arthritis and systemic lupus erythematosus.
Arthritis, Rheumatoid
Macrophage migration inhibitory factor (MIF) inhibitor, Z-590 suppresses cartilage destruction in adjuvant-induced arthritis via inhibition of macrophage inflammatory activation.
Arthritis, Rheumatoid
Macrophage migration inhibitory factor (MIF): Genetic evidence for participation in early onset and early stage rheumatoid arthritis.
Arthritis, Rheumatoid
Macrophage migration inhibitory factor deficiency attenuates macrophage recruitment, glomerulonephritis, and lethality in MRL/lpr mice.
Arthritis, Rheumatoid
Macrophage migration inhibitory factor enhances osteoclastogenesis through upregulation of RANKL expression from fibroblast-like synoviocytes in patients with rheumatoid arthritis.
Arthritis, Rheumatoid
Macrophage migration inhibitory factor gene: influence on rheumatoid arthritis susceptibility.
Arthritis, Rheumatoid
Macrophage migration inhibitory factor in rheumatoid arthritis: clinical correlations.
Arthritis, Rheumatoid
Macrophage migration inhibitory factor in rheumatoid arthritis: evidence of proinflammatory function and regulation by glucocorticoids.
Arthritis, Rheumatoid
Macrophage migration inhibitory factor is essential for osteoclastogenic mechanisms in vitro and in vivo mouse model of arthritis.
Arthritis, Rheumatoid
Macrophage migration inhibitory factor is involved in the pathogenesis of collagen type II-induced arthritis in mice.
Arthritis, Rheumatoid
Macrophage migration inhibitory factor may play a protective role in osteoarthritis.
Arthritis, Rheumatoid
Macrophage migration inhibitory factor polymorphisms do not predict therapeutic response to glucocorticoids or to tumour necrosis factor alpha-neutralising treatments in rheumatoid arthritis.
Arthritis, Rheumatoid
Macrophage migration inhibitory factor promoter polymorphisms are associated with disease activity in rheumatoid arthritis patients from Southern Mexico.
Arthritis, Rheumatoid
Macrophage migration inhibitory factor up-regulates expression of matrix metalloproteinases in synovial fibroblasts of rheumatoid arthritis.
Arthritis, Rheumatoid
Macrophage migration inhibitory factor up-regulates the expression of interleukin-8 messenger RNA in synovial fibroblasts of rheumatoid arthritis patients: common transcriptional regulatory mechanism between interleukin-8 and interleukin-1beta.
Arthritis, Rheumatoid
Macrophage migration inhibitory factor upregulates angiogenic factors and correlates with clinical measures in rheumatoid arthritis.
Arthritis, Rheumatoid
Macrophage migration inhibitory factor: a key cytokine in RA, SLE and atherosclerosis.
Arthritis, Rheumatoid
Macrophage migration inhibitory factor: a mediator of matrix metalloproteinase-2 production in rheumatoid arthritis.
Arthritis, Rheumatoid
Macrophage migration inhibitory factor: a potential therapeutic target for rheumatoid arthritis.
Arthritis, Rheumatoid
Macrophage migration inhibitory factor: an emerging therapeutic target in rheumatoid arthritis.
Arthritis, Rheumatoid
MIF and TNF? serum levels in rheumatoid arthritis patients treated with disease-modifying antirheumatic drugs: a cross-sectional study.
Arthritis, Rheumatoid
MIF functional polymorphisms (-794 CATT5-8 and -173 G>C) are associated with MIF serum levels, severity and progression in male multiple sclerosis from western Mexican population.
Arthritis, Rheumatoid
MIF production by dendritic cells is differentially regulated by Toll-like receptors and increased during rheumatoid arthritis.
Arthritis, Rheumatoid
MIF, a controversial cytokine: a review of structural features, challenges, and opportunities for drug development.
Arthritis, Rheumatoid
MIF: a new cytokine link between rheumatoid arthritis and atherosclerosis.
Arthritis, Rheumatoid
Phylogeny and evolution of plant macrophage migration inhibitory factor/D-dopachrome tautomerase-like proteins.
Arthritis, Rheumatoid
Plant-derived anti-inflammatory compounds affect MIF tautomerase activity.
Arthritis, Rheumatoid
Polymorphisms in the macrophage migration inhibitory factor gene and bone loss in postmenopausal women.
Arthritis, Rheumatoid
Prognostic significance and dynamic change of plasma macrophage migration inhibitory factor in patients with acute ST-elevation myocardial infarction.
Arthritis, Rheumatoid
Reduced arthritis in MIF deficient mice is associated with reduced T cell activation: down-regulation of ERK MAP kinase phosphorylation.
Arthritis, Rheumatoid
Regulation of p53 by macrophage migration inhibitory factor in inflammatory arthritis.
Arthritis, Rheumatoid
Rituximab effectively reduces macrophage migration inhibitory factor in patients with active rheumatoid arthritis.
Arthritis, Rheumatoid
Role of macrophage migration inhibitory factor in head and neck cancer and novel therapeutic targets: A systematic review.
Arthritis, Rheumatoid
Serum levels of macrophage migration inhibitory factor are associated with rheumatoid arthritis course.
Arthritis, Rheumatoid
Serum macrophage migration inhibitory factor levels are correlated with response to tocilizumab therapy in patients with rheumatoid arthritis.
Arthritis, Rheumatoid
Structural basis for decreased induction of class IB PI3-kinases expression by MIF inhibitors.
Arthritis, Rheumatoid
Sustained changes in lipid profile and macrophage migration inhibitory factor (MIF) levels after anti-TNF therapy in rheumatoid arthritis.
Arthritis, Rheumatoid
Synthesis and bio-evaluation of human macrophage migration inhibitory factor inhibitor to develop anti-inflammatory agent.
Arthritis, Rheumatoid
Th1/Th17 cytokine profile is induced by macrophage migration inhibitory factor in peripheral blood mononuclear cells from rheumatoid arthritis patients.
Arthritis, Rheumatoid
The Frequency of anti-CCP antibodies in patients with rheumatoid arthritis and psoriatic arthritis and their relationship with clinical features and parameters of angiogenesis: A comparative study.
Arthritis, Rheumatoid
The microsatellite, macrophage migration inhibitory factor -794, may influence gene expression in human mononuclear cells stimulated with E. coli or S. pneumoniae.
Arthritis, Rheumatoid
The role of macrophage migration inhibitory factor in the inflammatory immune response and rheumatoid arthritis.
Aspergillosis
A role for macrophage migration inhibitory factor in protective immunity against Aspergillus fumigatus.
Asthma
Association of macrophage migration inhibitory factor promoter polymorphism -173G/C with susceptibility to childhood asthma.
Asthma
Association of MIF promoter polymorphisms with childhood asthma in a northeastern Chinese population.
Asthma
Blockade of macrophage migration inhibitory factor (MIF) prevents the antigen-induced response in a murine model of allergic airway inflammation.
Asthma
Crosstalk between MIF and Eotaxin in Allergic Eosinophil Activation Forms LTC4-Synthesizing Lipid Bodies.
Asthma
Human circulating eosinophils secrete macrophage migration inhibitory factor (MIF). Potential role in asthma.
Asthma
ISO-1, a macrophage migration inhibitory factor antagonist, inhibits airway remodeling in a murine model of chronic asthma.
Asthma
Macrophage migration inhibitory factor is critical to interleukin-5-driven eosinophilopoiesis and tissue eosinophilia triggered by Schistosoma mansoni infection.
Asthma
Macrophage migration inhibitory factor is essential for allergic asthma but not for Th2 differentiation.
Asthma
Macrophage migration inhibitory factor isolated from a parasite inhibited Th2 cytokine production in PBMCs of atopic asthma patients.
Asthma
MIF signaling blocking alleviates airway inflammation and airway epithelial barrier disruption in a HDM-induced asthma model.
Asthma
Novel arylazoarylmethane as potential inhibitor of macrophage migration inhibitory factor.
Asthma
Role of macrophage migration inhibitory factor (MIF) in allergic and endotoxin-induced airway inflammation in mice.
Asthma
Role of macrophage migration inhibitory factor in ovalbumin-induced airway inflammation in rats.
Asthma
Serum macrophage migration inhibitory factor as a potential biomarker to evaluate therapeutic response in patients with allergic asthma: an exploratory study.
Asthma
Structural basis for decreased induction of class IB PI3-kinases expression by MIF inhibitors.
Atherosclerosis
A MIF-Derived Cyclopeptide that Inhibits MIF Binding and Atherogenic Signaling via the Chemokine Receptor CXCR2.
Atherosclerosis
Activation of the JNK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on CXCR4 and CD74.
Atherosclerosis
Artesunate inhibits type I interferon-induced production of macrophage migration inhibitory factor in patients with systemic lupus erythematosus.
Atherosclerosis
Association between the -794 (CATT)5-8??MIF gene polymorphism and susceptibility to acute coronary syndrome in a western Mexican population.
Atherosclerosis
Attenuation of atherosclerotic lesions in diabetic apolipoprotein E-deficient mice using gene silencing of macrophage migration inhibitory factor.
Atherosclerosis
De novo expression of macrophage migration inhibitory factor in atherogenesis in rabbits.
Atherosclerosis
De Novo expression of macrophage migration inhibitory factor in atherogenesis.
Atherosclerosis
Elevated circulating levels of macrophage migration inhibitory factor in polycystic ovary syndrome.
Atherosclerosis
Evidence for vascular macrophage migration inhibitory factor in destabilization of human atherosclerotic plaques.
Atherosclerosis
Expression of Human Tissue Factor Pathway Inhibitor on Vascular Smooth Muscle Cells Inhibits Secretion of Macrophage Migration Inhibitory Factor and Attenuates Atherosclerosis in ApoE-/- Mice.
Atherosclerosis
Expression of macrophage migration inhibitory factor in different stages of human atherosclerosis.
Atherosclerosis
Gremlin-1 inhibits macrophage migration inhibitory factor-dependent monocyte function and survival.
Atherosclerosis
High Plasma Levels of Gremlin-1 and Macrophage Migration Inhibitory Factor, but Not Their Ratio, Indicate an Increased Risk for Acute Coronary Syndrome in Patients With Type 2 Diabetes Mellitus.
Atherosclerosis
Hypoxia stimulates the expression of macrophage migration inhibitory factor in human vascular smooth muscle cells via HIF-1alpha dependent pathway.
Atherosclerosis
Induction of MIF expression by oxidized LDL via activation of NF-kappaB in vascular smooth muscle cells.
Atherosclerosis
Influence of functional polymorphism in MIF promoter on sudden cardiac death in Chinese populations.
Atherosclerosis
Lack of association between macrophage migration inhibitory factor-173 gene polymorphism with disease susceptibility and cardiovascular risk in rheumatoid arthritis patients from northwestern Spain.
Atherosclerosis
Laminar Flow Attenuates Macrophage Migration Inhibitory Factor Expression in Endothelial Cells.
Atherosclerosis
Macrophage Migration Inhibitory Factor (MIF)-Based Therapeutic Concepts in Atherosclerosis and Inflammation.
Atherosclerosis
Macrophage migration inhibitory factor and the risk of myocardial infarction or death due to coronary artery disease in adults without prior myocardial infarction or stroke: the EPIC-Norfolk Prospective Population study.
Atherosclerosis
Macrophage migration inhibitory factor deficiency attenuates macrophage recruitment, glomerulonephritis, and lethality in MRL/lpr mice.
Atherosclerosis
Macrophage migration inhibitory factor deficiency impairs atherosclerosis in low-density lipoprotein receptor-deficient mice.
Atherosclerosis
Macrophage migration inhibitory factor induces MMP-9 expression: implications for destabilization of human atherosclerotic plaques.
Atherosclerosis
Macrophage migration inhibitory factor is associated with vascular dysfunction in patients with end-stage renal disease.
Atherosclerosis
Macrophage migration inhibitory factor is enhanced in acute coronary syndromes and is associated with the inflammatory response.
Atherosclerosis
Macrophage migration inhibitory factor: a key cytokine in RA, SLE and atherosclerosis.
Atherosclerosis
Macrophage migration inhibitory factor: a noncanonical chemokine important in atherosclerosis.
Atherosclerosis
Mechanisms of disease: macrophage migration inhibitory factor in SLE, RA and atherosclerosis.
Atherosclerosis
MIF gene rs755622 polymorphism positively associated with acute coronary syndrome in Chinese Han population: case-control study.
Atherosclerosis
MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment.
Atherosclerosis
Modulation of circulating macrophage migration inhibitory factor in the elderly.
Atherosclerosis
Phylogeny and evolution of plant macrophage migration inhibitory factor/D-dopachrome tautomerase-like proteins.
Atherosclerosis
Platelet-derived MIF: A novel platelet chemokine with distinct recruitment properties.
Atherosclerosis
Porphyromonas gingivalis ATCC 33277 promotes intercellular adhesion molecule-1 expression in endothelial cells and monocyte-endothelial cell adhesion through macrophage migration inhibitory factor.
Atherosclerosis
Reduction of the aortic inflammatory response in spontaneous atherosclerosis by blockade of macrophage migration inhibitory factor (MIF).
Atherosclerosis
Stabilization of atherosclerotic plaques by blockade of macrophage migration inhibitory factor after vascular injury in apolipoprotein E-deficient mice.
Atherosclerosis
Structural basis for decreased induction of class IB PI3-kinases expression by MIF inhibitors.
Atherosclerosis
Sustained changes in lipid profile and macrophage migration inhibitory factor (MIF) levels after anti-TNF therapy in rheumatoid arthritis.
Atherosclerosis
The expression of macrophage migration inhibitory factor and intercellular adhesion molecule-1 in rats with periodontitis and atherosclerosis.
Atherosclerosis
The macrophage migration inhibitory factor (MIF) gene polymorphism in Czech and Russian patients with myocardial infarction.
Atherosclerosis
The vascular biology of macrophage migration inhibitory factor (MIF). Expression and effects in inflammation, atherogenesis and angiogenesis.
Atherosclerosis
[Macrophage migration inhibitory factor (MIF) gene -173 G>C polymorphism and its relationship to coronary artery disease and type 2 diabetes].
Atrial Fibrillation
Involvement of Src in L-type Ca2+ channel depression induced by macrophage migration inhibitory factor in atrial myocytes.
Atrial Fibrillation
Involvement of Src tyrosine kinase and protein kinase C in the expression of macrophage migration inhibitory factor induced by H2O2 in HL-1 mouse cardiac muscle cells.
Atrial Fibrillation
Macrophage migration inhibitory factor increases atrial arrhythmogenesis through CD74 signaling.
Atrial Fibrillation
Serum macrophage migration inhibitory factor is correlated with atrial fibrillation.
Autoimmune Diseases
A Macrophage Migration Inhibitory Factor Polymorphism Is Associated with Autoimmune Hepatitis Severity in US and Japanese Patients.
Autoimmune Diseases
A new class of isothiocyanate-based irreversible inhibitors of macrophage migration inhibitory factor.
Autoimmune Diseases
Association of MIF promoter polymorphisms with psoriasis in a Han population in northeastern China.
Autoimmune Diseases
Association study between macrophage migration inhibitory factor-173 polymorphism and acute myeloid leukemia in taiwan.
Autoimmune Diseases
Biochemical and structural characterization of a novel cooperative binding mode by Pit-1 with CATT repeats in the macrophage migration inhibitory factor promoter.
Autoimmune Diseases
Characterization of molecular determinants of the conformational stability of macrophage migration inhibitory factor: leucine 46 hydrophobic pocket.
Autoimmune Diseases
Critical role of macrophage migration inhibitory factor activity in experimental autoimmune diabetes.
Autoimmune Diseases
Cutting edge: macrophage migration inhibitory factor is necessary for progression of experimental autoimmune encephalomyelitis.
Autoimmune Diseases
Functional MIF promoter haplotypes modulate Th17-related cytokine expression in peripheral blood mononuclear cells from control subjects and rheumatoid arthritis patients.
Autoimmune Diseases
Inhibition of experimental autoimmune uveoretinitis with anti-macrophage migration inhibitory factor antibodies.
Autoimmune Diseases
Inhibition of Macrophage Migration Inhibitory Factor by a Chimera of Two Allosteric Binders.
Autoimmune Diseases
Kinetic-based high-throughput screening assay to discover novel classes of macrophage migration inhibitory factor inhibitors.
Autoimmune Diseases
Macrophage migration inhibitory factor (MIF) as a therapeutic target for rheumatoid arthritis and systemic lupus erythematosus.
Autoimmune Diseases
Macrophage Migration Inhibitory Factor (MIF) Gene Promotor Polymorphism Is Associated with Increased Fibrosis in Biliary Atresia Patients, but Not with Disease Susceptibility.
Autoimmune Diseases
Macrophage migration inhibitory factor (MIF) in chinese amphioxus as a molecular marker of immune evolution during the transition of invertebrate/vertebrate.
Autoimmune Diseases
Macrophage migration inhibitory factor (MIF) promoter polymorphisms (-794 CATT5-8 and -173 G>C): association with MIF and TNF? in psoriatic arthritis.
Autoimmune Diseases
Macrophage migration inhibitory factor (MIF) seems crucially involved in Guillain-Barré syndrome and experimental allergic neuritis.
Autoimmune Diseases
Macrophage migration inhibitory factor (MIF): mechanisms of action and role in disease.
Autoimmune Diseases
Macrophage migration inhibitory factor and its role in autoimmune diseases.
Autoimmune Diseases
Macrophage Migration Inhibitory Factor in Alopecia Areata and Vitiligo: A Case-Controlled Serological Study.
Autoimmune Diseases
Macrophage migration inhibitory factor in mild cognitive impairment and Alzheimer's disease.
Autoimmune Diseases
Macrophage Migration Inhibitory Factor is not Associated with Sarcoidosis Susceptibility or Severity in Whites or Blacks.
Autoimmune Diseases
Macrophage migration inhibitory factor may contribute to vasculopathy in systemic sclerosis.
Autoimmune Diseases
Macrophage migration inhibitory factor promotes the migration of dendritic cells through CD74 and the activation of the Src/PI3K/myosin II pathway.
Autoimmune Diseases
MIF and insulin: Lifetime companions from common genesis to common pathogenesis.
Autoimmune Diseases
MIF functional polymorphisms (-794 CATT5-8 and -173 G>C) are associated with MIF serum levels, severity and progression in male multiple sclerosis from western Mexican population.
Autoimmune Diseases
Prognostic Implication of MIF Gene Expression in Childhood Acute Lymphoblastic Leukemia.
Autoimmune Diseases
Quantitation of macrophage migration inhibitory factor (MIF) using the one-step sandwich enzyme immunosorbent assay: elevated serum MIF concentrations in patients with autoimmune diseases and identification of MIF in erythrocytes.
Autoimmune Diseases
Regulation of IL-1 and TNF Receptor Expression and Function by Endogenous Macrophage Migration Inhibitory Factor.
Autoimmune Diseases
Ribosomal protein S19 interacts with macrophage migration inhibitory factor and attenuates its pro-inflammatory function.
Autoimmune Diseases
Serum macrophage migration inhibitory factor levels in Hashimoto's thyroiditis; a case control study.
Autoimmune Diseases
Structural and kinetic analyses of macrophage migration inhibitory factor active site interactions.
Autoimmune Diseases
Structure-activity relationships for binding of 4-substituted triazole-phenols to macrophage migration inhibitory factor (MIF).
Autoimmune Diseases
The N-terminus of MIF regulates the dynamic profile of residues involved in CD74 activation.
Bacteremia
Functional polymorphisms in the gene encoding macrophage migration inhibitory factor are associated with Gram-negative bacteremia in older adults.
Bacterial Infections
Macrophage migration inhibitory factor and innate immune responses to bacterial infections.
Bacterial Infections
Macrophage migration inhibitory factor reduces the growth of virulent Mycobacterium tuberculosis in human macrophages.
Bacterial Infections
The Effect of Macrophage Migration Inhibitory Factor on Intestinal Permeability: FITC-Dextran Serum Measurement and Transmission Electron Microscopy.
Benign Paroxysmal Positional Vertigo
Elevated serum macrophage migration inhibitory factor levels correlate with benign paroxysmal positional vertigo and recurrence events.
Biliary Atresia
Elevated Serum Macrophage Migration Inhibitory Factor Levels in Post-operative Biliary Atresia.
Biliary Atresia
Macrophage Migration Inhibitory Factor (MIF) Gene Promotor Polymorphism Is Associated with Increased Fibrosis in Biliary Atresia Patients, but Not with Disease Susceptibility.
Biliary Atresia
Positive association of macrophage migration inhibitory factor gene-173G/C polymorphism with biliary atresia.
Blister
UVB-induced inflammation gives increased d-dopachrome tautomerase activity in blister fluid which correlates with macrophage migration inhibitory factor.
Bone Resorption
Elevated Expression of Macrophage Migration Inhibitory Factor Promotes Inflammatory Bone Resorption Induced in a Mouse Model of Periradicular Periodontitis.
Borna Disease
Borna disease virus-induced accumulation of macrophage migration inhibitory factor in rat brain astrocytes is associated with inhibition of macrophage infiltration.
Borna Disease
Viral immune surveillance: Toward a TH17/TH9 gate to the central nervous system.
Brain Edema
[Study on the expression and the role of macrophage migration inhibitory factor in the brain of neonatal rats with hypoxia-ischemia brain damage].
Brain Injuries
Utility of serum macrophage migration inhibitory factor as a potential biomarker for detection of cerebrocardiac syndrome following severe traumatic brain injury.
Brain Injuries, Traumatic
Serum macrophage migration inhibitory factor concentrations correlate with prognosis of traumatic brain injury.
Brain Injuries, Traumatic
Utility of serum macrophage migration inhibitory factor as a potential biomarker for detection of cerebrocardiac syndrome following severe traumatic brain injury.
Brain Ischemia
Macrophage migration inhibitory factor promotes cell death and aggravates neurologic deficits after experimental stroke.
Brain Ischemia
The Association Between Serum Macrophage Migration Inhibitory Factor and Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage.
Brain Neoplasms
MIF-CD74 signaling impedes microglial M1 polarization and facilitates brain tumorigenesis.
Breast Neoplasms
A novel androstenedione derivative induces ROS-mediated autophagy and attenuates drug resistance in osteosarcoma by inhibiting macrophage migration inhibitory factor (MIF).
Breast Neoplasms
An HLA-presented fragment of macrophage migration inhibitory factor is a therapeutic target for invasive breast cancer.
Breast Neoplasms
Association of the genetic variants (-794 CATT5-8 and -173 G > C) of macrophage migration inhibitory factor (MIF) with higher soluble levels of MIF and TNF? in women with breast cancer.
Breast Neoplasms
Autophagy inhibition in breast cancer cells induces ROS-mediated MIF expression and M1 macrophage polarization.
Breast Neoplasms
Autophagy Inhibition Induces the Secretion of Macrophage Migration Inhibitory Factor (MIF) with Autocrine and Paracrine Effects on the Promotion of Malignancy in Breast Cancer.
Breast Neoplasms
Cell surface syndecan-1 contributes to binding and function of macrophage migration inhibitory factor (MIF) on epithelial tumor cells.
Breast Neoplasms
Detection of human leukocyte antigen biomarkers in breast cancer utilizing label-free biosensor technology.
Breast Neoplasms
Dual role of macrophage migration inhibitory factor (MIF) in human breast cancer.
Breast Neoplasms
Expression of macrophage migration inhibitory factor in human breast cancer: association with nodal spread.
Breast Neoplasms
Inhibiting the HSP90 chaperone destabilizes macrophage migration inhibitory factor and thereby inhibits breast tumor progression.
Breast Neoplasms
Involvement of macrophage migration inhibitory factor and its receptor (CD74) in human breast cancer.
Breast Neoplasms
Macrophage migration inhibitory factor involvement in breast cancer (Review).
Breast Neoplasms
Macrophage migration inhibitory factor promotes breast cancer metastasis via activation of HMGB1/TLR4/NF kappa B axis.
Breast Neoplasms
Macrophage migration inhibitory factor regulating the expression of VEGF-C through MAPK signal pathways in breast cancer MCF-7 cell.
Breast Neoplasms
miR-451a Inhibited Cell Proliferation and Enhanced Tamoxifen Sensitive in Breast Cancer via Macrophage Migration Inhibitory Factor.
Breast Neoplasms
Modulating mammary tumor growth, metastasis and immunosuppression by siRNA-induced MIF reduction in tumor microenvironment.
Breast Neoplasms
Overexpression of macrophage migration inhibitory factor induces angiogenesis in human breast cancer.
Breast Neoplasms
Small interfering RNAs induce macrophage migration inhibitory factor production and proliferation in breast cancer cells via a double-stranded RNA-dependent protein kinase-dependent mechanism.
Breast Neoplasms
Steroid receptor coactivator 3 regulates autophagy in breast cancer cells through macrophage migration inhibitory factor.
Breast Neoplasms
[The relationship between expression of macrophage migration inhibitory factor and prognosis of breast cancer]
Bronchiolitis
Blockage of the macrophage migration inhibitory factor expression by short interference RNA inhibited the rejection of an allogeneic tracheal graft.
Bronchopulmonary Dysplasia
A Polymorphism in the Macrophage Migration Inhibitory Factor Promoter is Associated With Bronchopulmonary Dysplasia.
Bronchopulmonary Dysplasia
Correction to: Inhibition of microRNA-451 is associated with increased expression of Macrophage Migration Inhibitory Factor and mitigation of the cardio-pulmonary phenotype in a murine model of Bronchopulmonary Dysplasia.
Bronchopulmonary Dysplasia
Inhibition of microRNA-451 is associated with increased expression of Macrophage Migration Inhibitory Factor and mitgation of the cardio-pulmonary phenotype in a murine model of Bronchopulmonary Dysplasia.
Bronchopulmonary Dysplasia
Small molecular modulation of macrophage migration inhibitory factor in the hyperoxia-induced mouse model of bronchopulmonary dysplasia.
Brucellosis
The IL4-VNTR P1 allele, IL4-VNTR P2P2 genotype and IL4-VNTR_IL6-174CG P2P1-GG genotype are susceptable with a increased risk in Brucelosis.
Caliciviridae Infections
Low serum levels of CCL5 are associated with longer duration of viral shedding in norovirus infection.
Carcinogenesis
(S,R)3-(4-Hydroxyphenyl)-4,5-Dihydro-5-Isoxazole Acetic Acid Methyl Ester Inhibits Epithelial-to-Mesenchymal Transition through TGF-?/Smad4 Axis in Nasopharyngeal Carcinoma.
Carcinogenesis
An antibody for macrophage migration inhibitory factor suppresses tumour growth and inhibits tumour-associated angiogenesis.
Carcinogenesis
Antral atrophy, intestinal metaplasia, and preneoplastic markers in Mexican children with Helicobacter pylori-positive and Helicobacter pylori-negative gastritis.
Carcinogenesis
Clinical significance of macrophage migration inhibitory factor in invasion of ovarian cancer.
Carcinogenesis
Clinicopathological Significance of Macrophage Migration Inhibitory Factor and its Relation with P53 in Gastric Cancer.
Carcinogenesis
Correlation between macrophage migration inhibitory factor and autophagy in Helicobacter pylori-associated gastric carcinogenesis.
Carcinogenesis
Deletion of macrophage migration inhibitory factor inhibits murine oral carcinogenesis: Potential role for chronic pro-inflammatory immune mediators.
Carcinogenesis
Direct interaction between NM23-H1 and macrophage migration inhibitory factor (MIF) is critical for alleviation of MIF-mediated suppression of p53 activity.
Carcinogenesis
Dysregulated D-dopachrome tautomerase, a hypoxia-inducible factor-dependent gene, cooperates with macrophage migration inhibitory factor in renal tumorigenesis.
Carcinogenesis
Elevated expression of macrophage migration inhibitory factor correlates with tumor recurrence and poor prognosis of patients with gliomas.
Carcinogenesis
Functional promoter polymorphisms of the macrophage migration inhibitory factor gene in gastric carcinogenesis.
Carcinogenesis
Helicobacter pylori CagA-dependent macrophage migration inhibitory factor produced by gastric epithelial cells binds to CD74 and stimulates procarcinogenic events.
Carcinogenesis
Histone deacetylase inhibitors repress macrophage migration inhibitory factor (MIF) expression by targeting MIF gene transcription through a local chromatin deacetylation.
Carcinogenesis
Increased epithelial and serum expression of macrophage migration inhibitory factor (MIF) in gastric cancer: potential role of MIF in gastric carcinogenesis.
Carcinogenesis
Induction of macrophage migration inhibitory factor by lysophosphatidic acid: relevance to tumor growth and angiogenesis.
Carcinogenesis
Involvement of macrophage migration inhibitory factor and its receptor (CD74) in human breast cancer.
Carcinogenesis
Macrophage immigration inhibitory factor promotes cell proliferation and inhibits apoptosis of cervical adenocarcinoma.
Carcinogenesis
Macrophage migration inhibitory factor (MIF) interacts with Bim and inhibits Bim-mediated apoptosis.
Carcinogenesis
Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity.
Carcinogenesis
Macrophage migration inhibitory factor anti-thrombin III complexes are decreased in bladder cancer patient serum: Complex formation as a mechanism of inactivation.
Carcinogenesis
Macrophage migration inhibitory factor directly interacts with hepatopoietin and regulates the proliferation of hepatoma cell.
Carcinogenesis
Macrophage migration inhibitory factor in the pathogenesis of leukemia (Review).
Carcinogenesis
Macrophage migration inhibitory factor induces autophagy via reactive oxygen species generation.
Carcinogenesis
Macrophage migration inhibitory factor interacts with thioredoxin-interacting protein and induces NF-?B activity.
Carcinogenesis
Macrophage migration inhibitory factor involvement in breast cancer (Review).
Carcinogenesis
Macrophage migration inhibitory factor promotes breast cancer metastasis via activation of HMGB1/TLR4/NF kappa B axis.
Carcinogenesis
Macrophage migration inhibitory factor promotes tumor aggressiveness of esophageal squamous cell carcinoma via activation of Akt and inactivation of GSK3?.
Carcinogenesis
Macrophage migration inhibitory factor promotes tumor invasion and metastasis via the Rho-dependent pathway.
Carcinogenesis
MIF family proteins in genitourinary cancer: tumorigenic roles and therapeutic potential.
Carcinogenesis
Phase I study of imalumab (BAX69), a fully human recombinant antioxidized macrophage migration inhibitory factor antibody in advanced solid tumours.
Carcinogenesis
Phylogeny and evolution of plant macrophage migration inhibitory factor/D-dopachrome tautomerase-like proteins.
Carcinogenesis
Possible pathogenetic relationship between Fabry disease and renal cell carcinoma.
Carcinogenesis
Regeneration of cervical reserve cell-like cells from human induced pluripotent stem cells (iPSCs): A new approach to finding targets for cervical cancer stem cell treatment.
Carcinogenesis
Regulation of constitutive and microbial pathogen-induced human macrophage migration inhibitory factor (MIF) gene expression.
Carcinogenesis
Regulation of IL-1 and TNF Receptor Expression and Function by Endogenous Macrophage Migration Inhibitory Factor.
Carcinogenesis
Role of Macrophage Migration Inhibitory Factor in the Regulatory T Cell Response of Tumor-Bearing Mice.
Carcinogenesis
Targeting MIF in Cancer: Therapeutic Strategies, Current Developments, and Future Opportunities.
Carcinogenesis
The Role of Macrophage Migration Inhibitory Factor (MIF) in Ultraviolet Radiation-Induced Carcinogenesis.
Carcinogenesis
Transient transfection of macrophage migration inhibitory factor small interfering RNA disrupts the biological behavior of oral squamous carcinoma cells.
Carcinoma
Clinical utility of serum amyloid A and macrophage migration inhibitory factor as serum biomarkers for the detection of nonsmall cell lung carcinoma.
Carcinoma
Cooperative regulation of non-small cell lung carcinoma angiogenic potential by macrophage migration inhibitory factor and its homolog, D-dopachrome tautomerase.
Carcinoma
Erratum: Role of macrophage migration inhibitory factor in mesenchymal epithelial transition of cervical carcinoma cells.
Carcinoma
Expression of Macrophage Migration Inhibitory Factor and CD74 in Cervical Squamous Cell Carcinoma.
Carcinoma
Expression of macrophage migration inhibitory factor in esophageal squamous cell carcinoma and effects of bile acids and NSAIDs.
Carcinoma
Expression of macrophage migration inhibitory factor is associated with enhanced angiogenesis and advanced stage in gastric carcinomas.
Carcinoma
HIF-?/MIF and NF-?B/IL-6 Axes Contribute to the Recruitment of CD11b+Gr-1+ Myeloid Cells in Hypoxic Microenvironment of HNSCC.
Carcinoma
In vitro cellular responses to autologous tumor extract detected by inhibition of macrophage migration.
Carcinoma
Increased expression of macrophage migration inhibitory factor during progression to hypopharyngeal squamous cell carcinoma.
Carcinoma
Involvement of HPV Infection in the Release of Macrophage Migration Inhibitory Factor in Head and Neck Squamous Cell Carcinoma.
Carcinoma
Macrophage migration inhibitory factor evaluation compared with prostate specific antigen as a biomarker in patients with prostate carcinoma.
Carcinoma
Macrophage migration inhibitory factor in head and neck squamous cell carcinoma: clinical and experimental studies.
Carcinoma
Macrophage migration inhibitory factor is a novel prognostic marker for human oral squamous cell carcinoma.
Carcinoma
Macrophage migration inhibitory factor promotes the invasion and metastasis of oral squamous cell carcinoma through matrix metalloprotein-2/9.
Carcinoma
Macrophage migration inhibitory factor promotes tumor aggressiveness of esophageal squamous cell carcinoma via activation of Akt and inactivation of GSK3?.
Carcinoma
Macrophage migration inhibitory factor stimulates angiogenic factor expression and correlates with differentiation and lymph node status in patients with esophageal squamous cell carcinoma.
Carcinoma
Macrophage migration inhibitory factor: a potential driver and biomarker for head and neck squamous cell carcinoma.
Carcinoma
Macrophage migration inhibitory factor: A promising oncogenic serological biomarker for oral squamous cell carcinoma.
Carcinoma
Overexpression of macrophage migration inhibitory factor in adenoid cystic carcinoma: correlation with enhanced metastatic potential.
Carcinoma
Pharmacological inhibition of macrophage migration inhibitory factor interferes with the proliferation and invasiveness of squamous carcinoma cells.
Carcinoma
Prognostic role of macrophage migration inhibitory factor expression in patients with squamous cell carcinoma of the lung.
Carcinoma
Prognostic role of macrophage migration inhibitory factor in patients with clear cell renal cell carcinoma.
Carcinoma
Prognostic significance of cytoplasmic macrophage migration inhibitory factor expression in patients with squamous cell carcinoma of the head and neck treated with concurrent chemoradiotherapy.
Carcinoma
Role of macrophage migration inhibitory factor in mesenchymal epithelial transition of cervical carcinoma cells [Retraction].
Carcinoma
Role of macrophage migration inhibitory factor in mesenchymal epithelial transition of cervical carcinoma cells.
Carcinoma
Serum and salivary macrophage migration inhibitory factor in patients with oral squamous cell carcinoma.
Carcinoma
The redox state of the lung cancer microenvironment depends on the levels of thioredoxin expressed by tumor cells and affects tumor progression and response to prooxidants.
Carcinoma
Tumor-derived macrophage migration inhibitory factor promotes an autocrine loop that enhances renal cell carcinoma.
Carcinoma
[Expression and significance of macrophage migration inhibitory factor in bladder urothelial cell carcinoma].
Carcinoma
[Expression of macrophage migration inhibition factor in pancreatic carcinoma tissue.]
Carcinoma
[Expression of macrophage migration inhibitory factor, p53 and CD34 in ovarian carcinoma]
Carcinoma, Adenoid Cystic
Overexpression of macrophage migration inhibitory factor in adenoid cystic carcinoma: correlation with enhanced metastatic potential.
Carcinoma, Hepatocellular
Evaluation of macrophage migration inhibitory factor as an imaging marker for hepatocellular carcinoma in murine models.
Carcinoma, Hepatocellular
Evaluation of prothrombin induced by vitamin K absence, macrophage migration inhibitory factor and Golgi protein-73 versus alpha fetoprotein for hepatocellular carcinoma diagnosis and surveillance.
Carcinoma, Hepatocellular
Macrophage migration inhibitory factor directly interacts with hepatopoietin and regulates the proliferation of hepatoma cell.
Carcinoma, Hepatocellular
Macrophage migration inhibitory factor exerts pro-proliferative and anti-apoptotic effects via CD74 in murine hepatocellular carcinoma.
Carcinoma, Hepatocellular
Macrophage migration inhibitory factor has a permissive role in concanavalin A-induced cell death of human hepatoma cells through autophagy.
Carcinoma, Hepatocellular
Macrophage migration inhibitory factor in hepatocellular carcinoma and liver cirrhosis; relevance to pathogenesis.
Carcinoma, Hepatocellular
Macrophage migration inhibitory factor plays a pivotal role in hepatocellular carcinoma and may be a noninvasive imaging target.
Carcinoma, Hepatocellular
Macrophage migration inhibitory factor: roles in regulating tumor cell migration and expression of angiogenic factors in hepatocellular carcinoma.
Carcinoma, Hepatocellular
MicroRNA-608 acts as a prognostic marker and inhibits the cell proliferation in hepatocellular carcinoma by macrophage migration inhibitory factor.
Carcinoma, Hepatocellular
MIF promoter polymorphism increases peripheral blood expression levels, contributing to increased susceptibility and poor prognosis in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Overexpression of macrophage migration inhibitory factor induces angiogenesis and deteriorates prognosis after radical resection for hepatocellular carcinoma.
Carcinoma, Hepatocellular
Significance of the vascular endothelial growth factor and the macrophage migration inhibitory factor in the progression of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Small interfering RNA (siRNA)-mediated knockdown of macrophage migration inhibitory factor (MIF) suppressed cyclin D1 expression and hepatocellular carcinoma cell proliferation.
Carcinoma, Hepatocellular
Validity of plasma macrophage migration inhibitory factor for diagnosis and prognosis of hepatocellular carcinoma.
Carcinoma, Hepatocellular
[Overexpression of miR-451a inhibits cell proliferation by targeted macrophage migration inhibitory factor in HepG2 cells].
Carcinoma, Hepatocellular
[Serum levels of macrophage migration inhibitory factor and interleukin-8 in hepatocellular carcinoma patients: their correlations with tumor progression and prognosis]
Carcinoma, Non-Small-Cell Lung
Cooperative regulation of non-small cell lung carcinoma angiogenic potential by macrophage migration inhibitory factor and its homolog, D-dopachrome tautomerase.
Carcinoma, Non-Small-Cell Lung
Expression of CD74, the receptor for macrophage migration inhibitory factor, in non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
Intratumoral expression of macrophage migration inhibitory factor is correlated with serum C-reactive protein and interleukin-6 in patients with non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
Macrophage migration inhibitory factor and CXC chemokine expression in non-small cell lung cancer: role in angiogenesis and prognosis.
Carcinoma, Non-Small-Cell Lung
Protein expression profiling identifies macrophage migration inhibitory factor and cyclophilin a as potential molecular targets in non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
Quantification of macrophage migration inhibitory factor mRNA expression in non-small cell lung cancer tissues and its clinical significance.
Carcinoma, Non-Small-Cell Lung
The expression of macrophage migration inhibitory factor in the non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
Translating biomarkers into clinical practice: prognostic implications of cyclophilin A and macrophage migratory inhibitory factor identified from protein expression profiles in non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
[Expression and significance of MIF and CD147 in non-small cell lung cancer]
Carcinoma, Renal Cell
Prognostic role of macrophage migration inhibitory factor in patients with clear cell renal cell carcinoma.
Carcinoma, Renal Cell
Tumor-derived macrophage migration inhibitory factor promotes an autocrine loop that enhances renal cell carcinoma.
Carcinoma, Squamous Cell
Expression of Macrophage Migration Inhibitory Factor and CD74 in Cervical Squamous Cell Carcinoma.
Carcinoma, Squamous Cell
HIF-?/MIF and NF-?B/IL-6 Axes Contribute to the Recruitment of CD11b+Gr-1+ Myeloid Cells in Hypoxic Microenvironment of HNSCC.
Carcinoma, Squamous Cell
Involvement of HPV Infection in the Release of Macrophage Migration Inhibitory Factor in Head and Neck Squamous Cell Carcinoma.
Carcinoma, Squamous Cell
Macrophage migration inhibitory factor in head and neck squamous cell carcinoma: clinical and experimental studies.
Carcinoma, Squamous Cell
Macrophage migration inhibitory factor: a potential driver and biomarker for head and neck squamous cell carcinoma.
Carcinoma, Squamous Cell
MIF Antagonist (CPSI-1306) Protects against UVB-Induced Squamous Cell Carcinoma.
Carcinoma, Squamous Cell
Pharmacological inhibition of macrophage migration inhibitory factor interferes with the proliferation and invasiveness of squamous carcinoma cells.
Carcinoma, Squamous Cell
Prognostic role of macrophage migration inhibitory factor expression in patients with squamous cell carcinoma of the lung.
Carcinoma, Squamous Cell
Prognostic significance of cytoplasmic macrophage migration inhibitory factor expression in patients with squamous cell carcinoma of the head and neck treated with concurrent chemoradiotherapy.
Carcinoma, Squamous Cell
Transient transfection of macrophage migration inhibitory factor small interfering RNA disrupts the biological behavior of oral squamous carcinoma cells.
Carcinoma, Squamous Cell
[Corrigendum] Transient transfection of macrophage migration inhibitory factor small interfering RNA disrupts the biological behavior of oral squamous carcinoma cells.
Cardiomegaly
Macrophage migration inhibitory factor antagonizes pressure overload-induced cardiac hypertrophy.
Cardiomegaly
Macrophage migration inhibitory factor deletion exacerbates pressure overload-induced cardiac hypertrophy through mitigating autophagy.
Cardiomyopathies
Elevated serum levels of macrophage migration inhibitory factor are associated with progressive chronic cardiomyopathy in patients with chagas disease.
Cardiomyopathies
Expressions of macrophage migration inhibitory factor in patients with chronic kidney disease.
Cardiomyopathies
Macrophage migration inhibitory factor deficiency augments doxorubicin-induced cardiomyopathy.
Cardiomyopathies
Mannose Binding Lectin and Macrophage Migration Inhibitory Factor Gene Polymorphisms in Turkish Children with Cardiomyopathy: No Association with MBL2 Codon 54 A/B Genotype, but an Association between MIF -173 CC Genotype.
Cardiovascular Diseases
Correlation between Plasma Macrophage Migration Inhibitory Factor Levels and Long-Term Prognosis in Patients with Acute Myocardial Infarction Complicated with Diabetes.
Cardiovascular Diseases
Design, Synthesis, and Biological Activity of New N-(Phenylmethyl)-benzoxazol-2-thiones as Macrophage Migration Inhibitory Factor (MIF) Antagonists: Efficacies in Experimental Pulmonary Hypertension.
Cardiovascular Diseases
Elevated levels of macrophage migration inhibitory factor in women with metabolic syndrome.
Cardiovascular Diseases
Elevated plasma macrophage migration inhibitor factor as a risk factor for the development of post-stroke depression in ischemic stroke.
Cardiovascular Diseases
Functional variants in the promoter region of macrophage migration inhibitory factor rs755622 gene (MIF G173C) among patients with heart failure: Association with echocardiographic indices and disease severity.
Cardiovascular Diseases
Functional variants of the macrophage migration inhibitory factor do not infer risk of cardiovascular disease in rheumatoid arthritis.
Cardiovascular Diseases
LPS-mediated cell surface expression of CD74 promotes the proliferation of B cells in response to MIF.
Cardiovascular Diseases
Macrophage migration inhibitory factor (MIF) and risk for coronary heart disease: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002.
Cardiovascular Diseases
Macrophage migration inhibitory factor inhibits neutrophil apoptosis by inducing cytokine release from mononuclear cells.
Cardiovascular Diseases
Macrophage migration inhibitory factor knockout attenuates endotoxin induced cardiac dysfunction in mice.
Cardiovascular Diseases
Macrophage migration inhibitory factor serves a pivotal role in the regulation of radiation-induced cardiac senescencethrough rebalancing the microRNA-34a/sirtuin 1 signaling pathway.
Cardiovascular Diseases
Macrophage migration inhibitory factor: a potential biomarker for cardiovascular disease in persons with HIV?
Cardiovascular Diseases
MIF family cytokines in cardiovascular diseases and prospects for precision-based therapeutics.
Cataract
Lens epithelial cell mRNA. III. Elevated expression of macrophage migration inhibitory factor mRNA in galactose cataracts.
Celiac Disease
Involvement of macrophage migration inhibitory factor gene in celiac disease susceptibility.
Central Nervous System Infections
Macrophage migration inhibitory factor in cerebrospinal fluid from patients with central nervous system infection.
Cerebral Hemorrhage
Macrophage migration inhibitory factor levels in serum from patients with acute intracerebral hemorrhage: Potential contribution to prognosis.
Cerebral Infarction
Baicalein attenuates caspase-independent cells death via inhibiting PARP-1 activation and AIF nuclear translocation in cerebral ischemia/reperfusion rats.
Chagas Disease
Association of the macrophage migration inhibitory factor -173G/C polymorphism with Chagas disease.
Chagas Disease
Elevated serum levels of macrophage migration inhibitory factor are associated with progressive chronic cardiomyopathy in patients with chagas disease.
Chagas Disease
Macrophage migration inhibitory factor contributes to host defense against acute Trypanosoma cruzi infection.
Chemical and Drug Induced Liver Injury
Macrophage migration inhibitory factor in drug-induced liver injury: a role in susceptibility and stress responsiveness.
Cholesteatoma
Characterization of patterns of expression of protein kinase C-alpha, -delta, -eta, -gamma and -zeta and their correlations to p53, galectin-3, the retinoic acid receptor-beta and the macrophage migration inhibitory factor (MIF) in human cholesteatomas.
Cholesteatoma
Detection of macrophage migration inhibitory factor (MIF) in human cholesteatomas and functional implications of correlations to recurrence status and to expression of matrix metalloproteinases-3/9, retinoic acid receptor-beta, and anti-apoptotic galectin-3.
Chondrosarcoma
Macrophage migration inhibitory factor increases cell motility and up-regulates ?v?3 integrin in human chondrosarcoma cells.
Chorioamnionitis
Systemic fetal inflammation and reduced concentrations of macrophage migration inhibitory factor in tracheobronchial aspirate fluid of extremely premature infants.
Choriocarcinoma
Macrophage migration inhibitory factor is differentially expressed in normal and choriocarcinoma trophoblast cells.
Chronic Periodontitis
Association of macrophage migration inhibitory factor gene polymorphisms with chronic periodontitis in a South Eastern Iranian population.
Chronic Periodontitis
Macrophage Migration Inhibitory Factor Levels in Gingival Crevicular Fluid, Saliva, and Serum of Chronic Periodontitis Patients.
Clostridium Infections
Neutralization of macrophage migration inhibitory factor improves host survival after Clostridium difficile infection.
Coinfection
KSHV co-infection regulates HPV16+ cervical cancer cells pathogenesis in vitro and in vivo.
Colitis
A low dose of fermented soy germ alleviates gut barrier injury, hyperalgesia and faecal protease activity in a rat model of inflammatory bowel disease.
Colitis
Amelioration of intestinal colitis by macrophage migration inhibitory factor isolated from intestinal parasites through Toll-like receptor 2.
Colitis
Association of the -173 G/C polymorphism of the macrophage migration inhibitory factor gene with ulcerative colitis.
Colitis
CD74 Signaling Links Inflammation to Intestinal Epithelial Cell Regeneration and Promotes Mucosal Healing.
Colitis
Contribution of the -173 G/C polymorphism of macrophage migration inhibitory factor gene to the risk of inflammatory bowel diseases.
Colitis
DNA vaccination targeting macrophage migration inhibitory factor prevents murine experimental colitis.
Colitis
Lack of macrophage migration inhibitory factor suppresses innate immune response in murine dextran sulfate sodium-induced colitis.
Colitis
Macrophage migration inhibitory factor contributes to the development of acute dextran sulphate sodium-induced colitis in Toll-like receptor 4 knockout mice.
Colitis
Macrophage migration inhibitory factor has a proinflammatory activity via the p38 pathway in glucocorticoid-resistant ulcerative colitis.
Colitis
Phylogeny and evolution of plant macrophage migration inhibitory factor/D-dopachrome tautomerase-like proteins.
Colitis
Resistance to experimental colitis depends on cytoprotective heat shock proteins in macrophage migration inhibitory factor null mice.
Colitis
Sex steroid regulation of macrophage migration inhibitory factor in normal and inflamed colon in the female rat.
Colitis
The macrophage migration inhibitory factor homolog of Entamoeba histolytica binds to and immunomodulates host macrophages.
Colitis
Transgenic over-expression of macrophage migration inhibitory factor renders mice markedly more susceptible to experimental colitis.
Colitis
Wuchereria bancrofti macrophage migration inhibitory factor-2 (rWbaMIF-2) ameliorates experimental colitis.
Colitis
[The role of macrophage migration inhibitory factor (MIF) for dextran sulfate sodium-induced colitis in mice]
Colitis, Ulcerative
Association between functional promoter polymorphisms of macrophage migration inhibitory factor (MIF) gene and ulcerative colitis in Japan.
Colitis, Ulcerative
Association of the -173 G/C polymorphism of the macrophage migration inhibitory factor gene with ulcerative colitis.
Colitis, Ulcerative
Baicalin Down-regulates the Expression of Macrophage Migration Inhibitory Factor (MIF) Effectively for Rats with Ulcerative Colitis.
Colitis, Ulcerative
Changes in the plasma level of macrophage migration inhibitory factor in ulcerative colitis patients treated with selective granulocyte and monocyte apheresis.
Colitis, Ulcerative
Macrophage migration inhibitory factor activates antigen-presenting dendritic cells and induces inflammatory cytokines in ulcerative colitis.
Colitis, Ulcerative
Macrophage migration inhibitory factor and activator protein-1 in ulcerative colitis.
Colitis, Ulcerative
Macrophage migration inhibitory factor has a proinflammatory activity via the p38 pathway in glucocorticoid-resistant ulcerative colitis.
Colitis, Ulcerative
Macrophage migration inhibitory factor in the sera and at the colonic mucosa in patients with ulcerative colitis: clinical implications and pathogenic significance.
Colitis, Ulcerative
Macrophage migration inhibitory factor polymorphism and the risk of ulcerative colitis and Crohn's disease in Asian and European populations: a meta-analysis.
Colitis, Ulcerative
Macrophage migration inhibitory factor, Toll-like receptor 4, and CD14 polymorphisms with altered expression levels in patients with ulcerative colitis.
Colitis, Ulcerative
Neutrophil dysfunction in steroid-overdosed patients with ulcerative colitis: potential relevance of macrophage migration inhibitory factor to increased postoperative morbidity.
Colitis, Ulcerative
New insights into the interplay between autophagy, gut microbiota and inflammatory responses in IBD.
Colitis, Ulcerative
[Interaction of MIF gene -173G/C polymorphism and GPX1 gene 594C/T polymorphism with high-fat diet in ulcerative colitis].
Colitis-Associated Neoplasms
Macrophage Migration Inhibitory Factor Promotes the Interaction between the Tumor, Macrophages, and T Cells to Regulate the Progression of Chemically Induced Colitis-Associated Colorectal Cancer.
Colonic Neoplasms
ALA-mediated photodynamic effect on apoptosis induction, and secretion of macrophage migration inhibitory factor (MIF) and of monocyte chemotactic protein (MCP-1), by colon cancer cells in normoxia and in hypoxia-like conditions in vitro.
Colonic Neoplasms
Chronic macrophage migration inhibitory factor exposure induces mesenchymal epithelial transition and promotes gastric and colon cancers.
Colonic Neoplasms
Development and application of a method for identification of isothiocyanate-targeted molecules in colon cancer cells.
Colonic Neoplasms
Evaluating macrophage migration inhibitory factor 1 expression as a prognostic biomarker in colon cancer.
Colonic Neoplasms
Macrophage migration inhibitory factor is a determinant of hypoxia-induced apoptosis in colon cancer cell lines.
Colonic Neoplasms
Macrophage migration inhibitory factor may be used as an early diagnostic marker in colorectal carcinomas.
Colonic Neoplasms
Macrophage migration inhibitory factor: a key cytokine and therapeutic target in colon cancer.
Colonic Neoplasms
The tumour suppressor effects and regulation of cancer stem cells by macrophage migration inhibitory factor targeted miR-451 in colon cancer.
Colorectal Neoplasms
Macrophage Migration Inhibitory Factor Is a Molecular Determinant of the Anti-EGFR Monoclonal Antibody Cetuximab Resistance in Human Colorectal Cancer Cells.
Colorectal Neoplasms
Macrophage migration inhibitory factor may be used as an early diagnostic marker in colorectal carcinomas.
Colorectal Neoplasms
Macrophage migration inhibitory factor promotes resistance to MEK blockade in KRAS mutant colorectal cancer cells.
Colorectal Neoplasms
Macrophage migration inhibitory factor siRNA inhibits hepatic metastases of colorectal cancer cells.
Colorectal Neoplasms
Prognostic values of galectin-3 and the macrophage migration inhibitory factor (MIF) in human colorectal cancers.
Colorectal Neoplasms
[MiR-451 regulates proliferation and migration of colorectal cells by targeting MIF].
Communicable Diseases
Elevated levels of macrophage migration inhibitory factor (MIF) in the plasma of HIV-1-infected patients and in HIV-1-infected cell cultures: a relevant role on viral replication.
Communicable Diseases
Identification and Structure-Activity Relationships of Dietary Flavonoids as Human Macrophage Migration Inhibitory Factor (MIF) Inhibitors.
Communicable Diseases
Transcription factor ICBP90 regulates the MIF promoter and immune susceptibility locus.
Conjunctivitis, Allergic
Correction: Role of macrophage migration inhibitory factor (MIF) in pollen-induced allergic conjunctivitis and pollen dermatitis in mice.
Conjunctivitis, Allergic
Role of Macrophage Migration Inhibitory Factor (MIF) in Pollen-Induced Allergic Conjunctivitis and Pollen Dermatitis in Mice.
Contracture
Macrophage migration inhibitory factor activates the inflammatory response in joint capsule fibroblasts following post-traumatic joint contracture.
Corneal Injuries
Expression of macrophage migration inhibitory factor in corneal wound healing in rats.
Corneal Neovascularization
Role of macrophage migration inhibitory factor in corneal neovascularization.
Coronary Artery Disease
Association between MIF gene promoter rs755622 and susceptibility to coronary artery disease and inflammatory cytokines in the Chinese Han population.
Coronary Artery Disease
Exhaustion is associated with low macrophage migration inhibitory factor expression in patients with coronary artery disease.
Coronary Artery Disease
Gremlin-1 C-Terminus Regulates Function of Macrophage Migration Inhibitory Factor (MIF).
Coronary Artery Disease
High plasma levels of macrophage migration inhibitory factor are associated with adverse long-term outcome in patients with stable coronary artery disease and impaired glucose tolerance or type 2 diabetes mellitus.
Coronary Artery Disease
Impact of counterbalance between macrophage migration inhibitory factor and its inhibitor Gremlin-1 in patients with coronary artery disease.
Coronary Artery Disease
Increased circulating macrophage migration inhibitory factor levels are associated with coronary artery disease.
Coronary Artery Disease
Increased expression of macrophage migration inhibitory factor in aorta of patients with coronary atherosclerosis.
Coronary Artery Disease
Macrophage migration inhibitory factor and the risk of myocardial infarction or death due to coronary artery disease in adults without prior myocardial infarction or stroke: the EPIC-Norfolk Prospective Population study.
Coronary Artery Disease
MIF Gene Polymorphism rs755622 Is Associated With Coronary Artery Disease and Severity of Coronary Lesions in a Chinese Kazakh Population: A Case-Control Study.
Coronary Artery Disease
Serum macrophage migration inhibitory factor levels are associated with angiographically complex coronary lesions in patients with coronary artery disease.
Coronary Disease
Macrophage migration inhibitory factor (MIF) and risk for coronary heart disease: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002.
Coronary Disease
Macrophage migration inhibitory factor polymorphism is associated with susceptibility to inflammatory coronary heart disease.
Coronary Disease
[Association between plasma macrophage migration inhibitory factor concentration and coronary artery lesion severity.]
Coronary Disease
[Association of the polymorphism of macrophage migration inhibitory factor gene with coronary heart disease in Chinese population]
Coronary Occlusion
Macrophage migration inhibitory factor (MIF) is associated with degree of collateralization in patients with totally occluded coronary arteries.
COVID-19
Does Macrophage Migration Inhibitory Factor predict the prognosis of COVID-19 disease?
COVID-19
Evaluation of the relationship between macrophage migration inhibitory factor level and clinical course in patients with COVID-19 pneumonia.
COVID-19
Macrophage Migration Inhibitory Factor (MIF) Plasma Concentration in Critically Ill COVID-19 Patients: A Prospective Observational Study.
Crohn Disease
A polymorphism in the macrophage migration inhibitory factor gene is involved in the genetic predisposition of Crohn's disease and associated with cumulative steroid doses.
Crohn Disease
Circulating monocytes and plasma inflammatory biomarkers in active Crohn's disease: elevated oxidized low-density lipoprotein and the anti-inflammatory effect of atorvastatin.
Crohn Disease
Macrophage migration inhibitory factor (MIF) -173G/C promoter polymorphism influences upper gastrointestinal tract involvement and disease activity in patients with Crohn's disease.
Crohn Disease
Macrophage migration inhibitory factor polymorphism and the risk of ulcerative colitis and Crohn's disease in Asian and European populations: a meta-analysis.
Crohn Disease
New insights into the interplay between autophagy, gut microbiota and inflammatory responses in IBD.
Cystic Fibrosis
Aerosolized drug-loaded nanoparticles targeting migration inhibitory factors inhibit Pseudomonas aeruginosa-induced inflammation and biofilm formation.
Cystic Fibrosis
Cystic fibrosis, disease severity, and a macrophage migration inhibitory factor polymorphism.
Cystic Fibrosis
Impact of MIF Gene Promoter Polymorphism on F508del Cystic Fibrosis Patients.
Cystic Fibrosis
Macrophage migration inhibitory factor enhances Pseudomonas aeruginosa biofilm formation potentially contributing to cystic fibrosis pathogenesis.
Cystic Fibrosis
Macrophage migration inhibitory factor enzymatic activity, lung inflammation, and cystic fibrosis.
Cystitis
Alterations of Macrophage Migration Inhibitory Factor Expression in the Nervous System of the Rat Cystitis Model.
Cystitis
Antagonism of macrophage migration inhibitory factor decreases cyclophosphamide cystitis in mice.
Cystitis
Cyclophosphamide-induced cystitis increases bladder CXCR4 expression and CXCR4-macrophage migration inhibitory factor association.
Cystitis
Hydrochloric acid induced changes in macrophage migration inhibitory factor in the bladder, peripheral and central nervous system of the rat.
Cystitis
Upregulation of macrophage migration inhibitory factor (MIF) and CD74, receptor for MIF, in rat bladder during persistent cyclophosphamide-induced inflammation.
Cysts
Macrophage migration inhibitory factor is regulated by HIF-1? and cAMP and promotes renal cyst cell proliferation in a macrophage-independent manner.
Cysts
Macrophage migration inhibitory factor promotes cyst growth in polycystic kidney disease.
Cysts
Polycystic kidney disease: Macrophage migration inhibitory factor regulates cyst growth in ADPKD.
Dementia
Macrophage Migration Inhibitory Factor is Associated with Biomarkers of Alzheimer's Disease Pathology and Predicts Cognitive Decline in Mild Cognitive Impairment and Mild Dementia.
Dengue
Contribution of macrophage migration inhibitory factor to the pathogenesis of dengue virus infection.
Dengue
CORRELATION OF SERUM LEVELS OF MACROPHAGE MIGRATION INHIBITORY FACTOR WITH DISEASE SEVERITY AND CLINICAL OUTCOME IN DENGUE PATIENTS.
Dengue
Dengue virus enhances thrombomodulin and ICAM-1 expression through the macrophage migration inhibitory factor induction of the MAPK and PI3K signaling pathways.
Dengue
Dengue Virus Nonstructural Protein 1 Induces Vascular Leakage through Macrophage Migration Inhibitory Factor and Autophagy.
Dengue
Macrophage migration inhibitory factor induced by dengue virus infection increases vascular permeability.
Dengue
Macrophage migration inhibitory factor is critical for dengue NS1-induced endothelial glycocalyx degradation and hyperpermeability.
Dengue
Minocycline suppresses dengue virus replication by down-regulation of macrophage migration inhibitory factor-induced autophagy.
Dengue
Pathogenic roles of macrophage migration inhibitory factor during dengue virus infection.
Dengue
Roles of Macrophage Migration Inhibitory Factor in Dengue Pathogenesis: From Pathogenic Factor to Therapeutic Target.
Dermatitis
Berberine induces anti-atopic dermatitis effects through the downregulation of cutaneous EIF3F and MALT1 in NC/Nga mice with atopy-like dermatitis.
Dermatitis
Correction: Role of macrophage migration inhibitory factor (MIF) in pollen-induced allergic conjunctivitis and pollen dermatitis in mice.
Dermatitis
Macrophage Migration Inhibitory Factor (MIF) Drives Murine Psoriasiform Dermatitis.
Dermatitis
Role of Macrophage Migration Inhibitory Factor (MIF) in Pollen-Induced Allergic Conjunctivitis and Pollen Dermatitis in Mice.
Dermatitis, Atopic
Association of Macrophage Migration Inhibitory Factor Polymorphisms with Total Plasma IgE Levels in Patients with Atopic Dermatitis in Korea.
Dermatitis, Atopic
DNA vaccination against macrophage migration inhibitory factor improves atopic dermatitis in murine models.
Dermatitis, Atopic
Increase in macrophage migration inhibitory factor levels in lacrimal fluid of patients with severe atopic dermatitis.
Dermatitis, Atopic
Increased production of macrophage migration inhibitory factor by PBMCs of atopic dermatitis.
Dermatitis, Atopic
Macrophage migration inhibitory factor (MIF) in the stratum corneum: a marker of the local severity of atopic dermatitis.
Dermatitis, Atopic
Macrophage migration inhibitory factor is an essential immunoregulatory cytokine in atopic dermatitis.
Dermatitis, Atopic
Macrophage migration inhibitory factor promoter 173G/C polymorphism is associated with atopic dermatitis risk.
Dermatitis, Atopic
Measurement of serum macrophage migration inhibitory factor (MIF) and correlation with severity and pruritus scores in client owned dogs with atopic dermatitis.
Dermatitis, Contact
Impaired contact hypersensitivity in macrophage migration inhibitory factor-deficient mice.
Dermatitis, Contact
Macrophage migration inhibitory factor in zinc-allergic systemic contact dermatitis.
Diabetes Mellitus
Attenuation of atherosclerotic lesions in diabetic apolipoprotein E-deficient mice using gene silencing of macrophage migration inhibitory factor.
Diabetes Mellitus
Fenofibrate attenuates fatty acid-induced islet ?-cell dysfunction and apoptosis via inhibiting the NF-?B/MIF dependent inflammatory pathway.
Diabetes Mellitus
High Plasma Levels of Gremlin-1 and Macrophage Migration Inhibitory Factor, but Not Their Ratio, Indicate an Increased Risk for Acute Coronary Syndrome in Patients With Type 2 Diabetes Mellitus.
Diabetes Mellitus
High plasma levels of macrophage migration inhibitory factor are associated with adverse long-term outcome in patients with stable coronary artery disease and impaired glucose tolerance or type 2 diabetes mellitus.
Diabetes Mellitus
Macrophage migration inhibitory factor (MIF) is necessary for progression of autoimmune diabetes mellitus.
Diabetes Mellitus
Macrophage Migration Inhibitory Factor and Malondialdehyde as Potential Predictors of Vascular Risk Complications in Type 2 Diabetes Mellitus: Cross-Sectional Case Control Study in Saudi Arabia.
Diabetes Mellitus
Macrophage migration inhibitory factor may contribute to hypertrophy of lumbar ligamentum flavum in type 2 diabetes mellitus.
Diabetes Mellitus
Polymorphisms of the macrophage migration inhibitory factor gene in a UK population with Type 1 diabetes mellitus.
Diabetes Mellitus
Proinflammatory cytokine MIF plays a role in the pathogenesis of type-2 diabetes mellitus, but does not affect hepatic mitochondrial function.
Diabetes Mellitus, Type 1
Critical role of macrophage migration inhibitory factor activity in experimental autoimmune diabetes.
Diabetes Mellitus, Type 1
Macrophage migration inhibitory factor (MIF) is necessary for progression of autoimmune diabetes mellitus.
Diabetes Mellitus, Type 1
Monocyte chemoattractant protein 1 and macrophage migration inhibitory factor in children with type 1 diabetes.
Diabetes Mellitus, Type 1
Polymorphisms of the macrophage migration inhibitory factor gene in a UK population with Type 1 diabetes mellitus.
Diabetes Mellitus, Type 2
Association of systemic concentrations of macrophage migration inhibitory factor with impaired glucose tolerance and type 2 diabetes: results from the Cooperative Health Research in the Region of Augsburg, Survey 4 (KORA S4).
Diabetes Mellitus, Type 2
Effect of macrophage migration inhibitory factor (MIF) gene variants and MIF serum concentrations on the risk of type 2 diabetes: results from the MONICA/KORA Augsburg Case-Cohort Study, 1984-2002.
Diabetes Mellitus, Type 2
Elevated serum content of macrophage migration inhibitory factor in patients with type 2 diabetes.
Diabetes Mellitus, Type 2
High Plasma Levels of Gremlin-1 and Macrophage Migration Inhibitory Factor, but Not Their Ratio, Indicate an Increased Risk for Acute Coronary Syndrome in Patients With Type 2 Diabetes Mellitus.
Diabetes Mellitus, Type 2
High plasma levels of macrophage migration inhibitory factor are associated with adverse long-term outcome in patients with stable coronary artery disease and impaired glucose tolerance or type 2 diabetes mellitus.
Diabetes Mellitus, Type 2
Macrophage migration inhibitory factor (MIF) enhances palmitic acid- and glucose-induced murine beta cell dysfunction and destruction in vitro.
Diabetes Mellitus, Type 2
Macrophage Migration Inhibitory Factor and Malondialdehyde as Potential Predictors of Vascular Risk Complications in Type 2 Diabetes Mellitus: Cross-Sectional Case Control Study in Saudi Arabia.
Diabetes Mellitus, Type 2
Macrophage migration inhibitory factor is a therapeutic target in treatment of non-insulin-dependent diabetes mellitus.
Diabetes Mellitus, Type 2
Macrophage migration inhibitory factor may contribute to hypertrophy of lumbar ligamentum flavum in type 2 diabetes mellitus.
Diabetes Mellitus, Type 2
Proinflammatory cytokine MIF plays a role in the pathogenesis of type-2 diabetes mellitus, but does not affect hepatic mitochondrial function.
Diabetes Mellitus, Type 2
Role of Macrophage Migration Inhibitory Factor in Obesity, Insulin Resistance, Type 2 Diabetes, and Associated Hepatic Co-Morbidities: A Comprehensive Review of Human and Rodent Studies.
Diabetes Mellitus, Type 2
Serum Matrix Metalloproteinase 9 and Macrophage Migration Inhibitory Factor (MIF) Are Increased in Young Healthy Nonobese Subjects with Positive Family History of Type 2 Diabetes.
Diabetes, Gestational
Association between macrophage migration inhibitory factor rs1007888 and GDM.
Diabetes, Gestational
Association of Macrophage Migration Inhibitory Factor Polymorphisms with Gestational Diabetes Mellitus in Han Chinese Women.
Diabetes, Gestational
Genetic variation in macrophage migration inhibitory factor associated with gestational diabetes mellitus and metabolic syndrome.
Diabetes, Gestational
[Association between single nucleotide polymorphism of macrophage migration inhibitory factor-rs1007888 and the pathogenesis of gestational diabetes mellitus].
Diabetes, Gestational
[Expression of macrophage migration inhibitory factor gene in placenta tissue and its correlation with gestational diabetes mellitus].
Diabetic Cardiomyopathies
Hyperglycemic myocardial damage is mediated by proinflammatory cytokine: macrophage migration inhibitory factor.
Diabetic Cardiomyopathies
Macrophage migration inhibitory factor promotes expression of GLUT4 glucose transporter through MEF2 and Zac1 in cardiomyocytes.
Diabetic Nephropathies
Inhibition of Macrophage Migration Inhibitory Factor Reduces Diabetic Nephropathy in Type II Diabetes Mice.
Diabetic Nephropathies
Macrophage migration inhibitory factor antagonist (p425) ameliorates kidney histopathological and functional changes in diabetic rats.
Diabetic Nephropathies
TWEAK increases CD74 expression and sensitizes to DDT proinflammatory actions in tubular cells.
Diabetic Neuropathies
Expression of macrophage migration inhibitory factor in footpad skin lesions with diabetic neuropathy.
Diabetic Retinopathy
Absence of macrophage migration inhibitory factor reduces proliferative retinopathy in a mouse model.
Diabetic Retinopathy
Aqueous levels of macrophage migration inhibitory factor and monocyte chemotactic protein-1 in patients with diabetic retinopathy.
Diabetic Retinopathy
Macrophage migration inhibitory factor levels in the vitreous of patients with proliferative diabetic retinopathy.
Diabetic Retinopathy
The Proinflammatory and Proangiogenic Macrophage Migration Inhibitory Factor Is a Potential Regulator in Proliferative Diabetic Retinopathy.
Diffuse Axonal Injury
Inhibition of Macrophage Migration Inhibitory Factor Protects against Inflammation through a Toll-like Receptor-Related Pathway after Diffuse Axonal Injury in Rats.
Disseminated Intravascular Coagulation
High macrophage migration inhibitory factor levels in disseminated intravascular coagulation patients with systemic inflammation.
Distemper
Contribution of astrocytes and macrophage migration inhibitory factor to immune-mediated canine encephalitis caused by the distemper virus.
Distemper
Distemper virus infection in ferrets: an animal model of measles-induced immunosuppression.
Down Syndrome
Macrophage migration inhibitory factor and chemokine RANTES in young pediatric patients with congenital cardiac communications: Relation to hemodynamic parameters and the presence of Down syndrome.
Dysentery, Amebic
Entamoeba histolytica-Encoded Homolog of Macrophage Migration Inhibitory Factor Contributes to Mucosal Inflammation during Amebic Colitis.
Encephalitis
Association between high expression macrophage migration inhibitory factor (MIF) alleles and West Nile virus encephalitis.
Encephalitis
Borna disease virus-induced accumulation of macrophage migration inhibitory factor in rat brain astrocytes is associated with inhibition of macrophage infiltration.
Encephalitis
Contribution of astrocytes and macrophage migration inhibitory factor to immune-mediated canine encephalitis caused by the distemper virus.
Encephalitis
Viral immune surveillance: Toward a TH17/TH9 gate to the central nervous system.
Encephalitis, Japanese
Japanese encephalitis virus up-regulates expression of macrophage migration inhibitory factor (MIF) mRNA in the mouse brain.
Encephalitis, Tick-Borne
The increased concentration of macrophage migration inhibitory factor in serum and cerebrospinal fluid of patients with tick-borne encephalitis.
Encephalomyelitis
Cutting edge: macrophage migration inhibitory factor is necessary for progression of experimental autoimmune encephalomyelitis.
Encephalomyelitis
In vivo blockade of macrophage migration inhibitory factor ameliorates acute experimental autoimmune encephalomyelitis by impairing the homing of encephalitogenic T cells to the central nervous system.
Encephalomyelitis, Autoimmune, Experimental
Cutting edge: macrophage migration inhibitory factor is necessary for progression of experimental autoimmune encephalomyelitis.
Encephalomyelitis, Autoimmune, Experimental
In vivo blockade of macrophage migration inhibitory factor ameliorates acute experimental autoimmune encephalomyelitis by impairing the homing of encephalitogenic T cells to the central nervous system.
Endometrial Neoplasms
Chemokines mRNA expression in relation to the Macrophage Migration Inhibitory Factor (MIF) mRNA and Vascular Endothelial Growth Factor (VEGF) mRNA expression in the microenvironment of endometrial cancer tissue and normal endometrium: A pilot study.
Endometrial Neoplasms
Correlations of leukemia inhibitory factor and macrophage migration inhibitory factor with endometrial carcinoma.
Endometriosis
A novel gene-wide haplotype at the macrophage migration inhibitory factor (MIF) locus is associated with endometrioma.
Endometriosis
Association between macrophage migration inhibitory factor in the endometrium and estrogen in endometriosis.
Endometriosis
Elevated levels of macrophage migration inhibitory factor in the peripheral blood of women with endometriosis.
Endometriosis
Elevations in peritoneal fluid macrophage migration inhibitory factor are independent of the depth of invasion or stage of endometriosis.
Endometriosis
Expression of macrophage migration inhibitory factor in human endometriosis: relation to disease stage, menstrual cycle and infertility.
Endometriosis
Expression of MMIF, HIF-1? and VEGF in Serum and Endometrial Tissues of Patients with Endometriosis.
Endometriosis
Hepatocyte nuclear factor (HNF)-1? and its physiological importance in endometriosis.
Endometriosis
Interleukin-1 stimulates macrophage migration inhibitory factor secretion in ectopic endometrial cells of women with endometriosis.
Endometriosis
Macrophage migration inhibitory factor antagonist blocks the development of endometriosis in vivo.
Endometriosis
Macrophage migration inhibitory factor as a potential biomarker of endometriosis.
Endometriosis
Macrophage migration inhibitory factor expression in the intrauterine endometrium of women with endometriosis varies with disease stage, infertility status, and pelvic pain.
Endometriosis
Macrophage migration inhibitory factor is involved in a positive feedback loop increasing aromatase expression in endometriosis.
Endometriosis
Macrophage migration inhibitory factor is involved in ectopic endometrial tissue growth and peritoneal-endometrial tissue interaction in vivo: a plausible link to endometriosis development.
Endometriosis
Marked elevation of macrophage migration inhibitory factor in the peritoneal fluid of women with endometriosis.
Endometriosis
Panel of markers can accurately predict endometriosis in a subset of patients.
Endometriosis
Recent advances in the understanding of endometriosis: the role of inflammatory mediators in disease pathogenesis and treatment.
Endometriosis
Spontaneous and stimulated secretion of monocyte chemotactic protein-1 and macrophage migration inhibitory factor by peritoneal macrophages in women with and without endometriosis.
Endometriosis
Stimulation of macrophage migration inhibitory factor expression in endometrial stromal cells by interleukin 1, beta involving the nuclear transcription factor NFkappaB.
Endometriosis
The Relationship between Functional Promoter Variants of Macrophage Migration Inhibitory Factor and Endometriosis.
Endometriosis
Up-regulation of cyclooxygenase-2 expression and prostaglandin E2 production in human endometriotic cells by macrophage migration inhibitory factor: involvement of novel kinase signaling pathways.
Endotoxemia
Differential regulation of macrophage activation by the MIF cytokine superfamily members MIF and MIF-2 in adipose tissue during endotoxemia.
Endotoxemia
Human circulating eosinophils secrete macrophage migration inhibitory factor (MIF). Potential role in asthma.
Endotoxemia
Macrophage migration inhibitory factor (MIF) in meningococcal septic shock and experimental human endotoxemia.
Endotoxemia
Macrophage migration inhibitory factor in acute lung injury: expression, biomarker, and associations.
Endotoxemia
Role of macrophage migration inhibitory factor in acute lung injury in mice with acute pancreatitis complicated by endotoxemia.
Endotoxemia
The pathogenic role of macrophage migration inhibitory factor in immunologically induced kidney disease in the rat.
Endotoxemia
TNF-alpha up-regulates renal MIF expression in rat crescentic glomerulonephritis.
Enterocolitis
Increased levels of macrophage migration inhibitory factor in sera of patients with Escherichia coli O157:H7-induced enterocolitis.
Enterocolitis, Necrotizing
The macrophage migration inhibitory factor -173G/C polymorphism is not significantly associated with necrotizing enterocolitis in preterm infants.
Enterocolitis, Necrotizing
Up-regulation of macrophage migration inhibitory factor in infants with acute neonatal necrotizing enterocolitis.
Eosinophilia
Macrophage migration inhibitory factor is critical to interleukin-5-driven eosinophilopoiesis and tissue eosinophilia triggered by Schistosoma mansoni infection.
Eosinophilic Esophagitis
Macrophage migration inhibitory factor promotes eosinophil accumulation and tissue remodeling in eosinophilic esophagitis.
Epilepsy
Profile of MIF in Developing Hippocampus: Association With Cell Proliferation and Neurite Outgrowth.
Epstein-Barr Virus Infections
Combination of Plasma MIF and VCA-IgA Improves the Diagnostic Specificity for Patients With Nasopharyngeal Carcinoma.
Erythema Nodosum
Macrophage migration inhibitory factor (MIF) -173 polymorphism is associated with clinical erythema nodosum in Löfgren's syndrome.
Erythema Nodosum
Macrophage migration inhibitory factor gene polymorphism is associated with sarcoidosis in biopsy proven erythema nodosum.
Erythema Nodosum
Serum macrophage migration inhibitory factor levels in leprosy patients with erythema nodosum leprosum.
Esophageal Squamous Cell Carcinoma
Expression of macrophage migration inhibitory factor in esophageal squamous cell carcinoma and effects of bile acids and NSAIDs.
Esophageal Squamous Cell Carcinoma
Macrophage migration inhibitory factor promotes tumor aggressiveness of esophageal squamous cell carcinoma via activation of Akt and inactivation of GSK3?.
Esophageal Squamous Cell Carcinoma
Macrophage migration inhibitory factor stimulates angiogenic factor expression and correlates with differentiation and lymph node status in patients with esophageal squamous cell carcinoma.
Esophagitis, Peptic
Leptin Aggravates Reflux Esophagitis by Increasing Tissue Levels of Macrophage Migration Inhibitory Factor in Rats.
Eye Infections
Homotrimeric Macrophage Migration Inhibitory Factor (MIF) Drives Inflammatory Responses in the Corneal Epithelium by Promoting Caveolin-rich Platform Assembly in Response to Infection.
Familial Mediterranean Fever
Increased levels of macrophage migration inhibitory factor in patients with familial mediterranean Fever.
Familial Primary Pulmonary Hypertension
The small molecule macrophage migration inhibitory factor antagonist MIF098, inhibits pulmonary hypertension associated with murine SLE.
Fatty Liver
Involvement of exercise-induced macrophage migration inhibitory factor in the prevention of fatty liver disease.
Fatty Liver
Macrophage migration inhibitory factor contributes to ethanol-induced liver injury by mediating cell injury, steatohepatitis, and steatosis.
Fatty Liver
Unexpected Pro-Fibrotic Effect of MIF in Non-Alcoholic Steatohepatitis Is Linked to a Shift in NKT Cell Populations.
Febrile Neutropenia
Comparative levels of macrophage migration inhibitory factor, procalcitonin, osteoprotegerin, interleukin-8, hs-C reactive protein, d-dimer in febrile neutropenia, newly diagnosed cancer patients, and infectious fever.
Fetal Growth Retardation
Macrophage migration inhibitory factor in fetoplacental tissues from preeclamptic pregnancies with or without fetal growth restriction.
Gallbladder Neoplasms
Macrophage migration inhibitory factor - a therapeutic target in gallbladder cancer.
Gastritis
Antral atrophy, intestinal metaplasia, and preneoplastic markers in Mexican children with Helicobacter pylori-positive and Helicobacter pylori-negative gastritis.
Gastritis
Essential role for macrophage migration inhibitory factor in gastritis induced by Helicobacter pylori.
Gastritis
Functional polymorphisms in the promoter region of macrophage migration inhibitory factor and chronic gastritis.
Gastritis, Atrophic
Inflammatory cytokine gene polymorphisms increase the risk of atrophic gastritis and intestinal metaplasia.
Gastrointestinal Neoplasms
Chronic macrophage migration inhibitory factor exposure induces mesenchymal epithelial transition and promotes gastric and colon cancers.
Gastrointestinal Neoplasms
Macrophage migration inhibitory factor in hepatocellular carcinoma and liver cirrhosis; relevance to pathogenesis.
Gastrointestinal Neoplasms
microRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells.
Giant Cell Arteritis
Lack of association between macrophage migration inhibitory factor gene polymorphism and giant cell arteritis.
Gingivitis
Monocyte chemotactic protein-1, RANTES and macrophage migration inhibitory factor levels in gingival crevicular fluid of metabolic syndrome patients with gingivitis.
Gingivitis
Salivary and Serum Markers Related to Innate Immunity in Generalized Aggressive Periodontitis.
Glioblastoma
Cancer Stem Cell-Secreted Macrophage Migration Inhibitory Factor Stimulates Myeloid Derived Suppressor Cell Function and Facilitates Glioblastoma Immune Evasion.
Glioblastoma
Glioblastoma Myeloid-Derived Suppressor Cell Subsets Express Differential Macrophage Migration Inhibitory Factor Receptor Profiles That Can Be Targeted to Reduce Immune Suppression.
Glioblastoma
Ibudilast sensitizes glioblastoma to temozolomide by targeting Macrophage Migration Inhibitory Factor (MIF).
Glioblastoma
Macrophage migration inhibitory factor (MIF) expression in human glioblastomas correlates with vascular endothelial growth factor (VEGF) expression.
Glioblastoma
Macrophage migration inhibitory factor (MIF) inhibitor 4-IPP downregulates stemness phenotype and mesenchymal trans-differentiation after irradiation in glioblastoma multiforme.
Glioblastoma
Macrophage migration inhibitory factor enhances autophagy by regulating ROCK1 activity and contributes to the escape of dendritic cell surveillance in glioblastoma.
Glioblastoma
Macrophage migration inhibitory factor promotes vasculogenic mimicry formation induced by hypoxia via CXCR4/AKT/EMT pathway in human glioblastoma cells.
Glioblastoma
Overexpression of macrophage migration inhibitory factor and functionally-related genes, D-DT, CD74, CD44, CXCR2 and CXCR4, in glioblastoma.
Glioblastoma
Pathogenic role for macrophage migration inhibitory factor in glioblastoma and its targeting with specific inhibitors as novel tailored therapeutic approach.
Glioblastoma
Role of macrophage migration inhibitory factor in primary glioblastoma multiforme cells.
Glioblastoma
Up-regulation of macrophage migration inhibitory factor gene and protein expression in glial tumor cells during hypoxic and hypoglycemic stress indicates a critical role for angiogenesis in glioblastoma multiforme.
Glioma
Elevated expression of macrophage migration inhibitory factor correlates with tumor recurrence and poor prognosis of patients with gliomas.
Glioma
Exosome-mediated transfer of MIF confers temozolomide resistance by regulating TIMP3/PI3K/AKT axis in gliomas.
Glioma
Macrophage migration inhibitory factor (MIF) expression in human malignant gliomas contributes to immune escape and tumour progression.
Glioma
Macrophage migration inhibitory factor (MIF) inhibitor 4-IPP downregulates stemness phenotype and mesenchymal trans-differentiation after irradiation in glioblastoma multiforme.
Glioma
miR-608 inhibits the migration and invasion of glioma stem cells by targeting macrophage migration inhibitory factor.
Glioma
The dexamethasone-induced inhibition of proliferation, migration and invasion in glioma cell lines is antagonized by macrophage migration inhibitory factor (MIF) and can be enhanced by specific MIF inhibitors.
Glioma
[Promoting migration and apoptosis of glioma cells by macrophage migration inhibitory factor].
Glomerulonephritis
A small-molecule macrophage migration inhibitory factor antagonist protects against glomerulonephritis in lupus-prone NZB/NZW F1 and MRL/lpr mice.
Glomerulonephritis
Anti-macrophage migration inhibitory factor reduces transforming growth factor-beta 1 expression in experimental IgA nephropathy.
Glomerulonephritis
De Novo renal expression of macrophage migration inhibitory factor during the development of rat crescentic glomerulonephritis.
Glomerulonephritis
Expression of macrophage migration inhibitory factor in human glomerulonephritis.
Glomerulonephritis
Expression of macrophage migration inhibitory factor in patients with myeloperoxidase anti-neutrophil cytoplasmic antibody-associated glomerulonephritis.
Glomerulonephritis
Increased production of macrophage migration inhibitory factor by T cells in patients with IgA nephropathy.
Glomerulonephritis
Inhibition of macrophage migration inhibitory factor (MIF) tautomerase and biological activities by acetaminophen metabolites.
Glomerulonephritis
Macrophage migration inhibitory factor deficiency attenuates macrophage recruitment, glomerulonephritis, and lethality in MRL/lpr mice.
Glomerulonephritis
Macrophage migration inhibitory factor regulates integrin-?1 and cyclin D1 expression via ERK pathway in podocytes.
Glomerulonephritis
Macrophage migration inhibitory factor urinary excretion revisited MIF a potent predictor of the immunosuppressive treatment outcomes in patients with proliferative primary glomerulonephritis.
Glomerulonephritis
Pharmacokinetics, disease-modifying activity, and safety of an experimental therapeutic targeting an immunological isoform of macrophage migration inhibitory factor, in rat glomerulonephritis.
Glomerulonephritis
Reversal of established rat crescentic glomerulonephritis by blockade of macrophage migration inhibitory factor (MIF): potential role of MIF in regulating glucocorticoid production.
Glomerulonephritis
Serum levels of macrophage migration inhibitory factor in various types of glomerulonephritis.
Glomerulonephritis
TNF-alpha up-regulates renal MIF expression in rat crescentic glomerulonephritis.
Glomerulonephritis
Transgene of MIF induces podocyte injury and progressive mesangial sclerosis in the mouse kidney.
Glomerulonephritis
Urine macrophage migration inhibitory factor reflects the severity of renal injury in human glomerulonephritis.
Glomerulonephritis, IGA
Increased production of macrophage migration inhibitory factor by T cells in patients with IgA nephropathy.
Glomerulonephritis, IGA
Polymeric IgA increases the synthesis of macrophage migration inhibitory factor by human mesangial cells in IgA nephropathy.
Glomerulonephritis, IGA
Urinary levels of macrophage migration inhibitory factor in patients with IgA nephropathy.
Glomerulonephritis, Membranous
MALDI-MSI Pilot Study Highlights Glomerular Deposits of Macrophage Migration Inhibitory Factor (MIF) as a Possible Indicator of Response to Therapy in Membranous Nephropathy.
Glucose Intolerance
Association of systemic concentrations of macrophage migration inhibitory factor with impaired glucose tolerance and type 2 diabetes: results from the Cooperative Health Research in the Region of Augsburg, Survey 4 (KORA S4).
Glucose Intolerance
High plasma levels of macrophage migration inhibitory factor are associated with adverse long-term outcome in patients with stable coronary artery disease and impaired glucose tolerance or type 2 diabetes mellitus.
Glucose Intolerance
The role of endogenous glucocorticoids in glucose metabolism and immune status of MIF-deficient mice.
Gout
Macrophage migration inhibitory factor drives neutrophil accumulation by facilitating IL-1? production in a murine model of acute gout.
Gout
Reciprocal interaction between macrophage migration inhibitory factor and interleukin-8 in gout.
Graft vs Host Disease
Effect of macrophage migration inhibitory factor (MIF) on acute graft-versus-host disease in a murine model of allogeneic stem cell transplantation.
Graft vs Host Disease
Serum macrophage migration inhibitory factor (MIF) levels after allogeneic hematopoietic stem cell transplantation.
Granuloma
Increased density of macrophage migration inhibitory factor (MIF) in tuberculosis granuloma.
Granuloma
Involvement of macrophage migration inhibitory factor (MIF) in experimental uric acid nephropathy.
Granulomatosis with Polyangiitis
Role of macrophage migration inhibitory factor in granulomatosis with polyangiitis.
Granulomatosis with Polyangiitis
Serum level of macrophage migration inhibitory factor as a useful parameter of clinical course in patients with Wegener's granulomatosis and relapsing polychondritis.
Graves Disease
Dual effect of a polymorphism in the macrophage migration inhibitory factor gene is associated with new-onset graves disease in a taiwanese chinese population.
Guillain-Barre Syndrome
Macrophage migration inhibitory factor (MIF) seems crucially involved in Guillain-Barré syndrome and experimental allergic neuritis.
Guillain-Barre Syndrome
Macrophage migration inhibitory factor is necessary for the Lipo-oligosaccharide-induced response by modulation of Toll-like receptor 4 in monocytes from GBS patients.
Hamartoma
The -173 G/C polymorphism of the promoter region macrophage migration inhibitory factor gene is not associated with incidence of pulmonary hamartoma.
Head and Neck Neoplasms
Macrophage migration inhibitory factor modulates proliferation, cell cycle, and apoptotic activity in head and neck cancer cell lines.
Head and Neck Neoplasms
Role of macrophage migration inhibitory factor in head and neck cancer and novel therapeutic targets: A systematic review.
Head and Neck Neoplasms
Tumor-derived macrophage migration inhibitory factor modulates the biology of head and neck cancer cells via neutrophil activation.
Hearing Loss
Macrophage Migration Inhibitory Factor Deficiency Causes Prolonged Hearing Loss After Acoustic Overstimulation.
Hearing Loss, Noise-Induced
Macrophage Migration Inhibitory Factor Deficiency Causes Prolonged Hearing Loss After Acoustic Overstimulation.
Hearing Loss, Sensorineural
Association between Macrophage Migration Inhibitory Factor Gene Variation and Response to Glucocorticoid Treatment in Sudden Sensorineural Hearing Loss.
Hearing Loss, Sensorineural
The polymorphisms of the MBL2 and MIF genes associated with Pediatric Cochlear Implant Patients.
Heart Arrest
Blood levels of macrophage migration inhibitory factor after successful resuscitation from cardiac arrest.
Heart Diseases
Expression of macrophage migration inhibitory factor in acute ischemic myocardial injury.
Heart Diseases
Soluble CD74 Reroutes MIF/CXCR4/AKT-Mediated Survival of Cardiac Myofibroblasts to Necroptosis.
Heart Failure
Circulating macrophage migration inhibitory factor (MIF) in patients with heart failure.
Heart Failure
Functional variants in the promoter region of macrophage migration inhibitory factor rs755622 gene (MIF G173C) among patients with heart failure: Association with echocardiographic indices and disease severity.
Heart Failure
Myocardial Expression of Macrophage Migration Inhibitory Factor in Patients with Heart Failure.
Heart Failure
Predictive potential of macrophage migration inhibitory factor (MIF) in patients with heart failure with preserved ejection fraction (HFpEF).
Heart Failure
Prognostic impact of macrophage migration inhibitory factor in patients with non-ischemic heart failure undergoing endomyocardial biopsy.
Heart Failure
T cell and monocyte/macrophage activation markers associate with adverse outcome, but give limited prognostic value in anemic patients with heart failure: results from RED-HF.
Heart Failure
[Relationship between macrophage migration inhibitory factor and cardiac function in patients with congestive heart failure]
Henipavirus Infections
Viral immune surveillance: Toward a TH17/TH9 gate to the central nervous system.
Hepatitis
Serum and ascites levels of macrophage migration inhibitory factor, TNF-alpha and IL-6 in patients with chronic virus hepatitis B and hepatitis cirrhosis.
Hepatitis B
Relationship among MIF, MCP-1, viral loads, and HBs Ag levels in chronic hepatitis B patients.
Hepatitis B
Role of macrophage migration inhibitory factor in hepatitis B virus-specific cytotoxic-T-lymphocyte-induced liver injury.
Hepatitis B
Serum and ascites levels of macrophage migration inhibitory factor, TNF-alpha and IL-6 in patients with chronic virus hepatitis B and hepatitis cirrhosis.
Hepatitis B, Chronic
Gene polymorphisms of macrophage migration inhibitory factor affect susceptibility to chronic hepatitis B virus infection in an Iranian cohort.
Hepatitis B, Chronic
Macrophage migration inhibitory factor expression correlates with inflammatory changes in human chronic hepatitis B infection.
Hepatitis C
Genetic Variants in the Promoter Region of the Macrophage Migration Inhibitory Factor are Associated with the Severity of Hepatitis C Virus-Induced Liver Fibrosis.
Hepatitis C
Viral immune surveillance: Toward a TH17/TH9 gate to the central nervous system.
Hepatitis, Autoimmune
A Macrophage Migration Inhibitory Factor Polymorphism Is Associated with Autoimmune Hepatitis Severity in US and Japanese Patients.
Hepatitis, Autoimmune
Correction: Polymorphism in Macrophage Migration Inhibitory Factor -173GC in Pediatric Patients with Autoimmune Hepatitis.
Hepatitis, Autoimmune
Polymorphism in Macrophage Migration Inhibitory Factor -173GC in Pediatric Patients with Autoimmune Hepatitis.
Hepatitis, Autoimmune
The role of macrophage migration inhibitory factor (MIF) in autoimmune liver disease.
Herpes Zoster
Epididymosomes are involved in the acquisition of new sperm proteins during epididymal transit.
HIV Infections
Low expression Macrophage Migration Inhibitory Factor (MIF) alleles and tuberculosis in HIV infected South Africans.
Hyperalgesia
Spinal macrophage migration inhibitory factor contributes to the pathogenesis of inflammatory hyperalgesia in rats.
Hyperalgesia
Spinal macrophage migration inhibitory factor is a major contributor to rodent neuropathic pain-like hypersensitivity.
Hyperalgesia
Systemic administration of propentofylline, ibudilast, and (+)-naltrexone each reverses mechanical allodynia in a novel rat model of central neuropathic pain.
Hyperglycemia
Current advances in sepsis and septic shock with particular emphasis on the role of insulin.
Hyperglycemia
The role of endogenous glucocorticoids in glucose metabolism and immune status of MIF-deficient mice.
Hyperpigmentation
The regulation of protein kinase casein kinase II by apigenin is involved in the inhibition of ultraviolet B-induced macrophage migration inhibitory factor-mediated hyperpigmentation.
Hypersensitivity
An essential role for macrophage migration inhibitory factor in the tuberculin delayed-type hypersensitivity reaction.
Hypersensitivity
Antigen induced inhibition of autoimmune response to rat male accessory glands: role of thymocytes on the efferent phase of the suppression.
Hypersensitivity
Blockade of macrophage migration inhibitory factor does not prevent acute renal allograft rejection.
Hypersensitivity
Cardiac allograft rejection in the absence of macrophage migration inhibitory factor.
Hypersensitivity
Cell-mediated immunity in ferrets. Delayed dermal hypersensitivity, lymphocyte transformation, and macrophage migration inhibitory factor production.
Hypersensitivity
De Novo renal expression of macrophage migration inhibitory factor during the development of rat crescentic glomerulonephritis.
Hypersensitivity
Elevated levels of serum macrophage migration inhibitory factor in patients with pulmonary tuberculosis.
Hypersensitivity
In vitro cellular responses to autologous tumor extract detected by inhibition of macrophage migration.
Hypersensitivity
In vivo blockade of macrophage migration inhibitory factor prevents skin graft destruction after indirect allorecognition.
Hypersensitivity
Increased production of macrophage migration inhibitory factor by PBMCs of atopic dermatitis.
Hypersensitivity
Involvement of macrophage migration inhibitory factor (MIF) in experimental uric acid nephropathy.
Hypersensitivity
Macrophage migration inhibitory factor is an essential immunoregulatory cytokine in atopic dermatitis.
Hypersensitivity
Macrophage migration inhibitory factor is critical to interleukin-5-driven eosinophilopoiesis and tissue eosinophilia triggered by Schistosoma mansoni infection.
Hypersensitivity
Macrophage migration inhibitory factor mediates peripheral nerve injury-induced hypersensitivity by curbing dopaminergic descending inhibition.
Hypersensitivity
Serum and BAL macrophage migration inhibitory factor levels in HIV infected Tanzanians with pulmonary tuberculosis or other lung diseases.
Hypersensitivity
Spinal macrophage migration inhibitory factor is a major contributor to rodent neuropathic pain-like hypersensitivity.
Hypersensitivity
The immune response to infection with vaccinia virus in mice. II. Appearance of hypersensitivity, production of macrophage migration inhibitory factor and transformation of spleen cells in response to virus antigens.
Hypersensitivity
The pathogenic role of macrophage migration inhibitory factor in immunologically induced kidney disease in the rat.
Hypersensitivity, Delayed
Immune protective mechanisms during pregnancy. I. Cell-mediated immunity against Listeria monocytogenes in pregnant mice.
Hypersensitivity, Delayed
Macrophage migration inhibitory factor (MIF) in guinea pigs and humans with delayed hypersensitivity.
Hypersensitivity, Delayed
Recombinant adenovirus vector bearing antisense macrophage migration inhibitory factor cDNA prevents acute lipopolysaccharide-induced liver failure in mice.
Hypersensitivity, Delayed
Studies on the biosynthesis of macrophage migration inhibitory factor in delayed hypersensitivity. I. Effects of inhibitors of nucleic acid and protein synthesis on the production of macrophage migration inhibitory factor.
Hypertension
Complexity of macrophage migration inhibitory factor (MIF) and other angiogenic biomarkers profiling in pulmonary arterial hypertension.
Hypertension
Design, Synthesis, and Biological Activity of New N-(Phenylmethyl)-benzoxazol-2-thiones as Macrophage Migration Inhibitory Factor (MIF) Antagonists: Efficacies in Experimental Pulmonary Hypertension.
Hypertension
Effect of bariatric surgery-induced weight loss on renal and systemic inflammation and blood pressure: a 12-month prospective study.
Hypertension
Elevated serum levels of macrophage migration inhibitory factor and stem cell growth factor ? in patients with idiopathic and systemic sclerosis associated pulmonary arterial hypertension.
Hypertension
Macrophage migration inhibitory factor (MIF) in the development and progression of pulmonary arterial hypertension.
Hypertension
Macrophage migration inhibitory factor as a novel biomarker of portopulmonary hypertension.
Hypertension, Pulmonary
Design, Synthesis, and Biological Activity of New N-(Phenylmethyl)-benzoxazol-2-thiones as Macrophage Migration Inhibitory Factor (MIF) Antagonists: Efficacies in Experimental Pulmonary Hypertension.
Hypertension, Pulmonary
Effects of IL-1beta, TNF-alpha, and macrophage migration inhibitory factor on prostacyclin synthesis in rat pulmonary artery smooth muscle cells.
Hypertension, Pulmonary
Macrophage migration inhibitory factor and chemokine RANTES in young pediatric patients with congenital cardiac communications: Relation to hemodynamic parameters and the presence of Down syndrome.
Hypertension, Pulmonary
Macrophage migration inhibitory factor mediates hypoxia-induced pulmonary hypertension.
Hypertension, Pulmonary
Multiple roles of macrophage migration inhibitory factor in pulmonary hypertension.
Hypertension, Pulmonary
Relation of Macrophage Migration Inhibitory Factor to Pulmonary Hemodynamics and Vascular Structure and Carbamyl-Phosphate Synthetase I Genetic Variations in Pediatric Patients with Congenital Cardiac Shunts.
Hypertension, Pulmonary
Role of macrophage migration inhibitory factor in the proliferation of smooth muscle cell in pulmonary hypertension.
Hypertension, Pulmonary
The effects of genetic deletion of Macrophage migration inhibitory factor on the chronically hypoxic pulmonary circulation.
Hypertension, Pulmonary
The small molecule macrophage migration inhibitory factor antagonist MIF098, inhibits pulmonary hypertension associated with murine SLE.
Hypertension, Renovascular
Increased Expression of Macrophage Migration Inhibitory Factor in the Nucleus of the Solitary Tract Attenuates Renovascular Hypertension in Rats.
Idiopathic Pulmonary Fibrosis
Analysis of macrophage migration inhibitory factor (MIF) in patients with idiopathic pulmonary fibrosis.
Idiopathic Pulmonary Fibrosis
Macrophage migration inhibitory factor in lung tissue of idiopathic pulmonary fibrosis patients.
Immune System Diseases
Association of tuberculosis and polymorphisms in the promoter region of macrophage migration inhibitory factor (MIF) in a Southwestern China Han population.
Immune System Diseases
Development of a novel method to measure macrophage migration inhibitory factor (MIF) in sera of patients with rheumatoid arthritis by combined electrochemical immunosensor.
Immune System Diseases
Discovery of novel MIF inhibitors that attenuate microglial inflammatory activation by structures-based virtual screening and in vitro bioassays.
Immune System Diseases
Functional polymorphisms in the promoter region of macrophage migration inhibitory factor and chronic gastritis.
Immune System Diseases
Functional promoter polymorphisms of macrophage migration inhibitory factor in peptic ulcer diseases.
Immune System Diseases
Macrophage Migration Inhibitory Factor Mediates Neuroprotective Effects by Regulating Inflammation, Apoptosis and Autophagy in Parkinson's Disease.
Immune System Diseases
Macrophage migration inhibitory factor promotes renal injury induced by ischemic reperfusion.
Immune System Diseases
Phylogeny and evolution of plant macrophage migration inhibitory factor/D-dopachrome tautomerase-like proteins.
Immune System Diseases
Small-molecule inhibitors of macrophage migration inhibitory factor (MIF) as an emerging class of therapeutics for immune disorders.
Infarction, Middle Cerebral Artery
Enriched environment downregulates macrophage migration inhibitory factor and increases parvalbumin in the brain following experimental stroke.
Infarction, Middle Cerebral Artery
Macrophage migration inhibitory factor promotes cell death and aggravates neurologic deficits after experimental stroke.
Infections
A Brugia malayi homolog of macrophage migration inhibitory factor reveals an important link between macrophages and eosinophil recruitment during nematode infection.
Infections
A critical role for the host mediator macrophage migration inhibitory factor in the pathogenesis of malarial anemia.
Infections
Alpha-thrombin stimulates expression of macrophage migration inhibitory factor in skin fibroblasts.
Infections
Azithromycin and spiramycin induce anti-inflammatory response in human trophoblastic (BeWo) cells infected by Toxoplasma gondii but are able to control infection.
Infections
Characterization of Chinese giant salamander iridovirus tissue tropism and inflammatory response after infection.
Infections
Characterization of MIF family proteins: MIF and DDT from rock bream, Oplegnathus fasciatus.
Infections
Chimeric DNA vaccines encoding Eimeria acervulina macrophage migration inhibitory factor (E.MIF) induce partial protection against experimental Eimeria infection.
Infections
Comparative analysis of the interaction of Helicobacter pylori with human dendritic cells, macrophages, and monocytes.
Infections
Contribution of macrophage migration inhibitory factor to the pathogenesis of dengue virus infection.
Infections
CORRELATION OF SERUM LEVELS OF MACROPHAGE MIGRATION INHIBITORY FACTOR WITH DISEASE SEVERITY AND CLINICAL OUTCOME IN DENGUE PATIENTS.
Infections
Detection of macrophage migration inhibitory factor (MIF) in human cholesteatomas and functional implications of correlations to recurrence status and to expression of matrix metalloproteinases-3/9, retinoic acid receptor-beta, and anti-apoptotic galectin-3.
Infections
Differential susceptibility of human trophoblastic (BeWo) and uterine cervical (HeLa) cells to Neospora caninum infection.
Infections
Distemper virus infection in ferrets: an animal model of measles-induced immunosuppression.
Infections
Drug repositioning and pharmacophore identification in the discovery of hookworm MIF inhibitors.
Infections
Elevated levels of macrophage migration inhibitory factor (MIF) in the plasma of HIV-1-infected patients and in HIV-1-infected cell cultures: a relevant role on viral replication.
Infections
Experimental infection of inbred mice with herpes simplex virus type 1. I. Investigation of humoral and cellular immunity and of interferon induction.
Infections
Expression of erythropoietic cytokines in ?-tocopherol transfer protein knockout mice with murine malaria infection.
Infections
Gastric cancer susceptibility in gastric cancer relatives: Attributable risks of Macrophage migration inhibitory factor promoter polymorphism and Helicobacter pylori.
Infections
Gastric epithelial expression of macrophage migration inhibitory factor is not altered by Helicobacter pylori infection in humans.
Infections
Homotrimeric Macrophage Migration Inhibitory Factor (MIF) Drives Inflammatory Responses in the Corneal Epithelium by Promoting Caveolin-rich Platform Assembly in Response to Infection.
Infections
Immunohistochemical detection of macrophage migration inhibitory factor in fetal and adult bovine epididymis: release by the apocrine secretion mode?
Infections
Increased density of macrophage migration inhibitory factor (MIF) in tuberculosis granuloma.
Infections
Increased macrophage migration inhibitory factor (MIF) plasma levels in acute HIV-1 infection.
Infections
Inflammatory cytokine gene polymorphisms increase the risk of atrophic gastritis and intestinal metaplasia.
Infections
Influence of Epstein-Barr virus and human papillomavirus infection on macrophage migration inhibitory factor and macrophage polarization in nasopharyngeal carcinoma.
Infections
Interaction Between Macrophage Migration Inhibitory Factor and CD74 in Human Immunodeficiency Virus Type I Infected Primary Monocyte-Derived Macrophages Triggers the Production of Proinflammatory Mediators and Enhances Infection of Unactivated CD4+ T Cells.
Infections
Macrophage migration inhibitory factor (MIF) and pregnancy may impact the balance of intestinal cytokines and the development of intestinal pathology caused by Toxoplasma gondii infection.
Infections
Macrophage migration inhibitory factor (MIF) is a critical mediator of the innate immune response to Mycobacterium tuberculosis.
Infections
Macrophage migration inhibitory factor -173 G/C polymorphism is associated with an increased risk of pulmonary tuberculosis in Zahedan, Southeast Iran.
Infections
Macrophage migration inhibitory factor and innate immune responses to bacterial infections.
Infections
Macrophage migration inhibitory factor and interleukin-8 produced by gastric epithelial cells during Helicobacter pylori exposure induce expression and activation of the epidermal growth factor receptor.
Infections
Macrophage migration inhibitory factor and placental malaria infection in an area characterized by unstable malaria transmission in central Sudan.
Infections
Macrophage migration inhibitory factor as a redox-sensitive cytokine in cardiac myocytes.
Infections
Macrophage migration inhibitory factor contributes to host defense against acute Trypanosoma cruzi infection.
Infections
Macrophage migration inhibitory factor expression correlates with inflammatory changes in human chronic hepatitis B infection.
Infections
Macrophage migration inhibitory factor gene -173G>C polymorphism and risk of bladder cancer in southeast China: a case-control analysis.
Infections
Macrophage migration inhibitory factor homolog from Plasmodium yoelii modulates monocyte recruitment and activation in spleen during infection.
Infections
Macrophage migration inhibitory factor in cerebrospinal fluid from patients with central nervous system infection.
Infections
Macrophage migration inhibitory factor is critical to interleukin-5-driven eosinophilopoiesis and tissue eosinophilia triggered by Schistosoma mansoni infection.
Infections
Macrophage Migration Inhibitory Factor is Increased in the Urine of Patients With Urinary Tract Infection: Macrophage Migration Inhibitory Factor-Protein Complexes in Human Urine.
Infections
Macrophage migration inhibitory factor levels correlate with an infection in trauma patients.
Infections
Macrophage migration inhibitory factor regulates interleukin-6 production by facilitating nuclear factor-kappa B activation during Vibrio vulnificus infection.
Infections
Macrophage Migration Inhibitory Factor Triggers Inflammatory Responses During Very Virulent Infectious Bursal Disease Virus Infection.
Infections
Macrophage migration inhibitory factor, infection, the brain, and corticosteroids.
Infections
MIF participates in Toxoplasma gondii-induced pathology following oral infection.
Infections
MIF Promotes Classical Activation and Conversion of Inflammatory Ly6C(high) Monocytes into TipDCs during Murine Toxoplasmosis.
Infections
NADPH oxidase 4 is required for the generation of macrophage migration inhibitory factor and host defense against Toxoplasma gondii infection.
Infections
Natural killer cell activity in experimental paracoccidioidomycosis of the Syrian hamster.
Infections
Neutralization of macrophage migration inhibitory factor improves host survival after Clostridium difficile infection.
Infections
Pathogenic roles of macrophage migration inhibitory factor during dengue virus infection.
Infections
Plasma concentration of malaria parasite-derived macrophage migration inhibitory factor in uncomplicated malaria patients correlates with parasitemia and disease severity.
Infections
Reduced levels of transforming growth factor-beta1, interleukin-12 and increased migration inhibitory factor are associated with severe malaria.
Infections
Ribosomal protein S19 interacts with macrophage migration inhibitory factor and attenuates its pro-inflammatory function.
Infections
Structural and functional comparison of MIF ortholog from Plasmodium yoelii with MIF from its rodent host.
Infections
Systemic fetal inflammation and reduced concentrations of macrophage migration inhibitory factor in tracheobronchial aspirate fluid of extremely premature infants.
Infections
The association between MIF-173 G>C polymorphism and prostate cancer in southern Chinese.
Infections
The effect of Helicobacter pylori infection on expression of macrophage migration inhibitory factor by T cells and macrophages in gastric mucosa.
Infections
The effect of snakehead fish extract supplementation to first-line eradication regimen on macrophage migration inhibitory factor (MIF) expression in rats induced by Helicobacter pylori infection.
Infections
The immune response to infection with vaccinia virus in mice. II. Appearance of hypersensitivity, production of macrophage migration inhibitory factor and transformation of spleen cells in response to virus antigens.
Infections
The proinflammatory mediator macrophage migration inhibitory factor induces glucose catabolism in muscle.
Infections
The relevance of the migration inhibitory factor (MIF) for peripheral tissue response in murine sublethal systemic Aspergillus fumigatus infection.
Infections
The role of macrophage migration inhibitory factor in lethal Listeria monocytogenes infection in mice.
Infections
Urinary macrophage migration inhibitory factor in children with urinary tract infection.
Infections
Urinary macrophage migration inhibitory factor serves as a potential biomarker for acute kidney injury in patients with acute pyelonephritis.
Infections
Urine macrophage migration inhibitory factor (MIF) in children with urinary tract infection: a possible predictor of acute pyelonephritis.
Infections
Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infections: a prospective study.
Infections
Usefulness of the IgA and IgG Responses to Macrophage Migration Inhibitory Factor for the Diagnosis of Tuberculosis.
Infections
WITHDRAWN: Macrophage migration inhibitory factor (MIF) and pregnancy may impact the balance of intestinal cytokines and the development of intestinal pathology caused by Toxoplasma gondii infection.
Infertility
Association between macrophage migration inhibitory factor in the endometrium and estrogen in endometriosis.
Infertility
Direct effect of macrophage migration inhibitory factor on sperm function: possible involvement in endometriosis-associated infertility.
Infertility
Expression of macrophage migration inhibitory factor in human endometriosis: relation to disease stage, menstrual cycle and infertility.
Infertility
Macrophage migration inhibitory factor expression in the intrauterine endometrium of women with endometriosis varies with disease stage, infertility status, and pelvic pain.
Inflammatory Bowel Diseases
A low dose of fermented soy germ alleviates gut barrier injury, hyperalgesia and faecal protease activity in a rat model of inflammatory bowel disease.
Inflammatory Bowel Diseases
Amelioration of dextran sulfate sodium-induced colitis by anti-macrophage migration inhibitory factor antibody in mice.
Inflammatory Bowel Diseases
Association of MIF-173 gene polymorphism with inflammatory bowel disease in Chinese Han population.
Inflammatory Bowel Diseases
Association of the macrophage migration inhibitory factor gene polymorphisms with inflammatory bowel disease.
Inflammatory Bowel Diseases
Association of the macrophage migration inhibitory factor gene--173G/C polymorphism with inflammatory bowel disease: a meta-analysis of 4296 subjects.
Inflammatory Bowel Diseases
CD74 Signaling Links Inflammation to Intestinal Epithelial Cell Regeneration and Promotes Mucosal Healing.
Inflammatory Bowel Diseases
Contribution of the -173 G/C polymorphism of macrophage migration inhibitory factor gene to the risk of inflammatory bowel diseases.
Inflammatory Bowel Diseases
Emerging views of mitophagy in immunity and autoimmune diseases.
Inflammatory Bowel Diseases
Inflammatory bowel disease as a disorder of an imbalance between pro- and anti-inflammatory molecules and deficiency of resolution bioactive lipids.
Inflammatory Bowel Diseases
Macrophage migration inhibitory factor (MIF) -173G/C promoter polymorphism influences upper gastrointestinal tract involvement and disease activity in patients with Crohn's disease.
Inflammatory Bowel Diseases
Macrophage migration inhibitory factor gene polymorphisms in inflammatory bowel disease: an association study in New Zealand Caucasians and meta-analysis.
Inflammatory Bowel Diseases
Macrophage migration inhibitory factor polymorphism and the risk of ulcerative colitis and Crohn's disease in Asian and European populations: a meta-analysis.
Inflammatory Bowel Diseases
Meta-analysis of macrophage migration inhibitory factor (MIF) gene -173G/C polymorphism and inflammatory bowel disease (IBD) risk.
Inflammatory Bowel Diseases
MIF as a disease target: ISO-1 as a proof-of-concept therapeutic.
Inflammatory Bowel Diseases
Molecular function of macrophage migration inhibitory factor and a novel therapy for inflammatory bowel disease.
Inflammatory Bowel Diseases
New insights into the interplay between autophagy, gut microbiota and inflammatory responses in IBD.
Inflammatory Bowel Diseases
Overview of the role of macrophage migration inhibitory factor (MIF) in inflammatory bowel disease.
Inflammatory Bowel Diseases
Synthesis and bio-evaluation of human macrophage migration inhibitory factor inhibitor to develop anti-inflammatory agent.
Inflammatory Bowel Diseases
The -173 G/C Polymorphism of the MIF Gene and Inflammatory Bowel Disease Risk: A Meta-Analysis.
Inflammatory Bowel Diseases
The macrophage migration inhibitory factor -173G/C polymorphism is not significantly associated with necrotizing enterocolitis in preterm infants.
Inflammatory Bowel Diseases
Transgenic over-expression of macrophage migration inhibitory factor renders mice markedly more susceptible to experimental colitis.
Influenza, Human
Macrophage migration inhibitory factor enhances influenza-associated mortality in mice.
Influenza, Human
Release of macrophage migration inhibitory factor and CXCL8/interleukin-8 from lung epithelial cells rendered necrotic by influenza A virus infection.
Influenza, Human
Role of macrophage migration inhibitory factor in influenza H5N1 virus pneumonia.
Insulin Resistance
A defect in the activity of Delta6 and Delta5 desaturases may be a factor predisposing to the development of insulin resistance syndrome.
Insulin Resistance
Disturbances of systemic and hippocampal insulin sensitivity in macrophage migration inhibitory factor (MIF) knockout male mice lead to behavioral changes associated with decreased PSA-NCAM levels.
Insulin Resistance
Enhanced angiotensin converting enzyme 2 regulates the insulin/Akt signalling pathway by blockade of macrophage migration inhibitory factor expression.
Insulin Resistance
Enhanced Inflammation without Impairment of Insulin Signaling in the Visceral Adipose Tissue of 5?-Dihydrotestosterone-Induced Animal Model of Polycystic Ovary Syndrome.
Insulin Resistance
Insights into the role of macrophage migration inhibitory factor in obesity and insulin resistance.
Insulin Resistance
Macrophage migration inhibitory factor deficiency ameliorates high-fat diet induced insulin resistance in mice with reduced adipose inflammation and hepatic steatosis.
Insulin Resistance
Macrophage migration inhibitory factor mediates metabolic dysfunction induced by atypical antipsychotic therapy.
Insulin Resistance
Macrophage migration inhibitory factor: critical role in obesity, insulin resistance, and associated comorbidities.
Insulin Resistance
Plasma concentrations of macrophage migration inhibitory factor are elevated in Pima Indians compared to Caucasians and are associated with insulin resistance.
Insulin Resistance
Relationship Between Serum Macrophage Migration Inhibitory Factor Level and Insulin Resistance, High-Sensitivity C-Reactive Protein and Visceral Fat Mass in Prediabetes.
Insulin Resistance
Role of Macrophage Migration Inhibitory Factor in Obesity, Insulin Resistance, Type 2 Diabetes, and Associated Hepatic Co-Morbidities: A Comprehensive Review of Human and Rodent Studies.
Intervertebral Disc Degeneration
Migration Inhibitory Factor Enhances Inflammation via CD74 in Cartilage End Plates with Modic Type 1 Changes on MRI.
Intracranial Arteriovenous Malformations
Macrophage migration inhibitory factor reduces apoptosis in cerebral arteriovenous malformations.
Iridocyclitis
Increase of macrophage migration inhibitory factor in sera of patients with iridocyclitis.
Ischemic Stroke
Early treadmill exercise increases macrophage migration inhibitory factor expression after cerebral ischemia/reperfusion.
Ischemic Stroke
Macrophage Migration Inhibitory Factor Alters Functional Properties of CA1 Hippocampal Neurons in Mouse Brain Slices.
Ischemic Stroke
Macrophage Migration Inhibitory Factor Levels Correlate with Stroke Recurrence in Patients with Ischemic Stroke.
Ischemic Stroke
Serum level of macrophage migration inhibitory factor predicts severity and prognosis in patients with ischemic stroke.
Ischemic Stroke
Serum macrophage migration inhibitory factor levels are associated with infarct volumes and long-term outcomes in patients with acute ischemic stroke.
Joint Diseases
Gene polymorphisms of the macrophage migration inhibitory factor and acute pancreatitis.
Keloid
[High expression of macrophage migration inhibitory factor and its role in cellular proliferation and extracellular matrix production in keloid fibroblasts]
Keloid
[Interaction between macrophage migration inhibitory factor and lysophosphatidic acid in formation of keloid tissue]]
Keratitis
Expression of macrophage migration inhibitory factor during Pseudomonas keratitis.
Keratitis
Expression of macrophage migration inhibitory factor in Aspergillus fumigatus keratitis.
Keratitis
Inhibition of macrophage migration inhibitory factor ameliorates ocular Pseudomonas aeruginosa-induced keratitis.
Kidney Diseases
Interferon-gamma induces macrophage migration inhibitory factor synthesis and secretion by tubular epithelial cells.
Kidney Diseases
Macrophage migration inhibitory factor as a potential predictor for requirement of renal replacement therapy after orthotopic liver transplantation.
Kidney Diseases
MIF, CD74 and other partners in kidney disease: Tales of a promiscuous couple.
Kidney Diseases
The pathogenic role of macrophage migration inhibitory factor in immunologically induced kidney disease in the rat.
Kidney Failure, Chronic
Filtration of Macrophage Migration Inhibitory Factor (MIF) in Patients with End Stage Renal Disease Undergoing Hemodialysis.
Kidney Failure, Chronic
Macrophage migration inhibitory factor is associated with vascular dysfunction in patients with end-stage renal disease.
Leishmaniasis, Visceral
Variations in macrophage migration inhibitory factor gene are not associated with visceral leishmaniasis in India.
Leprosy
Serum macrophage migration inhibitory factor levels in leprosy patients with erythema nodosum leprosum.
Leukemia
Correlations of leukemia inhibitory factor and macrophage migration inhibitory factor with endometrial carcinoma.
Leukemia
Folliculo-stellate cells - potential mediators of the inflammaging-induced hyperactivity of the hypothalamic-pituitary-adrenal axis in healthy elderly individuals.
Leukemia
Identification of macrophage migration inhibitory factor in human leukemia HL-60 cells and its induction by lipopolysaccharide.
Leukemia, Lymphocytic, Chronic, B-Cell
Delayed development of chronic lymphocytic leukemia in the absence of macrophage migration inhibitory factor.
Liver Cirrhosis
Genetic Variants in the Promoter Region of the Macrophage Migration Inhibitory Factor are Associated with the Severity of Hepatitis C Virus-Induced Liver Fibrosis.
Liver Cirrhosis
Immunohistochemical study of macrophage migration inhibitory factor in rat liver fibrosis induced by thioacetamide.
Liver Cirrhosis
Macrophage migration inhibitory factor (MIF) exerts antifibrotic effects in experimental liver fibrosis via CD74.
Liver Cirrhosis
Macrophage migration inhibitory factor in hepatocellular carcinoma and liver cirrhosis; relevance to pathogenesis.
Liver Cirrhosis
Macrophage migration inhibitory factor is required for recruitment of scar-associated macrophages during liver fibrosis.
Liver Cirrhosis, Biliary
The role of macrophage migration inhibitory factor (MIF) in autoimmune liver disease.
Liver Diseases
Hypothesis: Targeted Ikk? deletion upregulates MIF signaling responsiveness and MHC class II expression in mouse hepatocytes.
Liver Diseases
Involvement of exercise-induced macrophage migration inhibitory factor in the prevention of fatty liver disease.
Liver Diseases
Macrophage migration inhibitory factor expression and MIF gene -173 G/C polymorphism in nonalcoholic fatty liver disease.
Liver Diseases
Novel Role of Macrophage Migration Inhibitory Factor in Upstream Control of the Unfolded Protein Response After Ethanol Feeding in Mice.
Liver Diseases
The role of macrophage migration inhibitory factor (MIF) in autoimmune liver disease.
Liver Diseases
Unexpected Pro-Fibrotic Effect of MIF in Non-Alcoholic Steatohepatitis Is Linked to a Shift in NKT Cell Populations.
Liver Diseases, Alcoholic
Increased serum levels of macrophage migration inhibitory factor in alcoholic liver diseases and their expression in liver tissues.
Liver Diseases, Alcoholic
Macrophage Migration Inhibitory Factor: New Insights into the Pathogenesis of Alcoholic Liver Disease.
Liver Failure
Recombinant adenovirus vector bearing antisense macrophage migration inhibitory factor cDNA prevents acute lipopolysaccharide-induced liver failure in mice.
Liver Neoplasms
Efficacy analysis of combined detection of 5 Serological Tumor markers including MIF and PIVKA-II for early diagnosis of Primary Hepatic Cancer.
Liver Neoplasms
Evaluation of serum PIVKA-II and MIF as diagnostic markers for HCV/HBV induced hepatocellular carcinoma.
Liver Neoplasms
In Vivo Imaging of the Macrophage Migration Inhibitory Factor in Liver Cancer with an Activity-Based Probe.
Liver Neoplasms
Macrophage migration inhibitory factor predicts an unfavorable outcome after transarterial chemoembolization for hepatic malignancies.
Lung Diseases
Macrophage migration inhibitory factor mediates hypoxia-induced pulmonary hypertension.
Lung Diseases
Serum and BAL macrophage migration inhibitory factor levels in HIV infected Tanzanians with pulmonary tuberculosis or other lung diseases.
Lung Injury
Downregulation of migration inhibitory factor is critical for estrogen-mediated attenuation of lung tissue damage following trauma-hemorrhage.
Lung Injury
Endothelial CD74 mediates macrophage migration inhibitory factor protection in hyperoxic lung injury.
Lung Injury
ESTROGEN AUGMENTS THE PROTECTION OF HYPERTONIC SALINE TREATMENT FROM MESENTERIC ISCHEMIA REPERFUSION INJURY.
Lung Injury
Macrophage migration inhibitory factor antagonist (S,R)3?(4?hydroxyphenyl)?4,5?dihydro?5?isoxazole acetic acid methyl ester attenuates inflammation and lung injury in rats with acute pancreatitis in pregnancy.
Lung Injury
Macrophage migration inhibitory factor promotes tumor growth in the context of lung injury and repair.
Lung Injury
Role for macrophage migration inhibitory factor in acute respiratory distress syndrome.
Lung Injury
Role of macrophage migration inhibitory factor in bleomycin-induced lung injury and fibrosis in mice.
Lung Injury
Tanshinone IIA attenuates seawater aspiration-induced lung injury by inhibiting macrophage migration inhibitory factor.
Lung Neoplasms
A novel, macrophage migration inhibitory factor suicide substrate inhibits motility and growth of lung cancer cells.
Lung Neoplasms
Cooperative regulation of non-small cell lung carcinoma angiogenic potential by macrophage migration inhibitory factor and its homolog, D-dopachrome tautomerase.
Lung Neoplasms
Correction: Functional disruption of macrophage migration inhibitory factor (MIF) suppresses proliferation of human h460 lung cancer cells by caspase-dependent apoptosis.
Lung Neoplasms
Dissociation of MIF-rpS3 complex and sequential NF-?B activation is involved in IR-induced metastatic conversion of NSCLC.
Lung Neoplasms
Effect and molecular mechanism of mir-146a on proliferation of lung cancer cells by targeting and regulating MIF gene.
Lung Neoplasms
Expression of CD74, the receptor for macrophage migration inhibitory factor, in non-small cell lung cancer.
Lung Neoplasms
Functional disruption of macrophage migration inhibitory factor (MIF) suppresses proliferation of human H460 lung cancer cells by caspase-dependent apoptosis.
Lung Neoplasms
Intratumoral expression of macrophage migration inhibitory factor is correlated with serum C-reactive protein and interleukin-6 in patients with non-small cell lung cancer.
Lung Neoplasms
Macrophage migration inhibitory factor (MIF) enzymatic activity and lung cancer.
Lung Neoplasms
Macrophage migration inhibitory factor and CXC chemokine expression in non-small cell lung cancer: role in angiogenesis and prognosis.
Lung Neoplasms
Macrophage migration inhibitory factor promotes Warburg effect via activation of the NF??B/HIF?1? pathway in lung cancer.
Lung Neoplasms
Protein expression profiling identifies macrophage migration inhibitory factor and cyclophilin a as potential molecular targets in non-small cell lung cancer.
Lung Neoplasms
Proteolysis Targeting Chimera (PROTAC) for Macrophage Migration Inhibitory Factor (MIF) Has Anti-Proliferative Activity in Lung Cancer Cells.
Lung Neoplasms
Quantification of macrophage migration inhibitory factor mRNA expression in non-small cell lung cancer tissues and its clinical significance.
Lung Neoplasms
RNF138-mediated ubiquitination of rpS3 is required for resistance of glioblastoma cells to radiation-induced apoptosis.
Lung Neoplasms
The expression of macrophage migration inhibitory factor in the non-small cell lung cancer.
Lung Neoplasms
Translating biomarkers into clinical practice: prognostic implications of cyclophilin A and macrophage migratory inhibitory factor identified from protein expression profiles in non-small cell lung cancer.
Lung Neoplasms
[Expression and significance of MIF and CD147 in non-small cell lung cancer]
Lupus Erythematosus, Discoid
Macrophage Migration Inhibitory Factor (MIF) and Its Homologue d-Dopachrome Tautomerase (DDT) Inversely Correlate with Inflammation in Discoid Lupus Erythematosus.
Lupus Erythematosus, Systemic
Analysis of urinary macrophage migration inhibitory factor in systemic lupus erythematosus.
Lupus Erythematosus, Systemic
Artesunate inhibits type I interferon-induced production of macrophage migration inhibitory factor in patients with systemic lupus erythematosus.
Lupus Erythematosus, Systemic
Circulating macrophage migration inhibitory factor levels and its polymorphisms in systemic lupus erythematosus: A meta-analysis.
Lupus Erythematosus, Systemic
Dual effect of the macrophage migration inhibitory factor gene on the development and severity of human systemic lupus erythematosus.
Lupus Erythematosus, Systemic
Emerging views of mitophagy in immunity and autoimmune diseases.
Lupus Erythematosus, Systemic
Evidence of association of macrophage migration inhibitory factor gene polymorphisms with systemic lupus erythematosus.
Lupus Erythematosus, Systemic
Experience with milatuzumab, an anti-CD74 antibody against immunomodulatory macrophage migration inhibitory factor (MIF) receptor, for systemic lupus erythematosus (SLE).
Lupus Erythematosus, Systemic
Levels of the macrophage migration inhibitory factor and polymorphisms in systemic lupus erythematosus: a meta-analysis.
Lupus Erythematosus, Systemic
Macrophage migration inhibitory factor (MIF) as a therapeutic target for rheumatoid arthritis and systemic lupus erythematosus.
Lupus Erythematosus, Systemic
Macrophage migration inhibitory factor in systemic lupus erythematosus.
Lupus Erythematosus, Systemic
Macrophage migration inhibitory factor: a key cytokine in RA, SLE and atherosclerosis.
Lupus Erythematosus, Systemic
Macrophage migration inhibitory factor: Association of -794 CATT5-8 and -173 G>C polymorphisms with TNF-? in systemic lupus erythematosus.
Lupus Erythematosus, Systemic
MIF functional polymorphisms (-794 CATT5-8 and -173 G>C) are associated with MIF serum levels, severity and progression in male multiple sclerosis from western Mexican population.
Lupus Erythematosus, Systemic
MiRNA Regulation of MIF in SLE and Attenuation of Murine Lupus Nephritis With miR-654.
Lupus Erythematosus, Systemic
New insights into the role and mechanism of macrophage migration inhibitory factor in steroid-resistant patients with systemic lupus erythematosus.
Lupus Erythematosus, Systemic
Role of macrophage migration inhibitory factor in head and neck cancer and novel therapeutic targets: A systematic review.
Lupus Erythematosus, Systemic
Urine macrophage migration inhibitory factor in pediatric systemic lupus erythematosus.
Lupus Erythematosus, Systemic
[The expression of migration inhibitory factor in peripheral blood mononuclear cell and its correlation with disease activity in systemic lupus erythematosus]
Lupus Erythematosus, Systemic
[The relationship between mRNA level of glucocorticoid receptor ?, heat shock protein 90, protein level of macrophage migration inhibitory factor and glucocorticoid resistance in systemic lupus erythematosus].
Lupus Nephritis
Assessment of serum macrophage migration inhibitory factor (MIF), adiponectin, and other adipokines as potential markers of proteinuria and renal dysfunction in lupus nephritis: a cross-sectional study.
Lupus Nephritis
miR-152 Attenuates the Severity of Lupus Nephritis Through the Downregulation of Macrophage Migration Inhibitory Factor (MIF)-Induced Expression of COL1A1.
Lupus Nephritis
MiRNA Regulation of MIF in SLE and Attenuation of Murine Lupus Nephritis With miR-654.
Lupus Nephritis
Urine macrophage migration inhibitory factor in pediatric systemic lupus erythematosus.
Lymphatic Metastasis
Carcinoid tumors of the lung: immuno- and ligandohistochemistry, analysis of integrated optical density, syntactic structure analysis, clinical data, and prognosis of patients treated surgically.
Lymphatic Metastasis
Correlation of macrophage migration inhibitory factor gene polymorphism with the risk of early-stage cervical cancer and lymphatic metastasis.
Lymphoma
An essential role for macrophage migration inhibitory factor (MIF) in angiogenesis and the growth of a murine lymphoma.
Lymphoma, B-Cell
A study on the biological function of heat shock factor 1 proteins in breast cancer.
Lymphoma, B-Cell
Tanshinone IIA pretreatment attenuates ischemia/reperfusion-induced renal injury.
Malaria
A critical role for the host mediator macrophage migration inhibitory factor in the pathogenesis of malarial anemia.
Malaria
A decrease of plasma macrophage migration inhibitory factor concentration is associated with lower numbers of circulating lymphocytes in experimental Plasmodium falciparum malaria.
Malaria
A macrophage migration inhibitory factor promoter polymorphism is associated with high-density parasitemia in children with malaria.
Malaria
Decreased circulating macrophage migration inhibitory factor (MIF) protein and blood mononuclear cell MIF transcripts in children with Plasmodium falciparum malaria.
Malaria
Detection of Plasmodium falciparum derived macrophage migration inhibitory factor homologue in the sera of malaria patients.
Malaria
Elevated levels of the Plasmodium yoelii homologue of macrophage migration inhibitory factor attenuate blood-stage malaria.
Malaria
Expression of erythropoietic cytokines in ?-tocopherol transfer protein knockout mice with murine malaria infection.
Malaria
Higher production of peripheral blood macrophage migration inhibitory factor in healthy children with a history of mild malaria relative to children with a history of severe malaria.
Malaria
Immunity to placental malaria. IV. Placental malaria is associated with up-regulation of macrophage migration inhibitory factor in intervillous blood.
Malaria
Macrophage migration inhibitory factor and placental malaria infection in an area characterized by unstable malaria transmission in central Sudan.
Malaria
Macrophage migration inhibitory factor homolog from Plasmodium yoelii modulates monocyte recruitment and activation in spleen during infection.
Malaria
Neutralization of the Plasmodium-encoded MIF ortholog confers protective immunity against malaria infection.
Malaria
Phylogeny and evolution of plant macrophage migration inhibitory factor/D-dopachrome tautomerase-like proteins.
Malaria
Plasma concentration of malaria parasite-derived macrophage migration inhibitory factor in uncomplicated malaria patients correlates with parasitemia and disease severity.
Malaria
Reduced levels of transforming growth factor-beta1, interleukin-12 and increased migration inhibitory factor are associated with severe malaria.
Malaria
Structural and functional comparison of MIF ortholog from Plasmodium yoelii with MIF from its rodent host.
Malaria, Cerebral
Macrophage migration inhibitory factor is associated with mortality in cerebral malaria patients in India.
Malaria, Falciparum
A decrease of plasma macrophage migration inhibitory factor concentration is associated with lower numbers of circulating lymphocytes in experimental Plasmodium falciparum malaria.
Malaria, Falciparum
Decreased circulating macrophage migration inhibitory factor (MIF) protein and blood mononuclear cell MIF transcripts in children with Plasmodium falciparum malaria.
Marek Disease
Potential Role of Macrophage Migration Inhibitory Factor in the Pathogenesis of Marek's Disease.
Maternal Death
Macrophage Migration Inhibitory Factor (MIF) Prevents Maternal Death, but Contributes to Poor Fetal Outcome During Congenital Toxoplasmosis.
Melanoma
Cell Surface CD74-MIF Interactions Drive Melanoma Survival in Response to Interferon-?.
Melanoma
High expression of macrophage migration inhibitory factor in human melanoma cells and its role in tumor cell growth and angiogenesis.
Melanoma
Interference of macrophage migration inhibitory factor expression in a mouse melanoma inhibits tumor establishment by up-regulating thrombospondin-1.
Melanoma
Macrophage migration inhibitory factor engages PI3K/Akt signalling and is a prognostic factor in metastatic melanoma.
Melanoma
Macrophage migration inhibitory factor produced by the tumour stroma but not by tumour cells regulates angiogenesis in the B16-F10 melanoma model.
Melanoma
Macrophage migration inhibitory factor-CD74 interaction regulates the expression of programmed cell death ligand 1 in melanoma cells.
Melanoma
MIF inhibition reverts the gene expression profile of human melanoma cell line-induced MDSCs to normal monocytes.
Melanoma
MIF Is Necessary for Late-Stage Melanoma Patient MDSC Immune Suppression and Differentiation.
Melanoma
Role of macrophage migration inhibitory factor in primary glioblastoma multiforme cells.
Melanoma
The Expression of CD74-Regulated Inflammatory Markers in Stage IV Melanoma: Risk of CNS Metastasis and Patient Survival.
Melanoma
The macrophage migration inhibitory factor (MIF)-homologue D-dopachrome tautomerase is a therapeutic target in a murine melanoma model.
Melanoma
[BCG-induced production of a factor inhibiting macrophage migration and growth of melanoma B16]
Melioidosis
Expression and function of macrophage migration inhibitory factor (MIF) in melioidosis.
Meningioma
Increased co-expression of macrophage migration inhibitory factor and matrix metalloproteinase 9 is associated with tumor recurrence of meningioma.
Meningitis
Association of macrophage migration inhibitory factor (MIF) polymorphisms with risk of meningitis from Streptococcus pneumoniae.
Meningitis, Bacterial
Functional polymorphisms of macrophage migration inhibitory factor as predictors of morbidity and mortality of pneumococcal meningitis.
Meningitis, Bacterial
Individual responsiveness of macrophage migration inhibitory factor predicts long-term cognitive impairment after bacterial meningitis.
Meningitis, Pneumococcal
Functional polymorphisms of macrophage migration inhibitory factor as predictors of morbidity and mortality of pneumococcal meningitis.
Meningitis, Pneumococcal
Individual responsiveness of macrophage migration inhibitory factor predicts long-term cognitive impairment after bacterial meningitis.
Meningitis, Pneumococcal
Macrophage migration inhibitory factor, infection, the brain, and corticosteroids.
Meningitis, Pneumococcal
Patterns of protein expression in infectious meningitis: a cerebrospinal fluid protein array analysis.
Meningococcal Infections
A functional microsatellite of the macrophage migration inhibitory factor gene associated with meningococcal disease.
Meningococcal Infections
Macrophage migration inhibitory factor (MIF) in meningococcal septic shock and experimental human endotoxemia.
Metabolic Diseases
Macrophage migration inhibitory factor in the regulation of myoblast proliferation and differentiation.
Metabolic Syndrome
Elevated levels of macrophage migration inhibitory factor in women with metabolic syndrome.
Metabolic Syndrome
Genetic variation in macrophage migration inhibitory factor associated with gestational diabetes mellitus and metabolic syndrome.
Metabolic Syndrome
Macrophage migration inhibitory factor inhibition is deleterious for high-fat diet-induced cardiac dysfunction.
Metabolic Syndrome
Monocyte chemotactic protein-1, RANTES and macrophage migration inhibitory factor levels in gingival crevicular fluid of metabolic syndrome patients with gingivitis.
Microscopic Polyangiitis
Increased serum levels of macrophage migration inhibitory factor (MIF) in patients with microscopic polyangiitis.
Mucocutaneous Lymph Node Syndrome
High mobility group box 1 (HMGB1) and macrophage migration inhibitory factor (MIF) in Kawasaki disease.
Mucocutaneous Lymph Node Syndrome
Increased serum levels of macrophage migration inhibitory factor in patients with Kawasaki disease.
Mucocutaneous Lymph Node Syndrome
Macrophage migration inhibitory factor -173 polymorphism and risk of coronary alterations in children with Kawasaki disease.
Multiple Myeloma
Intratumor Heterogeneity of MIF Expression Correlates With Extramedullary Involvement of Multiple Myeloma.
Multiple Sclerosis
Association of macrophage migration inhibitory factor gene promoter polymorphisms with multiple sclerosis in Turkish patients.
Multiple Sclerosis
Contribution of the macrophage migration inhibitory factor superfamily of cytokines in the pathogenesis of preclinical and human multiple sclerosis: In silico and in vivo evidences.
Multiple Sclerosis
CSF macrophage migration inhibitory factor levels did not predict steroid treatment response after optic neuritis in patients with multiple sclerosis.
Multiple Sclerosis
Macrophage migration inhibitory factor as a target molecule in multiple sclerosis.
Multiple Sclerosis
Macrophage migration inhibitory factor in the cerebrospinal fluid of patients with conventional and optic-spinal forms of multiple sclerosis and neuro-Behçet's disease.
Multiple Sclerosis
Macrophage migration inhibitory factor potentiates autoimmune-mediated neuroinflammation.
Multiple Sclerosis
MIF and D-DT are potential disease severity modifiers in male MS subjects.
Multiple Sclerosis
Profile of MIF in Developing Hippocampus: Association With Cell Proliferation and Neurite Outgrowth.
Multiple Sclerosis
Studies of cellular sensitization to myelin antigens in multiple sclerosis. Dissociation of MIF and LBT production in response to a peptide encephalitogenic in rhesus monkeys.
Multiple Sclerosis
Synthesis and bio-evaluation of human macrophage migration inhibitory factor inhibitor to develop anti-inflammatory agent.
Multiple Sclerosis
The macrophage migration inhibitory factor pathway in human B cells is tightly controlled and dysregulated in multiple sclerosis.
Multiple Sclerosis
Upregulated Expression of Macrophage Migration Inhibitory Factor, Its Analogue D-Dopachrome Tautomerase, and the CD44 Receptor in Peripheral CD4 T Cells from Clinically Isolated Syndrome Patients with Rapid Conversion to Clinical Defined Multiple Sclerosis.
Muscular Dystrophy, Duchenne
Transcriptomic Analysis Reveals Involvement of the Macrophage Migration Inhibitory Factor Gene Network in Duchenne Muscular Dystrophy.
Myocardial Infarction
Admission macrophage migration inhibitory factor predicts long-term prognosis in patients with ST-elevation myocardial infarction.
Myocardial Infarction
Circulating MIF Levels Predict Clinical Outcomes in Patients With ST-Elevation Myocardial Infarction After Percutaneous Coronary Intervention.
Myocardial Infarction
Correlation between Plasma Macrophage Migration Inhibitory Factor Levels and Long-Term Prognosis in Patients with Acute Myocardial Infarction Complicated with Diabetes.
Myocardial Infarction
Differential roles of cardiac and leukocyte derived macrophage migration inhibitory factor in inflammatory responses and cardiac remodelling post myocardial infarction.
Myocardial Infarction
Elevation of plasma level of macrophage migration inhibitory factor in patients with acute myocardial infarction.
Myocardial Infarction
Elevation of plasma levels of macrophage migration inhibitory factor in patients with acute myocardial infarction.
Myocardial Infarction
Influence of functional polymorphism in MIF promoter on sudden cardiac death in Chinese populations.
Myocardial Infarction
Lack of Macrophage Migration Inhibitory Factor Reduces Susceptibility to Ventricular Arrhythmias During the Acute Phase of Myocardial Infarction.
Myocardial Infarction
Macrophage migration inhibitory factor (MIF) elevation in acute myocardial infarction is arteriogenic.
Myocardial Infarction
Macrophage Migration Inhibitory Factor (MIF) Expression Increases during Myocardial Infarction and Supports Pro-Inflammatory Signaling in Cardiac Fibroblasts.
Myocardial Infarction
Macrophage migration inhibitory factor and the risk of myocardial infarction or death due to coronary artery disease in adults without prior myocardial infarction or stroke: the EPIC-Norfolk Prospective Population study.
Myocardial Infarction
Macrophage migration inhibitory factor facilitates the therapeutic efficacy of mesenchymal stem cells derived exosomes in acute myocardial infarction through upregulating miR-133a-3p.
Myocardial Infarction
Prognostic significance and dynamic change of plasma macrophage migration inhibitory factor in patients with acute ST-elevation myocardial infarction.
Myocardial Infarction
The macrophage migration inhibitory factor (MIF) gene polymorphism in Czech and Russian patients with myocardial infarction.
Myocardial Ischemia
Increase of macrophage migration inhibitory factor (MIF) expression in cardiomyocytes during chronic hypoxia.
Myocarditis
Blockade of macrophage migration inhibitory factor ameliorates experimental autoimmune myocarditis.
Myocarditis
Pathogenesis of coxsackievirus B3-induced myocarditis: role of macrophage migration inhibitory factor.
Myositis
Co-Localization of Macrophage Inhibitory Factor and Nix in Skeletal Muscle of the Aged Male Interleukin 10 Null Mouse.
Myositis
Critical role for macrophage migration inhibitory factor (MIF) in Ross River virus-induced arthritis and myositis.
Myositis
Macrophage migration inhibitory factor in normal human skeletal muscle and inflammatory myopathies.
Myositis
Macrophage Migration Inhibitory Factor Receptor CD74 Mediates Alphavirus-Induced Arthritis and Myositis in Murine Models of Alphavirus Infection.
Nasal Polyps
The effects of systemic steroid therapy on macrophage migration inhibitory factor concentrations in patients with nasal polyps.
Nasal Polyps
The role of serum macrophage migration inhibitory factor in preoperative prediction of chronic rhinosinusitis with nasal polyps endotypes.
Nasopharyngeal Carcinoma
Combination of Plasma MIF and VCA-IgA Improves the Diagnostic Specificity for Patients With Nasopharyngeal Carcinoma.
Nasopharyngeal Carcinoma
Increased expression of macrophage migration inhibitory factor and DJ-1 contribute to cell invasion and metastasis of nasopharyngeal carcinoma.
Nasopharyngeal Carcinoma
Influence of Epstein-Barr virus and human papillomavirus infection on macrophage migration inhibitory factor and macrophage polarization in nasopharyngeal carcinoma.
Nasopharyngeal Carcinoma
Macrophage migration inhibitory factor contributes angiogenesis by up-regulating IL-8 and correlates with poor prognosis of patients with primary nasopharyngeal carcinoma.
Nasopharyngeal Carcinoma
Macrophage migration inhibitory factor enhances neoplastic cell invasion by inducing the expression of matrix metalloproteinase 9 and interleukin-8 in nasopharyngeal carcinoma cell lines.
Nasopharyngeal Carcinoma
Plasma Macrophage Migration Inhibitory Factor and CCL3 as Potential Biomarkers for Distinguishing Patients with Nasopharyngeal Carcinoma from High Risk Individuals Who Have Positive Epstein-Barr Virus Capsid Antigen-Specific IgA.
Nasopharyngeal Carcinoma
Role of MIF/CXCL8/CXCR2 signaling in the growth of nasopharyngeal carcinoma tumor spheres.
Nasopharyngeal Carcinoma
[Effect of macrophage migration inhibitory factor (MIF) on expression of MMP-2,MMP-9,and IL-8 in nasopharyngeal carcinoma cell strains]
Nasopharyngeal Carcinoma
[Increased cell migration of nasopharyngeal carcinoma cell lines in vitro by macrophage migration inhibitory factor]
Nematode Infections
A Brugia malayi homolog of macrophage migration inhibitory factor reveals an important link between macrophages and eosinophil recruitment during nematode infection.
Neoplasm Metastasis
Carcinoid tumors of the lung: immuno- and ligandohistochemistry, analysis of integrated optical density, syntactic structure analysis, clinical data, and prognosis of patients treated surgically.
Neoplasm Metastasis
Clinical utility of serum macrophage migration inhibitory factor in men with prostate cancer as a novel biomarker of detection and disease progression.
Neoplasm Metastasis
Dissociation of MIF-rpS3 complex and sequential NF-?B activation is involved in IR-induced metastatic conversion of NSCLC.
Neoplasm Metastasis
Enhanced expression of macrophage migration inhibitory factor in prostatic adenocarcinoma metastases.
Neoplasm Metastasis
Functional disruption of macrophage migration inhibitory factor (MIF) suppresses proliferation of human H460 lung cancer cells by caspase-dependent apoptosis.
Neoplasm Metastasis
Increased expression of macrophage migration inhibitory factor and DJ-1 contribute to cell invasion and metastasis of nasopharyngeal carcinoma.
Neoplasm Metastasis
Inhibition of tumor growth and metastasis in vitro and in vivo by targeting macrophage migration inhibitory factor in human neuroblastoma.
Neoplasm Metastasis
ISO-66, a novel inhibitor of macrophage migration, shows efficacy in melanoma and colon cancer models.
Neoplasm Metastasis
Macrophage migration inhibitory factor contributes to the immune escape of ovarian cancer by down-regulating NKG2D.
Neoplasm Metastasis
Macrophage migration inhibitory factor enhances neoplastic cell invasion by inducing the expression of matrix metalloproteinase 9 and interleukin-8 in nasopharyngeal carcinoma cell lines.
Neoplasm Metastasis
Macrophage migration inhibitory factor in the pathogenesis of leukemia (Review).
Neoplasm Metastasis
Macrophage migration inhibitory factor inhibition as a novel therapeutic approach against triple-negative breast cancer.
Neoplasm Metastasis
Macrophage Migration Inhibitory Factor Is Secreted by Rhabdomyosarcoma Cells, Modulates Tumor Metastasis by Binding to CXCR4 and CXCR7 Receptors and Inhibits Recruitment of Cancer-Associated Fibroblasts.
Neoplasm Metastasis
Macrophage migration inhibitory factor promotes breast cancer metastasis via activation of HMGB1/TLR4/NF kappa B axis.
Neoplasm Metastasis
Macrophage migration inhibitory factor promotes osteosarcoma growth and lung metastasis through activating the RAS/MAPK pathway.
Neoplasm Metastasis
Macrophage migration inhibitory factor promotes the invasion and metastasis of oral squamous cell carcinoma through matrix metalloprotein-2/9.
Neoplasm Metastasis
Macrophage migration inhibitory factor promotes tumor growth and metastasis by inducing myeloid-derived suppressor cells in the tumor microenvironment.
Neoplasm Metastasis
Macrophage migration inhibitory factor promotes tumor invasion and metastasis via the Rho-dependent pathway.
Neoplasm Metastasis
Macrophage migration inhibitory factor promotes Warburg effect via activation of the NF??B/HIF?1? pathway in lung cancer.
Neoplasm Metastasis
Macrophage migration inhibitory factor siRNA inhibits hepatic metastases of colorectal cancer cells.
Neoplasm Metastasis
Ovarian cancer cell-derived migration inhibitory factor enhances tumor growth, progression, and angiogenesis.
Neoplasm Metastasis
Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver.
Neoplasm Metastasis
Targeting MIF in Cancer: Therapeutic Strategies, Current Developments, and Future Opportunities.
Neoplasm Metastasis
Upregulation of macrophage migration inhibitory factor promotes tumor metastasis and correlates with poor prognosis of pancreatic ductal adenocarcinoma.
Neoplasm Metastasis
[Increased cell migration of nasopharyngeal carcinoma cell lines in vitro by macrophage migration inhibitory factor]
Neoplasms
(S,R)3-(4-Hydroxyphenyl)-4,5-Dihydro-5-Isoxazole Acetic Acid Methyl Ester Inhibits Epithelial-to-Mesenchymal Transition through TGF-?/Smad4 Axis in Nasopharyngeal Carcinoma.
Neoplasms
7-Hydroxycoumarins are Affinity-based Fluorescent Probes for Competitive Binding Studies of Macrophage Migration Inhibitory Factor.
Neoplasms
A Fluorescence Polarization Assay for Binding to Macrophage Migration Inhibitory Factor and Crystal Structures for Complexes of Two Potent Inhibitors.
Neoplasms
A Long-Term High-Fat/High-Sucrose Diet Promotes Kidney Lipid Deposition and Causes Apoptosis and Glomerular Hypertrophy in Bama Minipigs.
Neoplasms
A potent immunomodulatory compound, (S,R)-3-Phenyl-4,5-dihydro-5-isoxazole acetic acid, prevents spontaneous and accelerated forms of autoimmune diabetes in NOD mice and inhibits the immunoinflammatory diabetes induced by multiple low doses of streptozotocin in CBA/H mice.
Neoplasms
A Pronounced Inflammatory Activity Characterizes the Early Fracture Healing Phase in Immunologically Restricted Patients.
Neoplasms
A STUDY OF THE CLINICAL AND BIOCHEMICAL PROFILE OF PERITONEAL DIALYSIS FLUID LOW IN GLUCOSE DEGRADATION PRODUCTS.
Neoplasms
Accelerated degradation of collagen membranes in type 1 diabetic rats is associated with increased expression and production of several inflammatory molecules.
Neoplasms
Acetylcholinesterase and butyrylcholinesterase as possible markers of low-grade systemic inflammation.
Neoplasms
Activated protein C inhibits tumor necrosis factor and macrophage migration inhibitory factor production in monocytes.
Neoplasms
Alterations in the function of circulating mononuclear cells derived from patients with Crohn's disease treated with mastic.
Neoplasms
An antibody for macrophage migration inhibitory factor suppresses tumour growth and inhibits tumour-associated angiogenesis.
Neoplasms
Analysis of chicken TLR4, CD28, MIF, MD-2, and LITAF genes in a Salmonella enteritidis resource population.
Neoplasms
Antitumor immunity in strain 2 guinea pigs immunized with potassium chloride extracts of L2C tumor cells.
Neoplasms
APOE3, but Not APOE4, Bone Marrow Transplantation Mitigates Behavioral and Pathological Changes in a Mouse Model of Alzheimer Disease.
Neoplasms
Apoptotic neutrophils release macrophage migration inhibitory factor upon stimulation with tumor necrosis factor-alpha.
Neoplasms
Assessing chronic pelvic pain syndrome patients: Blood plasma factors and cortisol saliva.
Neoplasms
Assessment of the ovine acute phase response and hepatic gene expression in response to Escherichia coli endotoxin.
Neoplasms
Association between macrophage migration inhibitory factor promoter region polymorphism (-173 G/C) and cancer: a meta-analysis.
Neoplasms
Association of CASP3 polymorphism with hematologic toxicity in patients with advanced non-small-cell lung carcinoma treated with platinum-based chemotherapy.
Neoplasms
Association of genetic polymorphisms in MIF with breast cancer risk in Chinese women.
Neoplasms
Association of Oxytocin with Glucose Intolerance and Inflammation Biomarkers in Metabolic Syndrome Patients with and without Prediabetes.
Neoplasms
Association of Peripheral Blood Levels of Cytokines With Autism Spectrum Disorder: A Meta-Analysis.
Neoplasms
Association of twelve immune-related genes with performance of three broiler lines in two different hygiene environments.
Neoplasms
Astragalus Polysaccharide (PG2) Suppresses Macrophage Migration Inhibitory Factor and Aggressiveness of Lung Adenocarcinoma Cells.
Neoplasms
Auraptene attenuates gastritis via reduction of Helicobacter pylori colonization and pro-inflammatory mediator production in C57BL/6 mice.
Neoplasms
Autophagy Inhibition Induces the Secretion of Macrophage Migration Inhibitory Factor (MIF) with Autocrine and Paracrine Effects on the Promotion of Malignancy in Breast Cancer.
Neoplasms
Benign metastasizing leiomyoma of the uterus: documentation of clinical, immunohistochemical and lectin-histochemical data of ten cases.
Neoplasms
Biochemical and structural characterization of a novel cooperative binding mode by Pit-1 with CATT repeats in the macrophage migration inhibitory factor promoter.
Neoplasms
Biomarkers in Exhaled Breath Condensate Are Not Predictive for Pulmonary Exacerbations in Children with Cystic Fibrosis: Results of a One-Year Observational Study.
Neoplasms
Cancer Stem Cell-Secreted Macrophage Migration Inhibitory Factor Stimulates Myeloid Derived Suppressor Cell Function and Facilitates Glioblastoma Immune Evasion.
Neoplasms
Cardiovascular protective role for activated protein C during endotoxemia in rats.
Neoplasms
CD4+ T cells play a dominant role in protection against New World leishmaniasis induced by vaccination with the P-4 amastigote antigen.
Neoplasms
Cell Surface CD74-MIF Interactions Drive Melanoma Survival in Response to Interferon-?.
Neoplasms
Cell surface syndecan-1 contributes to binding and function of macrophage migration inhibitory factor (MIF) on epithelial tumor cells.
Neoplasms
Cellular characterization of the peritumoral edema zone in malignant brain tumors.
Neoplasms
Change of macrophage migration inhibitory factor: possible indicator for postoperative prognosis.
Neoplasms
Changes in systemic and subcutaneous adipose tissue inflammation and oxidative stress in response to exercise training in obese black African women.
Neoplasms
Characterization of Chinese giant salamander iridovirus tissue tropism and inflammatory response after infection.
Neoplasms
Characterization of synthetic lung surfactant activity against proinflammatory cytokines in human monocytes.
Neoplasms
Circulating soluble levels of MIF in women with breast cancer in the molecular subtypes: relationship with Th17 cytokine profile.
Neoplasms
Clinical utility of serum amyloid A and macrophage migration inhibitory factor as serum biomarkers for the detection of nonsmall cell lung carcinoma.
Neoplasms
Clinicopathological Significance of Macrophage Migration Inhibitory Factor and its Relation with P53 in Gastric Cancer.
Neoplasms
Clinicopathological significance of the EMT-related proteins and their interrelationships in prostate cancer. An immunohistochemical study.
Neoplasms
Combination of Plasma MIF and VCA-IgA Improves the Diagnostic Specificity for Patients With Nasopharyngeal Carcinoma.
Neoplasms
Comment on "Osteopontin, Macrophage Migration Inhibitory Factor and Anti-Interleukin-8 Autoantibodies Complement CA125 for Detection of Early Stage Ovarian Cancer" Cancers 2019, 11, 596: Markers for Early Detection of Ovarian Cancer.
Neoplasms
Comparative levels of macrophage migration inhibitory factor, procalcitonin, osteoprotegerin, interleukin-8, hs-C reactive protein, d-dimer in febrile neutropenia, newly diagnosed cancer patients, and infectious fever.
Neoplasms
Comprehensive analysis of vitreous chemokines involved in ischemic retinal vein occlusion.
Neoplasms
Construction of Expanded Prefabricated Adipose Tissue Using an External Volume Expansion Device.
Neoplasms
Contribution of aorta glycosaminoglycans and PCSK9 to hyperlipidemia in experimental rabbits: the role of 10-dehdrogingerdione as effective modulator.
Neoplasms
Contribution of Macrophage Migration Inhibitory Factor -173G/C Gene Polymorphism to the Risk of Cancer in Chinese Population.
Neoplasms
Crosstalk between medulloblastoma cells and endothelium triggers a strong chemotactic signal recruiting T lymphocytes to the tumor microenvironment.
Neoplasms
Current advances in sepsis and septic shock with particular emphasis on the role of insulin.
Neoplasms
Cytokine activation is predictive of mortality in Zambian patients with AIDS-related diarrhoea.
Neoplasms
Cytokine production by mouse myeloid dendritic cells in relation to differentiation and terminal maturation induced by lipopolysaccharide or CD40 ligation.
Neoplasms
Cytokine profiling in endometrial secretions: a non-invasive window on endometrial receptivity.
Neoplasms
D-dopachrome tautomerase is over-expressed in pancreatic ductal adenocarcinoma and acts cooperatively with macrophage migration inhibitory factor to promote cancer growth.
Neoplasms
Delayed neutrophil apoptosis in granulomatosis with polyangiitis: dysregulation of neutrophil gene signature and circulating apoptosis-related proteins.
Neoplasms
Design, Synthesis, and Biological Activity of New N-(Phenylmethyl)-benzoxazol-2-thiones as Macrophage Migration Inhibitory Factor (MIF) Antagonists: Efficacies in Experimental Pulmonary Hypertension.
Neoplasms
Design, synthesis, and protein crystallography of biaryltriazoles as potent tautomerase inhibitors of macrophage migration inhibitory factor.
Neoplasms
Developmental endothelial locus-1 inhibits MIF production through suppression of NF-?B in macrophages.
Neoplasms
Differential protein expression in primary breast cancer and matched axillary node metastasis.
Neoplasms
Differential regulation of colony stimulating factor 1 and macrophage migration inhibitory factor expression by inflammatory cytokines in term human decidua: implications for macrophage trafficking at the fetal-maternal interface.
Neoplasms
Discovery of novel MIF inhibitors that attenuate microglial inflammatory activation by structures-based virtual screening and in vitro bioassays.
Neoplasms
Distinct Secretory Activity and Clinical Impact of Subcutaneous Abdominal Adipose Tissue in Women with Rheumatoid Arthritis and Osteoarthritis.
Neoplasms
Dual regulation of macrophage migration inhibitory factor (MIF) expression in hypoxia by CREB and HIF-1.
Neoplasms
Dysregulated D-dopachrome tautomerase, a hypoxia-inducible factor-dependent gene, cooperates with macrophage migration inhibitory factor in renal tumorigenesis.
Neoplasms
Effect of 6% Hydroxyethyl Starch 130/0.4 on Inflammatory Response and Pulmonary Function in Patients Having Cardiac Surgery: A Randomized Clinical Trial.
Neoplasms
Effect of asymmetric dimethylarginine on MIF expression and TNF-? and IL-8 secretion in THP-1 monocytes-derived macrophages.
Neoplasms
Effect of chronic ethanol consumption in female rats subjected to experimental sepsis.
Neoplasms
Effect of hypoxia on the expression of CCAAT/enhancer-binding protein ? and receptor activator of nuclear factor kappa-B ligand in periodontal ligament cells.
Neoplasms
Effect of miR-29c on renal fibrosis in diabetic rats via the AMPK/mTOR signaling pathway.
Neoplasms
Effects of IL-1beta, TNF-alpha, and macrophage migration inhibitory factor on prostacyclin synthesis in rat pulmonary artery smooth muscle cells.
Neoplasms
Effects of oleanolic acid on pulmonary morphofunctional and biochemical variables in experimental acute lung injury.
Neoplasms
Effects of whole body cryotherapy in patients with rheumatoid arthritis considering immune parameters.
Neoplasms
Efficacy analysis of combined detection of 5 Serological Tumor markers including MIF and PIVKA-II for early diagnosis of Primary Hepatic Cancer.
Neoplasms
Efficacy of bevacizumab combined with nedaplatin in the treatment of ovarian cancer and its effects on tumor markers and immunity of patients.
Neoplasms
Elevated expression of macrophage migration inhibitory factor correlates with tumor recurrence and poor prognosis of patients with gliomas.
Neoplasms
Elevated expression of transforming growth factor betas and the tumor necrosis factor family in lung adenocarcinomas induced by N-nitrosobis(2-hydroxypropyl)amine in rats.
Neoplasms
Emerging Role of the Macrophage Migration Inhibitory Factor Family of Cytokines in Neuroblastoma. Pathogenic Effectors and Novel Therapeutic Targets?
Neoplasms
Endometrial secretion analysis identifies a cytokine profile predictive of pregnancy in IVF.
Neoplasms
Epigenetic regulation in macrophage migration inhibitory factor (MIF)-mediated signaling in cancer and inflammation.
Neoplasms
Evaluating macrophage migration inhibitory factor 1 expression as a prognostic biomarker in colon cancer.
Neoplasms
Evaluation of macrophage migration inhibitory factor as an imaging marker for hepatocellular carcinoma in murine models.
Neoplasms
Evidence of dual function of macrophage migration inhibitory factor relevant to tumor progression and regression.
Neoplasms
Expression of CD74 is increased in neurofibrillary tangles in Alzheimer's disease.
Neoplasms
Expression of inflammatory mediators in the otitis media induced by Helicobacter pylori antigen in mice.
Neoplasms
Expression of Macrophage Migration Inhibitory Factor and CD74 in Cervical Squamous Cell Carcinoma.
Neoplasms
Expression of macrophage migration inhibitory factor by neuroblastoma leads to the inhibition of antitumor T cell reactivity in vivo.
Neoplasms
Expression of macrophage migration inhibitory factor is associated with enhanced angiogenesis and advanced stage in gastric carcinomas.
Neoplasms
Expression of macrophage migration inhibitory factor relates to survival in high-grade osteosarcoma.
Neoplasms
Expression of mRNA for interleukin-1beta, interleukin-6, tumor necrosis factor-alpha and macrophage migration inhibitory factor in HPA-axis tissues in Schistosoma mansoni-infected baboons (Papio cynocephalus).
Neoplasms
Ferroportin (SLC40A1) Q248H mutation is associated with lower circulating plasma tumor necrosis factor-alpha and macrophage migration inhibitory factor concentrations in African children.
Neoplasms
Functional disruption of macrophage migration inhibitory factor (MIF) suppresses proliferation of human H460 lung cancer cells by caspase-dependent apoptosis.
Neoplasms
Functional variants of MIF, INFG and TFNA genes are not associated with disease susceptibility or hearing loss progression in patients with Ménière's disease.
Neoplasms
Haplotypes of (-794(CATT)5-8/-173G>C) MIF gene polymorphisms and its soluble levels in basal cell carcinoma in western Mexican population.
Neoplasms
High expression of macrophage migration inhibitory factor in human melanoma cells and its role in tumor cell growth and angiogenesis.
Neoplasms
High-grade sarcoma diagnosis and prognosis: Biomarker discovery by mass spectrometry imaging.
Neoplasms
Histone deacetylase inhibitors repress macrophage migration inhibitory factor (MIF) expression by targeting MIF gene transcription through a local chromatin deacetylation.
Neoplasms
Hsp90-stabilized MIF supports tumor progression via macrophage recruitment and angiogenesis in colorectal cancer.
Neoplasms
Identification and quantification of proteins differentially secreted by a pair of normal and malignant breast-cancer cell lines.
Neoplasms
Identification and Structure-Activity Relationships of Dietary Flavonoids as Human Macrophage Migration Inhibitory Factor (MIF) Inhibitors.
Neoplasms
Identification of macrophage migration inhibitory factor in adipose tissue and its induction by tumor necrosis factor-alpha.
Neoplasms
Identification of macrophage migration inhibitory factor in murine neonatal calvariae and osteoblasts.
Neoplasms
Immunohistological pointers to a possible role for excessive cathelicidin (LL-37) expression by apocrine sweat glands in the pathogenesis of hidradenitis suppurativa/acne inversa.
Neoplasms
Immunophenotyping of the cluster of differentiation 74, migration inhibitory factor, and cluster of differentiation 44 expression on human breast cancer-derived cell lines.
Neoplasms
Impact of a low-glucose peritoneal dialysis regimen on fibrosis and inflammation biomarkers.
Neoplasms
In silico target fishing and pharmacological profiling for the isoquinoline alkaloids of Macleaya cordata (Bo Luo Hui).
Neoplasms
In vitro cellular responses to autologous tumor extract detected by inhibition of macrophage migration.
Neoplasms
Increased co-expression of macrophage migration inhibitory factor and matrix metalloproteinase 9 is associated with tumor recurrence of meningioma.
Neoplasms
Increased expression of macrophage migration inhibitory factor and DJ-1 contribute to cell invasion and metastasis of nasopharyngeal carcinoma.
Neoplasms
Induction of cytokines, chemokines and adhesion molecule mRNA in a rat forebrain reperfusion model.
Neoplasms
Induction of macrophage migration inhibitory factor by lysophosphatidic acid: relevance to tumor growth and angiogenesis.
Neoplasms
Induction of T-kininogen and tumor necrosis factor-alpha by macrophage migration inhibitory factor in vivo.
Neoplasms
Inflammation and cancer: macrophage migration inhibitory factor (MIF)--the potential missing link.
Neoplasms
Inflammation driven tumor-like signaling in prostatic epithelial cells by sexually transmitted Trichomonas vaginalis.
Neoplasms
Inflammation factors in hepatoblastoma and their clinical significance as diagnostic and prognostic biomarkers.
Neoplasms
Inflammatory and related biomarkers are associated with post-transplant diabetes mellitus in kidney recipients: a retrospective study.
Neoplasms
Inflammatory bowel disease as a disorder of an imbalance between pro- and anti-inflammatory molecules and deficiency of resolution bioactive lipids.
Neoplasms
Inflammatory cytokine-mediated induction of serine racemase in atopic dermatitis.
Neoplasms
Influence of Epstein-Barr virus and human papillomavirus infection on macrophage migration inhibitory factor and macrophage polarization in nasopharyngeal carcinoma.
Neoplasms
Inhibiting the HSP90 chaperone destabilizes macrophage migration inhibitory factor and thereby inhibits breast tumor progression.
Neoplasms
Inhibition of Macrophage Migration Inhibitory Factor by a Chimera of Two Allosteric Binders.
Neoplasms
Inhibition of macrophage migration inhibitory factor or its receptor (CD74) attenuates growth and invasion of DU-145 prostate cancer cells.
Neoplasms
Inhibition of tumor growth and metastasis in vitro and in vivo by targeting macrophage migration inhibitory factor in human neuroblastoma.
Neoplasms
Insulin in the critically ill with focus on cytokines, reactive oxygen species, HLA-DR expression.
Neoplasms
Interaction between lung cancer cells and astrocytes via specific inflammatory cytokines in the microenvironment of brain metastasis.
Neoplasms
Interaction of macrophage migration inhibitory factor with ceruloplasmin: role of labile copper ions.
Neoplasms
Interference of macrophage migration inhibitory factor expression in a mouse melanoma inhibits tumor establishment by up-regulating thrombospondin-1.
Neoplasms
Interleukin 6, soluble interleukin 2 receptor alpha (CD25), monocyte colony-stimulating factor, and hepatocyte growth factor linked with systemic hyperinflammation, innate immunity hyperactivation, and organ damage in COVID-19 pneumonia.
Neoplasms
Interrelationship of Cytokines, Hypothalamic-Pituitary-Adrenal Axis Hormones, and Psychosocial Variables in the Prediction of Preterm Birth.
Neoplasms
Intracellular distribution of macrophage migration inhibitory factor predicts the prognosis of patients with adenocarcinoma of the lung.
Neoplasms
Intratumor Heterogeneity of MIF Expression Correlates With Extramedullary Involvement of Multiple Myeloma.
Neoplasms
Intratumoral expression of macrophage migration inhibitory factor is correlated with serum C-reactive protein and interleukin-6 in patients with non-small cell lung cancer.
Neoplasms
Involvement of macrophage migration inhibitory factor (MIF) in the mechanism of tumor cell growth.
Neoplasms
Involvement of macrophage migration inhibitory factor in cancer and novel therapeutic targets.
Neoplasms
Is the modulatory effect of pregnancy in multiple sclerosis associated with changes in blood apoptotic molecules?
Neoplasms
ISO-66, a novel inhibitor of macrophage migration, shows efficacy in melanoma and colon cancer models.
Neoplasms
Kidney injury and alterations of inflammatory cytokine expressions in mice following long-term exposure to cerium chloride.
Neoplasms
Kinetic-based high-throughput screening assay to discover novel classes of macrophage migration inhibitory factor inhibitors.
Neoplasms
KINSENOSIDE ISOLATED FROM ANOECTOCHILUS FORMOSANUS SUPPRESSES LIPOPOLYSACCHARIDE-STIMULATED INFLAMMATORY REACTIONS IN MACROPHAGES AND ENDOTOXIN SHOCK IN MICE.
Neoplasms
Knockdown of D-dopachrome Tautomerase Inhibits Cell Proliferation in Human HepG2 Cell Line.
Neoplasms
Lacrimal gland inflammatory cytokine gene expression in the botulinum toxin B-induced murine dry eye model.
Neoplasms
Leptin Aggravates Reflux Esophagitis by Increasing Tissue Levels of Macrophage Migration Inhibitory Factor in Rats.
Neoplasms
Linking inflammation and neuroendocrine differentiation: the role of macrophage migration inhibitory factor-mediated signaling in prostate cancer.
Neoplasms
Little evidence of systemic and adipose tissue inflammation in overweight individuals().
Neoplasms
Loss of macrophage migration inhibitory factor impairs the growth properties of human HeLa cervical cancer cells.
Neoplasms
LPS-mediated cell surface expression of CD74 promotes the proliferation of B cells in response to MIF.
Neoplasms
Macrophage migration inhibitory factor (MIF) expression in human malignant gliomas contributes to immune escape and tumour progression.
Neoplasms
Macrophage migration inhibitory factor (MIF) is induced by cytotoxic drugs and is involved in immune escape and migration in childhood rhabdomyosarcoma.
Neoplasms
Macrophage migration inhibitory factor (MIF) plays a critical role in pathogenesis of ultraviolet-B (UVB) -induced nonmelanoma skin cancer (NMSC).
Neoplasms
Macrophage migration inhibitory factor (MIF) promoter polymorphisms (-794 CATT5-8 and -173 G>C): association with MIF and TNF? in psoriatic arthritis.
Neoplasms
Macrophage Migration Inhibitory Factor (MIF): Biological Activities and Relation with Cancer.
Neoplasms
Macrophage migration inhibitory factor (MIF): Its potential role in tumor growth and tumor-associated angiogenesis.
Neoplasms
Macrophage migration inhibitory factor anti-thrombin III complexes are decreased in bladder cancer patient serum: Complex formation as a mechanism of inactivation.
Neoplasms
Macrophage migration inhibitory factor contributes to the immune escape of ovarian cancer by down-regulating NKG2D.
Neoplasms
Macrophage migration inhibitory factor counterregulates dexamethasone-mediated suppression of hypoxia-inducible factor-1 alpha function and differentially influences human CD4+ T cell proliferation under hypoxia.
Neoplasms
Macrophage migration inhibitory factor deficiency is associated with altered cell growth and reduced susceptibility to Ras-mediated transformation.
Neoplasms
Macrophage migration inhibitory factor enhances neoplastic cell invasion by inducing the expression of matrix metalloproteinase 9 and interleukin-8 in nasopharyngeal carcinoma cell lines.
Neoplasms
Macrophage migration inhibitory factor exerts pro-proliferative and anti-apoptotic effects via CD74 in murine hepatocellular carcinoma.
Neoplasms
Macrophage migration inhibitory factor exhibits a pronounced circadian rhythm relevant to its role as a glucocorticoid counter-regulator.
Neoplasms
Macrophage migration inhibitory factor in prostatic adenocarcinoma: correlation with tumor grading and combination endocrine treatment-related changes.
Neoplasms
Macrophage migration inhibitory factor in rheumatoid arthritis: clinical correlations.
Neoplasms
Macrophage migration inhibitory factor in rheumatoid arthritis: evidence of proinflammatory function and regulation by glucocorticoids.
Neoplasms
Macrophage migration inhibitory factor induces epithelial to mesenchymal transition, enhances tumor aggressiveness and predicts clinical outcome in resected pancreatic ductal adenocarcinoma.
Neoplasms
Macrophage migration inhibitory factor inhibition as a novel therapeutic approach against triple-negative breast cancer.
Neoplasms
Macrophage migration inhibitory factor inhibits neutrophil apoptosis by inducing cytokine release from mononuclear cells.
Neoplasms
Macrophage migration inhibitory factor interacts with HBx and inhibits its apoptotic activity.
Neoplasms
Macrophage migration inhibitory factor interacts with thioredoxin-interacting protein and induces NF-?B activity.
Neoplasms
Macrophage migration inhibitory factor is a critical mediator of systemic inflammatory response syndrome.
Neoplasms
Macrophage Migration Inhibitory Factor Is a Molecular Determinant of the Anti-EGFR Monoclonal Antibody Cetuximab Resistance in Human Colorectal Cancer Cells.
Neoplasms
Macrophage migration inhibitory factor is differentially expressed in normal and choriocarcinoma trophoblast cells.
Neoplasms
Macrophage Migration Inhibitory Factor Is Secreted by Rhabdomyosarcoma Cells, Modulates Tumor Metastasis by Binding to CXCR4 and CXCR7 Receptors and Inhibits Recruitment of Cancer-Associated Fibroblasts.
Neoplasms
Macrophage migration inhibitory factor modulates proliferation, cell cycle, and apoptotic activity in head and neck cancer cell lines.
Neoplasms
Macrophage migration inhibitory factor of Syrian golden hamster shares structural and functional similarity with human counterpart and promotes pancreatic cancer.
Neoplasms
Macrophage migration inhibitory factor polymorphisms do not predict therapeutic response to glucocorticoids or to tumour necrosis factor alpha-neutralising treatments in rheumatoid arthritis.
Neoplasms
Macrophage migration inhibitory factor predicts an unfavorable outcome after transarterial chemoembolization for hepatic malignancies.
Neoplasms
Macrophage migration inhibitory factor produced by the tumour stroma but not by tumour cells regulates angiogenesis in the B16-F10 melanoma model.
Neoplasms
Macrophage migration inhibitory factor promotes breast cancer metastasis via activation of HMGB1/TLR4/NF kappa B axis.
Neoplasms
Macrophage Migration Inhibitory Factor Promotes the Interaction between the Tumor, Macrophages, and T Cells to Regulate the Progression of Chemically Induced Colitis-Associated Colorectal Cancer.
Neoplasms
Macrophage migration inhibitory factor promotes tumor aggressiveness of esophageal squamous cell carcinoma via activation of Akt and inactivation of GSK3?.
Neoplasms
Macrophage migration inhibitory factor promotes tumor growth and metastasis by inducing myeloid-derived suppressor cells in the tumor microenvironment.
Neoplasms
Macrophage migration inhibitory factor promotes tumor growth in the context of lung injury and repair.
Neoplasms
Macrophage migration inhibitory factor promotes tumor invasion and metastasis via the Rho-dependent pathway.
Neoplasms
Macrophage migration inhibitory factor promotes vasculogenic mimicry formation induced by hypoxia via CXCR4/AKT/EMT pathway in human glioblastoma cells.
Neoplasms
Macrophage migration inhibitory factor promotes Warburg effect via activation of the NF??B/HIF?1? pathway in lung cancer.
Neoplasms
Macrophage Migration Inhibitory Factor protects cancer cells from immunogenic cell death and impairs anti-tumor immune responses.
Neoplasms
Macrophage migration inhibitory factor protects from nonmelanoma epidermal tumors by regulating the number of antigen-presenting cells in skin.
Neoplasms
Macrophage migration inhibitory factor protein and mRNA expression in cutaneous melanocytic tumours.
Neoplasms
Macrophage migration inhibitory factor regulates mitochondrial dynamics and cell growth of human cancer cell lines through CD74-NF-?B signaling.
Neoplasms
Macrophage migration inhibitory factor regulating the expression of VEGF-C through MAPK signal pathways in breast cancer MCF-7 cell.
Neoplasms
Macrophage Migration Inhibitory Factor Secretion Is Induced by Ionizing Radiation and Oxidative Stress in Cancer Cells.
Neoplasms
Macrophage Migration Inhibitory Factor-CXCR4 Is the Dominant Chemotactic Axis in Human Mesenchymal Stem Cell Recruitment to Tumors.
Neoplasms
Macrophage migration inhibitory factor: a potential marker for cancer diagnosis and therapy.
Neoplasms
Macrophage migration inhibitory factor: a probable link between inflammation and cancer.
Neoplasms
Macrophage migration inhibitory factor: roles in regulating tumor cell migration and expression of angiogenic factors in hepatocellular carcinoma.
Neoplasms
Mechanisms of macrophage migration inhibitory factor (MIF)-dependent tumor microenvironmental adaptation.
Neoplasms
Metabolic alterations and systemic inflammation in overweight/obese children with obstructive sleep apnea.
Neoplasms
Metabolomic analysis coupled with extreme phenotype sampling identified that lysophosphatidylcholines are associated with multisite musculoskeletal pain.
Neoplasms
Methylenetetrahydrofolate reductase C667T polymorphism is associated with increased risk of coronary artery disease in a Chinese population.
Neoplasms
Microglial autophagy defect causes parkinson disease-like symptoms by accelerating inflammasome activation in mice.
Neoplasms
MIF allele-dependent regulation of the MIF coreceptor CD44 and role in rheumatoid arthritis.
Neoplasms
MIF and TNF? serum levels in rheumatoid arthritis patients treated with disease-modifying antirheumatic drugs: a cross-sectional study.
Neoplasms
MIF coordinates the cell cycle with DNA damage checkpoints. Lessons from knockout mouse models.
Neoplasms
MIF promotes perineural invasion through EMT in salivary adenoid cystic carcinoma.
Neoplasms
MIF Receptor CD74 is Restricted to Microglia/Macrophages, Associated with a M1-Polarized Immune Milieu and Prolonged Patient Survival in Gliomas.
Neoplasms
MIF, a controversial cytokine: a review of structural features, challenges, and opportunities for drug development.
Neoplasms
miR-608 inhibits the migration and invasion of glioma stem cells by targeting macrophage migration inhibitory factor.
Neoplasms
Modulation of inflammation and response to dexamethasone by Annexin 1 in antigen-induced arthritis.
Neoplasms
Molecular mechanism of kidney injury of mice caused by exposure to titanium dioxide nanoparticles.
Neoplasms
Molecular mechanisms and clinical studies of iguratimod for the treatment of ankylosing spondylitis.
Neoplasms
mRNA concentrations of MIF in subcutaneous abdominal adipose cells are associated with adipocyte size and insulin action.
Neoplasms
Multiplexed proximity ligation assays to profile putative plasma biomarkers relevant to pancreatic and ovarian cancer.
Neoplasms
New insights into the interplay between autophagy, gut microbiota and inflammatory responses in IBD.
Neoplasms
Non-alcoholic fatty liver disease is an independent risk factor for inflammation in obstructive sleep apnea syndrome in obese Asian Indians.
Neoplasms
Novel arylazoarylmethane as potential inhibitor of macrophage migration inhibitory factor.
Neoplasms
Null mutation for macrophage migration inhibitory factor (MIF) is associated with less aggressive bladder cancer in mice.
Neoplasms
Opposing roles of leptin and ghrelin in the equine corpus luteum regulation: an in vitro study.
Neoplasms
Oral squamous carcinoma cells promote macrophage polarization in an MIF-dependent manner.
Neoplasms
Osteopontin-positive infiltrating tumor-associated macrophages in bulky ampullary cancer predict survival.
Neoplasms
Osthole Attenuates Macrophage Activation in Experimental Asthma by Inhibitingthe NF-?B/MIF Signaling Pathway.
Neoplasms
Ovarian cancer cell-derived migration inhibitory factor enhances tumor growth, progression, and angiogenesis.
Neoplasms
Overexpression of macrophage migration inhibitory factor in adenoid cystic carcinoma: correlation with enhanced metastatic potential.
Neoplasms
Overexpression of macrophage migration inhibitory factor induces angiogenesis in human breast cancer.
Neoplasms
Oxidized macrophage migration inhibitory factor is a potential new tissue marker and drug target in cancer.
Neoplasms
Peroxisome Proliferator-Activated Receptor-gamma1 Gene Therapy Attenuates Atherosclerosis and Stabilizes Plaques in Apolipoprotein E-Deficient Mice.
Neoplasms
Pharmacological inhibition of macrophage migration inhibitory factor interferes with the proliferation and invasiveness of squamous carcinoma cells.
Neoplasms
Phase I study of imalumab (BAX69), a fully human recombinant antioxidized macrophage migration inhibitory factor antibody in advanced solid tumours.
Neoplasms
Plasma Macrophage Migration Inhibitory Factor and CCL3 as Potential Biomarkers for Distinguishing Patients with Nasopharyngeal Carcinoma from High Risk Individuals Who Have Positive Epstein-Barr Virus Capsid Antigen-Specific IgA.
Neoplasms
Potential Role of Macrophage Migration Inhibitory Factor in the Pathogenesis of Marek's Disease.
Neoplasms
Prevention of chronic deterioration of heart allograft by recombinant adeno-associated virus-mediated heme oxygenase-1 gene transfer.
Neoplasms
Primary study on the lesions and specific proteins in BEAS-2B cells induced with the 2009 A (H1N1) influenza virus.
Neoplasms
Production of macrophage migration inhibitory factor by human and murine neuroblastoma.
Neoplasms
Prognostic Implication of MIF Gene Expression in Childhood Acute Lymphoblastic Leukemia.
Neoplasms
Prognostic significance of cytoplasmic macrophage migration inhibitory factor expression in patients with squamous cell carcinoma of the head and neck treated with concurrent chemoradiotherapy.
Neoplasms
Prognostic significance of macrophage migration inhibitory factor expression in cancer patients: A systematic review and meta-analysis.
Neoplasms
Proinflammatory cytokines (tumor necrosis factor and interleukin 1) stimulate release of high mobility group protein-1 by pituicytes.
Neoplasms
Proliferation of NS0 cells in protein-free medium: the role of cell-derived proteins, known growth factors and cellular receptors.
Neoplasms
Protein expression profiling identifies macrophage migration inhibitory factor and cyclophilin a as potential molecular targets in non-small cell lung cancer.
Neoplasms
Proteolysis Targeting Chimera (PROTAC) for Macrophage Migration Inhibitory Factor (MIF) Has Anti-Proliferative Activity in Lung Cancer Cells.
Neoplasms
Proteomic analysis of osteogenic sarcoma: association of tumour necrosis factor with poor prognosis.
Neoplasms
Psychological distress and SSRI use predict variation in inflammatory cytokines during pregnancy.
Neoplasms
Pyrrolidine dithiocarbamate and dexamethasone are novel treatments of Acute Exogenous Lipoid Pneumonia.
Neoplasms
Recombinant Mycobacterium smegmatis delivering a fusion protein of human macrophage migration inhibitory factor (MIF) and IL-7 exerts an anticancer effect by inducing an immune response against MIF in a tumor-bearing mouse model.
Neoplasms
Reduction in arthritis severity and modulation of immune function in tissue factor cytoplasmic domain mutant mice.
Neoplasms
Relation between cytokine promoter gene polymorphism and toxicity of 5-fluorouracil plus cisplatin chemotherapy.
Neoplasms
Reply to Comment on "Osteopontin, Macrophage Migration Inhibitory Factor and Anti-Interleukin-8 Autoantibodies Complement CA125 for Detection of Early Stage Ovarian Cancer" Cancers 2019, 11, 596: Markers for Early Detection of Ovarian Cancer.
Neoplasms
Role of macrophage migration inhibitory factor in mesenchymal epithelial transition of cervical carcinoma cells.
Neoplasms
Role of macrophage migration inhibitory factor in otitis media with effusion in adults.
Neoplasms
Role of macrophage migration inhibitory factor in primary glioblastoma multiforme cells.
Neoplasms
Role of Macrophage Migration Inhibitory Factor in the Regulatory T Cell Response of Tumor-Bearing Mice.
Neoplasms
Serum and ascites levels of macrophage migration inhibitory factor, TNF-alpha and IL-6 in patients with chronic virus hepatitis B and hepatitis cirrhosis.
Neoplasms
Serum and salivary macrophage migration inhibitory factor in patients with oral squamous cell carcinoma.
Neoplasms
Serum macrophage migration inhibitory factor (MIF) levels after allogeneic hematopoietic stem cell transplantation.
Neoplasms
Sex steroid regulation of macrophage migration inhibitory factor in normal and inflamed colon in the female rat.
Neoplasms
Small-molecule inhibitors of macrophage migration inhibitory factor (MIF) as an emerging class of therapeutics for immune disorders.
Neoplasms
Structural and kinetic analyses of macrophage migration inhibitory factor active site interactions.
Neoplasms
Structural basis for decreased induction of class IB PI3-kinases expression by MIF inhibitors.
Neoplasms
Structure-activity relationships for binding of 4-substituted triazole-phenols to macrophage migration inhibitory factor (MIF).
Neoplasms
Suppression of tumor growth through introduction of an antisense plasmid of macrophage migration inhibitory factor.
Neoplasms
Surface expression of CD74 by type II alveolar epithelial cells: a potential mechanism for macrophage migration inhibitory factor-induced epithelial repair.
Neoplasms
Targeting Macrophage Migration Inhibitory Factor in Acute Pancreatitis and Pancreatic Cancer.
Neoplasms
Targeting MIF in Cancer: Therapeutic Strategies, Current Developments, and Future Opportunities.
Neoplasms
Targeting of interleukin-10 is superior to cytotoxic T-lymphocyte associated antigen 4 with human immunoglobulin G(1) for the prevention of chronic allograft deterioration in organ transplantation.
Neoplasms
Targeting the heat shock protein 90: a rational way to inhibit macrophage migration inhibitory factor function in cancer.
Neoplasms
The association between the migration inhibitory factor -173G/C polymorphism and cancer risk: a meta-analysis.
Neoplasms
The chronic spleen injury of mice following long-term exposure to titanium dioxide nanoparticles.
Neoplasms
The effects of spaceflight on mRNA levels for cytokines in proximal tibia of ovariectomized rats.
Neoplasms
The expression of macrophage migration inhibitory factor in the non-small cell lung cancer.
Neoplasms
The immunotoxicity of aluminum trichloride on rat peritoneal macrophages via ?2-adrenoceptors/cAMP pathway acted by norepinephrine.
Neoplasms
The increased concentration of macrophage migration inhibitory factor in serum and cerebrospinal fluid of patients with tick-borne encephalitis.
Neoplasms
The low expression of miR-451 predicts a worse prognosis in non-small cell lung cancer cases.
Neoplasms
The MIF -173G/C gene polymorphism increase gastrointestinal cancer and hematological malignancy risk: evidence from a meta-analysis and FPRP test.
Neoplasms
The modulation of PCSK-9 and GAGs by 10-dehydrogingerdione and pentoxifylline in hyperlipidemic rabbits.
Neoplasms
The N-terminus of MIF regulates the dynamic profile of residues involved in CD74 activation.
Neoplasms
The Role of Macrophage Migration Inhibitory Factor (MIF) in Ultraviolet Radiation-Induced Carcinogenesis.
Neoplasms
The short-term efficacy of DEB-TACE loaded with epirubicin and raltitrexed in the treatment of intermediate and advanced primary hepatocellular carcinoma.
Neoplasms
The tumour suppressor effects and regulation of cancer stem cells by macrophage migration inhibitory factor targeted miR-451 in colon cancer.
Neoplasms
The vitamin D analogue paricalcitol attenuates hepatic ischemia/reperfusion injury through down-regulation of Toll-like receptor 4 signaling in rats.
Neoplasms
Thioredoxin-1 suppresses systemic inflammatory responses against cigarette smoking.
Neoplasms
TLR7 and TLR8 agonist resiquimod (R848) differently regulates MIF expression in cells and organs.
Neoplasms
Tumor growth-promoting properties of macrophage migration inhibitory factor (MIF).
Neoplasms
Tumor necrosis factor-alpha regulates the gene expression of macrophage migration inhibitory factor through tyrosine kinase-dependent pathway in 3T3-L1 adipocytes.
Neoplasms
Tumor-derived macrophage migration inhibitory factor modulates the biology of head and neck cancer cells via neutrophil activation.
Neoplasms
Tumour necrosis factor-alpha up-regulates macrophage migration inhibitory factor expression in endometrial stromal cells via the nuclear transcription factor NF-kappaB.
Neoplasms
UHRF1 regulates the transcriptional repressor HBP1 through MIF in T acute lymphoblastic leukemia.
Neoplasms
Up-regulation of macrophage migration inhibitory factor gene and protein expression in glial tumor cells during hypoxic and hypoglycemic stress indicates a critical role for angiogenesis in glioblastoma multiforme.
Neoplasms
Update on the pathogenesis and treatment of systemic onset juvenile rheumatoid arthritis.
Neoplasms
Upregulation of macrophage migration inhibitory factor contributes to induced N-Myc expression by the activation of ERK signaling pathway and increased expression of interleukin-8 and VEGF in neuroblastoma.
Neoplasms
Upregulation of macrophage migration inhibitory factor promotes tumor metastasis and correlates with poor prognosis of pancreatic ductal adenocarcinoma.
Neoplasms
Urotensin II upregulates migration and cytokine gene expression in leukocytes of the African clawed frog, Xenopus laevis.
Neoplasms
Vitamin D Receptor Gene Polymorphisms and Risk of Knee Osteoarthritis: Possible Correlations with TNF-?, Macrophage Migration Inhibitory Factor, and 25-Hydroxycholecalciferol Status.
Neoplasms
[Increased cell migration of nasopharyngeal carcinoma cell lines in vitro by macrophage migration inhibitory factor]
Neoplasms
[Inhibitory effect of emodin on the growth of cervical cancer in tumor-transplanted mice and underlying mechanism].
Neoplasms
[Serum levels of macrophage migration inhibitory factor and interleukin-8 in hepatocellular carcinoma patients: their correlations with tumor progression and prognosis]
Neoplasms
[The relationship between expression of macrophage migration inhibitory factor and prognosis of breast cancer]
Nephritis
Interferon-gamma induces macrophage migration inhibitory factor synthesis and secretion by tubular epithelial cells.
Nephritis
Urinary Macrophage Migration Inhibitory Factor as a Noninvasive Biomarker in Pediatric Henoch-Schönlein Purpura Nephritis.
Nephritis
[Renal expression of macrophage migration inhibitory factor in children with Henoch-Sch-nlein purpura nephritis]
Nephrotic Syndrome
Association of macrophage migration inhibitory factor -173C allele polymorphism with steroid resistance in children with nephrotic syndrome.
Nephrotic Syndrome
Association of the macrophage migration inhibitory factor -173*C allele with childhood nephrotic syndrome.
Nephrotic Syndrome
Macrophage Migration Inhibitory Factor -173 G>C Gene Polymorphism Is Associated with Increased Risk of Nephrotic Syndrome in Children.
Nervous System Diseases
Adult astrocytes from reptiles are resistant to proinflammatory activation via sustaining Vav1 expression.
Nervous System Diseases
Optimization of Pyrazoles as Phenol Surrogates to Yield Potent Inhibitors of Macrophage Migration Inhibitory Factor.
Neuralgia
Expression of macrophage migration inhibitory factor in footpad skin lesions with diabetic neuropathy.
Neuralgia
Glucocorticoids and macrophage migration inhibitory factor (MIF) are neuroendocrine modulators of inflammation and neuropathic pain after spinal cord injury.
Neuralgia
Macrophage migration inhibitory factor (MIF) is essential for inflammatory and neuropathic pain and enhances pain in response to stress.
Neuralgia
Spinal macrophage migration inhibitory factor is a major contributor to rodent neuropathic pain-like hypersensitivity.
Neuritis
Macrophage migration inhibitory factor (MIF) seems crucially involved in Guillain-Barré syndrome and experimental allergic neuritis.
Neuritis
Roles of macrophage migration inhibitory factor in Guillain-Barré syndrome and experimental autoimmune neuritis: beneficial or harmful?
Neuritis, Autoimmune, Experimental
Macrophage migration inhibitory factor (MIF) seems crucially involved in Guillain-Barré syndrome and experimental allergic neuritis.
Neuritis, Autoimmune, Experimental
Roles of macrophage migration inhibitory factor in Guillain-Barré syndrome and experimental autoimmune neuritis: beneficial or harmful?
Neuroblastoma
Emerging Role of the Macrophage Migration Inhibitory Factor Family of Cytokines in Neuroblastoma. Pathogenic Effectors and Novel Therapeutic Targets?
Neuroblastoma
Expression of macrophage migration inhibitory factor by neuroblastoma leads to the inhibition of antitumor T cell reactivity in vivo.
Neuroblastoma
Inhibition of tumor growth and metastasis in vitro and in vivo by targeting macrophage migration inhibitory factor in human neuroblastoma.
Neuroblastoma
MicroRNA?451 inhibits neuroblastoma proliferation, invasion and migration by targeting macrophage migration inhibitory factor.
Neuroblastoma
Normalization and analysis of cDNA microarrays using within-array replications applied to neuroblastoma cell response to a cytokine.
Neuroblastoma
Overexpression of Macrophage Migration Inhibitory Factor and Its Homologue D-Dopachrome Tautomerase as Negative Prognostic Factor in Neuroblastoma.
Neuroblastoma
Production of macrophage migration inhibitory factor by human and murine neuroblastoma.
Neuroblastoma
Removing intensity effects and identifying significant genes for Affymetrix arrays in macrophage migration inhibitory factor-suppressed neuroblastoma cells.
Neuroblastoma
Upregulation of macrophage migration inhibitory factor contributes to induced N-Myc expression by the activation of ERK signaling pathway and increased expression of interleukin-8 and VEGF in neuroblastoma.
Neurodegenerative Diseases
Discovery of Novel Inhibitors of the Tautomerase Activity of Macrophage Migration Inhibitory Factor (MIF).
Neurogenic Inflammation
Substance P induced release of macrophage migration inhibitory factor from rat bladder epithelium.
Neuroinflammatory Diseases
CSF macrophage migration inhibitory factor levels did not predict steroid treatment response after optic neuritis in patients with multiple sclerosis.
Neuroinflammatory Diseases
Macrophage migration inhibitory factor potentiates autoimmune-mediated neuroinflammation.
Neuroinflammatory Diseases
New insights into meningitic Escherichia coli infection of brain microvascular endothelial cells from quantitative proteomics analysis.
Neurologic Manifestations
Macrophage migration inhibitory factor promotes cell death and aggravates neurologic deficits after experimental stroke.
Neurosyphilis
Macrophage migration inhibitory factor as a novel cerebrospinal fluid marker for neurosyphilis among HIV-negative patients.
Niemann-Pick Disease, Type C
New insights into the interplay between autophagy, gut microbiota and inflammatory responses in IBD.
Niemann-Pick Diseases
New insights into the interplay between autophagy, gut microbiota and inflammatory responses in IBD.
Non-alcoholic Fatty Liver Disease
Macrophage migration inhibitory factor expression and MIF gene -173 G/C polymorphism in nonalcoholic fatty liver disease.
Non-alcoholic Fatty Liver Disease
Non-alcoholic fatty liver disease is an independent risk factor for inflammation in obstructive sleep apnea syndrome in obese Asian Indians.
Non-alcoholic Fatty Liver Disease
Protective role of macrophage migration inhibitory factor in nonalcoholic steatohepatitis.
Non-alcoholic Fatty Liver Disease
Unexpected Pro-Fibrotic Effect of MIF in Non-Alcoholic Steatohepatitis Is Linked to a Shift in NKT Cell Populations.
Obesity
Energy Expenditure Regulation Via Macrophage Migration Inhibitory Factor (MIF) in Obesity and In Vitro Anti-MIF Effect of Alpinia Officinarum Hance Extraction.
Obesity
Impaired myocardial MIF/AMPK activation aggravates myocardial ischemia reperfusion injury in high-fat diet-induced obesity.
Obesity
Increased activity of interleukin-23/interleukin-17 proinflammatory axis in obese women.
Obesity
Insights into the role of macrophage migration inhibitory factor in obesity and insulin resistance.
Obesity
Macrophage migration inhibitory factor (MIF) knockout preserves cardiac homeostasis through alleviating Akt-mediated myocardial autophagy suppression in high-fat diet-induced obesity.
Obesity
Macrophage migration inhibitory factor deficiency protects pancreatic islets from palmitic acid-induced apoptosis.
Obesity
Macrophage migration inhibitory factor: critical role in obesity, insulin resistance, and associated comorbidities.
Obesity
Phenotyping of circulating extracellular vesicles (EVs) in obesity identifies large EVs as functional conveyors of Macrophage Migration Inhibitory Factor.
Obesity
Promoter polymorphism in the macrophage migration inhibitory factor gene is associated with obesity.
Obesity
Role of macrophage migration inhibitory factor in head and neck cancer and novel therapeutic targets: A systematic review.
Obesity
Role of Macrophage Migration Inhibitory Factor in Obesity, Insulin Resistance, Type 2 Diabetes, and Associated Hepatic Co-Morbidities: A Comprehensive Review of Human and Rodent Studies.
Obesity
Tautomerase Activity-Lacking of the Macrophage Migration Inhibitory Factor Alleviates the Inflammation and Insulin Tolerance in High Fat Diet-Induced Obese Mice.
Obesity
The macrophage migration inhibitory factor protein superfamily in obesity and wound repair.
Obesity, Abdominal
Enhanced Inflammation without Impairment of Insulin Signaling in the Visceral Adipose Tissue of 5?-Dihydrotestosterone-Induced Animal Model of Polycystic Ovary Syndrome.
Obesity, Morbid
Rectal epithelial cell mitosis and expression of macrophage migration inhibitory factor are increased 3 years after Roux-en-Y gastric bypass (RYGB) for morbid obesity: implications for long-term neoplastic risk following RYGB.
Optic Neuritis
CSF macrophage migration inhibitory factor levels did not predict steroid treatment response after optic neuritis in patients with multiple sclerosis.
Orchitis
Cell-mediated and humoral immune responses to aspermatogenic antigen in experimental allergic orchitis in the guinea-pig.
Osteoarthritis
Deletion of Macrophage Migration Inhibitory Factor Reduces Severity of Osteoarthritis in Aged Mice.
Osteoarthritis
Macrophage migration inhibitory factor may play a protective role in osteoarthritis.
Osteoarthritis
Secretory activity of subcutaneous abdominal adipose tissue in male patients with rheumatoid arthritis and osteoarthritis - association with clinical and laboratory data.
Osteoarthritis, Knee
Synovial Fluid Macrophage Migration Inhibitory Factor Levels Correlate with Severity of Self-Reported Pain in Knee Osteoarthritis Patients.
Osteoarthritis, Knee
Vitamin D Receptor Gene Polymorphisms and Risk of Knee Osteoarthritis: Possible Correlations with TNF-?, Macrophage Migration Inhibitory Factor, and 25-Hydroxycholecalciferol Status.
Osteoporosis
Transgenic mice overexpressing macrophage migration inhibitory factor (MIF) exhibit high-turnover osteoporosis.
Osteoporosis, Postmenopausal
[Role of macrophage migration inhibitory factor in pathogenesis of post-menopausal osteoporosis]
Osteosarcoma
A novel androstenedione derivative induces ROS-mediated autophagy and attenuates drug resistance in osteosarcoma by inhibiting macrophage migration inhibitory factor (MIF).
Osteosarcoma
Differential expression of cytokines in rat osteosarcoma and malignant fibrous histiocytoma cell lines induced by 4-(hydroxyamino)quinoline-1-oxide.
Osteosarcoma
Expression of macrophage migration inhibitory factor relates to survival in high-grade osteosarcoma.
Osteosarcoma
Macrophage migration inhibitory factor promotes osteosarcoma growth and lung metastasis through activating the RAS/MAPK pathway.
Osteosarcoma
MiR-451 suppresses proliferation, migration and promotes apoptosis of the human osteosarcoma by targeting macrophage migration inhibitory factor.
Otitis
Expression of macrophage migration inhibitory factor and CD74 in the inner ear and middle ear in lipopolysaccharide-induced otitis media.
Otitis Media
Blocking macrophage migration inhibitory factor activity alleviates mouse acute otitis media in vivo.
Otitis Media
Expression of macrophage migration inhibitory factor and CD74 in the inner ear and middle ear in lipopolysaccharide-induced otitis media.
Otitis Media
Role of Macrophage Migration Inhibitory Factor in NLRP3 Inflammasome Expression in Otitis Media.
Otitis Media
Role of macrophage migration inhibitory factor in otitis media with effusion in adults.
Otitis Media
Up-regulation of macrophage migration inhibitory factor induced by endotoxin in experimental otitis media with effusion in mice.
Otitis Media with Effusion
Role of macrophage migration inhibitory factor in otitis media with effusion in adults.
Otitis Media with Effusion
Up-regulation of macrophage migration inhibitory factor induced by endotoxin in experimental otitis media with effusion in mice.
Out-of-Hospital Cardiac Arrest
Blood levels of macrophage migration inhibitory factor after successful resuscitation from cardiac arrest.
Ovarian Neoplasms
Automated Assay of a Four-Protein Biomarker Panel for Improved Detection of Ovarian Cancer.
Ovarian Neoplasms
Clinical significance of macrophage migration inhibitory factor in invasion of ovarian cancer.
Ovarian Neoplasms
Combinatorial peptide libraries facilitate development of multiple reaction monitoring assays for low-abundance proteins.
Ovarian Neoplasms
Comment on "Osteopontin, Macrophage Migration Inhibitory Factor and Anti-Interleukin-8 Autoantibodies Complement CA125 for Detection of Early Stage Ovarian Cancer" Cancers 2019, 11, 596: Markers for Early Detection of Ovarian Cancer.
Ovarian Neoplasms
Human Leukocyte Antigen-Presented Macrophage Migration Inhibitory Factor Is a Surface Biomarker and Potential Therapeutic Target for Ovarian Cancer.
Ovarian Neoplasms
Macrophage migration inhibitory factor contributes to the immune escape of ovarian cancer by down-regulating NKG2D.
Ovarian Neoplasms
Multiplexed proximity ligation assays to profile putative plasma biomarkers relevant to pancreatic and ovarian cancer.
Ovarian Neoplasms
NF-kappaB, macrophage migration inhibitory factor and cyclooxygenase-inhibitions as likely mechanisms behind the acetaminophen- and NSAID-prevention of the ovarian cancer.
Ovarian Neoplasms
Osteopontin, Macrophage Migration Inhibitory Factor and Anti-Interleukin-8 Autoantibodies Complement CA125 for Detection of Early Stage Ovarian Cancer.
Ovarian Neoplasms
Ovarian cancer cell-derived migration inhibitory factor enhances tumor growth, progression, and angiogenesis.
Ovarian Neoplasms
Reply to Comment on "Osteopontin, Macrophage Migration Inhibitory Factor and Anti-Interleukin-8 Autoantibodies Complement CA125 for Detection of Early Stage Ovarian Cancer" Cancers 2019, 11, 596: Markers for Early Detection of Ovarian Cancer.
Pain Insensitivity, Congenital
Lymphocyte TRPV 1-4 Gene Expression and MIF Blood Levels in a Young Girl Clinically Diagnosed With HSAN IV.
Pancreatic Neoplasms
A Novel MIF Signaling Pathway Drives the Malignant Character of Pancreatic Cancer by Targeting NR3C2.
Pancreatic Neoplasms
Macrophage migration inhibitory factor is overexpressed in pancreatic cancer tissues and impairs insulin secretion function of beta-cell.
Pancreatic Neoplasms
Macrophage migration inhibitory factor of Syrian golden hamster shares structural and functional similarity with human counterpart and promotes pancreatic cancer.
Pancreatic Neoplasms
Multiplexed proximity ligation assays to profile putative plasma biomarkers relevant to pancreatic and ovarian cancer.
Pancreatic Neoplasms
Pilot study of blood biomarker candidates for detection of pancreatic cancer.
Pancreatic Neoplasms
Proteomic and tissue array profiling identifies elevated hypoxia-regulated proteins in pancreatic ductal adenocarcinoma.
Pancreatic Neoplasms
Targeting Macrophage Migration Inhibitory Factor in Acute Pancreatitis and Pancreatic Cancer.
Pancreatitis
Deletion of macrophage migration inhibitory factor ameliorates inflammation in mice model severe acute pancreatitis.
Pancreatitis
Different profiles of cytokine expression during mild and severe acute pancreatitis.
Pancreatitis
Gene polymorphisms of the macrophage migration inhibitory factor and acute pancreatitis.
Pancreatitis
Inhibition of macrophage migration inhibitory factor attenuates inflammation and fetal kidney injury in a rat model of acute pancreatitis in pregnancy.
Pancreatitis
Inhibition of macrophage migration inhibitory factor prevents thyroid dysfunction in pregnant rats with acute pancreatitis.
Pancreatitis
Macrophage migration inhibitory factor antagonist (S,R)3?(4?hydroxyphenyl)?4,5?dihydro?5?isoxazole acetic acid methyl ester attenuates inflammation and lung injury in rats with acute pancreatitis in pregnancy.
Pancreatitis
Macrophage migration inhibitory factor is a critical mediator of severe acute pancreatitis.
Pancreatitis
Macrophage migration inhibitory factor is an early marker of severe acute pancreatitis based on the revised Atlanta classification.
Pancreatitis
Protective effect of chlorogenic acid on the inflammatory damage of pancreas and lung in mice with l-arginine-induced pancreatitis.
Pancreatitis
Role of macrophage migration inhibitory factor in acute lung injury in mice with acute pancreatitis complicated by endotoxemia.
Pancreatitis
Serum macrophage migration inhibitory factor is an early marker of pancreatic necrosis in acute pancreatitis.
Pancreatitis
Targeting Macrophage Migration Inhibitory Factor in Acute Pancreatitis and Pancreatic Cancer.
Pancreatitis, Acute Necrotizing
Inhibition of macrophage migration inhibitory factor attenuates inflammation and fetal kidney injury in a rat model of acute pancreatitis in pregnancy.
Pancreatitis, Acute Necrotizing
Serum macrophage migration inhibitory factor is an early marker of pancreatic necrosis in acute pancreatitis.
Papillomavirus Infections
Influence of Epstein-Barr virus and human papillomavirus infection on macrophage migration inhibitory factor and macrophage polarization in nasopharyngeal carcinoma.
Papillomavirus Infections
Involvement of HPV Infection in the Release of Macrophage Migration Inhibitory Factor in Head and Neck Squamous Cell Carcinoma.
Paramyxoviridae Infections
Emerging views of mitophagy in immunity and autoimmune diseases.
Parasitemia
A macrophage migration inhibitory factor promoter polymorphism is associated with high-density parasitemia in children with malaria.
Parasitemia
Expression of erythropoietic cytokines in ?-tocopherol transfer protein knockout mice with murine malaria infection.
Parasitemia
Microbial translocation induces an intense proinflammatory response in visceral leishmaniasis patients co-infected with HIV-1.
Parasitemia
Plasma concentration of malaria parasite-derived macrophage migration inhibitory factor in uncomplicated malaria patients correlates with parasitemia and disease severity.
Parasitic Diseases
A computational assessment of the predicted structures of Human Macrophage Migration Inhibitory Factor 1 orthologs in parasites and its affinity to human CD74 receptor.
Parasitic Diseases
A macrophage migration inhibitory factor promoter polymorphism is associated with high-density parasitemia in children with malaria.
Parasitic Diseases
Decreased circulating macrophage migration inhibitory factor (MIF) protein and blood mononuclear cell MIF transcripts in children with Plasmodium falciparum malaria.
Parasitic Diseases
Higher production of peripheral blood macrophage migration inhibitory factor in healthy children with a history of mild malaria relative to children with a history of severe malaria.
Parasitic Diseases
MIF synergizes with Trypanosoma cruzi antigens to promote efficient dendritic cell maturation and IL-12 production via p38 MAPK.
Parasitic Diseases
Toxoplasma gondii: Impaired maturation and pro-inflammatory response of dendritic cells in MIF-deficient mice favors susceptibility to infection.
Parkinson Disease
Effects of macrophage migration inhibitory factor and macrophage migration stimulatory factor on function and survival of foetal dopaminergic grafts in the 6-hydroxydopamine rat model of Parkinson's disease.
Parkinson Disease
Macrophage Migration Inhibitory Factor Mediates Neuroprotective Effects by Regulating Inflammation, Apoptosis and Autophagy in Parkinson's Disease.
Parkinson Disease
Microglial autophagy defect causes parkinson disease-like symptoms by accelerating inflammasome activation in mice.
Parkinson Disease
Parkinson's disease is associated with increased serum levels of macrophage migration inhibitory factor.
Pemphigoid, Benign Mucous Membrane
Role of macrophage migration inhibitory factor in conjunctival pathology in ocular cicatricial pemphigoid.
Pemphigus
Marked elevation of serum macrophage migration inhibitory factor levels in patients with pemphigus vulgaris.
Pemphigus
Microphage migration inhibitory factor gene polymorphism is not associated with pemphigus vulgaris in Iranian patients.
Peptic Ulcer
Functional promoter polymorphisms of macrophage migration inhibitory factor in peptic ulcer diseases.
Periapical Periodontitis
Macrophage migration inhibitory factor gene polymorphisms as exacerbating factors of apical periodontitis.
Periodontitis
Elevated Expression of Macrophage Migration Inhibitory Factor Promotes Inflammatory Bone Resorption Induced in a Mouse Model of Periradicular Periodontitis.
Periodontitis
Expression profile of macrophage migration inhibitory factor in periodontitis.
Periodontitis
The expression of macrophage migration inhibitory factor and intercellular adhesion molecule-1 in rats with periodontitis and atherosclerosis.
Periodontitis
[Expression of SFRP1 and MIF in elderly patients with severe periodontitis and its correlation with cognitive function].
Peripheral Nerve Injuries
Changes in content of macrophage migration inhibitory factor secreted by Schwann cells after peripheral nerve injury.
Peripheral Nerve Injuries
[Expression of macrophage migration inhibitory factor mRNA in Schwann cells]
phenylpyruvate tautomerase deficiency
Macrophage migration inhibitory factor deficiency aggravates effects of fructose-enriched diet on lipid metabolism in the mouse liver.
phenylpyruvate tautomerase deficiency
Macrophage migration inhibitory factor deficiency ameliorates high-fat diet induced insulin resistance in mice with reduced adipose inflammation and hepatic steatosis.
phenylpyruvate tautomerase deficiency
Macrophage migration inhibitory factor deficiency attenuates macrophage recruitment, glomerulonephritis, and lethality in MRL/lpr mice.
phenylpyruvate tautomerase deficiency
Macrophage Migration Inhibitory Factor Deficiency Augments Cardiac Dysfunction in Type 1 Diabetic Murine Cardiomyocytes.
phenylpyruvate tautomerase deficiency
Macrophage migration inhibitory factor deficiency augments doxorubicin-induced cardiomyopathy.
phenylpyruvate tautomerase deficiency
Macrophage Migration Inhibitory Factor Deficiency Causes Prolonged Hearing Loss After Acoustic Overstimulation.
phenylpyruvate tautomerase deficiency
Macrophage migration inhibitory factor deficiency enhances immune response to Nippostrongylus brasiliensis.
phenylpyruvate tautomerase deficiency
Macrophage migration inhibitory factor deficiency impairs atherosclerosis in low-density lipoprotein receptor-deficient mice.
phenylpyruvate tautomerase deficiency
Macrophage migration inhibitory factor deficiency in chronic obstructive pulmonary disease.
phenylpyruvate tautomerase deficiency
Macrophage migration inhibitory factor deficiency is associated with altered cell growth and reduced susceptibility to Ras-mediated transformation.
phenylpyruvate tautomerase deficiency
Macrophage migration inhibitory factor deficiency is associated with impaired killing of gram-negative bacteria by macrophages and increased susceptibility to Klebsiella pneumoniae sepsis.
phenylpyruvate tautomerase deficiency
Macrophage migration inhibitory factor deficiency leads to age-dependent impairment of glucose homeostasis in mice.
phenylpyruvate tautomerase deficiency
Macrophage migration inhibitory factor deficiency protects pancreatic islets from cytokine-induced apoptosis in vitro.
phenylpyruvate tautomerase deficiency
Macrophage migration inhibitory factor deficiency protects pancreatic islets from palmitic acid-induced apoptosis.
Pituitary ACTH Hypersecretion
Response of serum macrophage migration inhibitory factor levels to stimulation or suppression of the hypothalamo-pituitary-adrenal axis in normal subjects and patients with Cushing's disease.
Pituitary Neoplasms
Immunocytochemical localization of macrophage migration inhibitory factor in human hypophysis and pituitary adenomas.
Pituitary Neoplasms
Macrophage migration inhibitory factor expression is increased in pituitary adenoma cell nuclei.
Pneumonia
Aggravation of Bleomycin-Induced Pulmonary Inflammation and Fibrosis in Mice Lacking Peroxiredoxin I.
Pneumonia
Evaluation of the relationship between macrophage migration inhibitory factor level and clinical course in patients with COVID-19 pneumonia.
Pneumonia
Macrophage migration inhibitory factor enzymatic activity, lung inflammation, and cystic fibrosis.
Pneumonia
Macrophage migration inhibitory factor promotes clearance of pneumococcal colonization.
Pneumonia
Role of macrophage migration inhibitory factor in influenza H5N1 virus pneumonia.
Pneumonia
The influence of macrophage migration inhibitory factor gene polymorphisms on outcome from community-acquired pneumonia.
Pneumonia, Pneumococcal
Macrophage Migration Inhibitory Factor Is Detrimental in Pneumococcal Pneumonia and a Target for Therapeutic Immunomodulation.
Polychondritis, Relapsing
Serum level of macrophage migration inhibitory factor as a useful parameter of clinical course in patients with Wegener's granulomatosis and relapsing polychondritis.
Polycystic Kidney Diseases
Macrophage migration inhibitory factor is regulated by HIF-1? and cAMP and promotes renal cyst cell proliferation in a macrophage-independent manner.
Polycystic Kidney Diseases
Macrophage migration inhibitory factor promotes cyst growth in polycystic kidney disease.
Polycystic Kidney Diseases
Polycystic kidney disease: Macrophage migration inhibitory factor regulates cyst growth in ADPKD.
Polycystic Kidney, Autosomal Dominant
Macrophage migration inhibitory factor promotes cyst growth in polycystic kidney disease.
Polycystic Kidney, Autosomal Dominant
Polycystic kidney disease: Macrophage migration inhibitory factor regulates cyst growth in ADPKD.
Polycystic Ovary Syndrome
A possible link between luteinizing hormone and macrophage migration inhibitory factor levels in polycystic ovary syndrome.
Polycystic Ovary Syndrome
Elevated circulating levels of macrophage migration inhibitory factor in polycystic ovary syndrome.
Polycystic Ovary Syndrome
Macrophage migration inhibitory factor in obese and non obese women with polycystic ovary syndrome.
Polycystic Ovary Syndrome
MIF May Participate in Pathogenesis of Polycystic Ovary Syndrome in Rats through MAPK Signalling Pathway.
Polymyositis
Roles of macrophage migration inhibitory factor in polymyositis: Inflammation and regeneration.
Post-Cardiac Arrest Syndrome
MIF reflects tissue damage rather than inflammation in post-cardiac arrest syndrome in a real life cohort.
Pre-Eclampsia
Increased levels of macrophage migration inhibitory factor (MIF) in preeclampsia.
Pre-Eclampsia
Lower Macrophage Migration Inhibitory Factor Concentrations in Maternal Serum Before Pre-Eclampsia Onset.
Pre-Eclampsia
Macrophage migration inhibition factor is elevated in pregnancy, but not to a greater extent in preeclampsia.
Pre-Eclampsia
Maternal and umbilical cord blood level of macrophage migration inhibitory factor and insulin like growth factor in Sudanese women with preeclampsia.
Pre-Eclampsia
Role of the Macrophage Migration Inhibitory Factor in the Pathophysiology of Pre-Eclampsia.
Pre-Eclampsia
[Association between severe preeclampsia and single nucleotide polymorphism of macrophage migration inhibitory factors -173G/C].
Pre-Eclampsia
[Expression of macrophage migration inhibitory factor and CD74 in preeclamptic placenta and its correlation with preeclampsia].
Precursor Cell Lymphoblastic Leukemia-Lymphoma
UHRF1 regulates the transcriptional repressor HBP1 through MIF in T acute lymphoblastic leukemia.
Prediabetic State
Relationship Between Serum Macrophage Migration Inhibitory Factor Level and Insulin Resistance, High-Sensitivity C-Reactive Protein and Visceral Fat Mass in Prediabetes.
Pregnancy Complications
Intervillous macrophage migration inhibitory factor is associated with adverse birth outcomes in a study population in Central India.
Premature Birth
Differential patterns of 27 cord blood immune biomarkers across gestational age.
Prostatic Hyperplasia
The role of macrophage migration inhibitory factor in promoting benign prostatic hyperplasia epithelial cell growth by modulating COX-2 and P53 signaling.
Prostatic Neoplasms
Clinical utility of serum macrophage migration inhibitory factor in men with prostate cancer as a novel biomarker of detection and disease progression.
Prostatic Neoplasms
COX-2 specific inhibitor, NS-398, increases macrophage migration inhibitory factor expression and induces neuroendocrine differentiation in C4-2b prostate cancer cells.
Prostatic Neoplasms
Diagnostic validity of macrophage migration inhibitory factor in serum of patients with prostate cancer: a re-evaluation.
Prostatic Neoplasms
Further evidence for increased macrophage migration inhibitory factor expression in prostate cancer.
Prostatic Neoplasms
Increased stability of macrophage migration inhibitory factor (MIF) in DU-145 prostate cancer cells.
Prostatic Neoplasms
Inhibition of macrophage migration inhibitory factor or its receptor (CD74) attenuates growth and invasion of DU-145 prostate cancer cells.
Prostatic Neoplasms
Linking inflammation and neuroendocrine differentiation: the role of macrophage migration inhibitory factor-mediated signaling in prostate cancer.
Prostatic Neoplasms
Macrophage migration inhibitory factor (MIF) gene polymorphisms are associated with increased prostate cancer incidence.
Prostatic Neoplasms
Macrophage migration inhibitory factor is a direct target of HBP1-mediated transcriptional repression that is overexpressed in prostate cancer.
Prostatic Neoplasms
Release of macrophage migration inhibitory factor by neuroendocrine-differentiated LNCaP cells sustains the proliferation and survival of prostate cancer cells.
Prostatic Neoplasms
Role of macrophage migration inhibitory factor in primary glioblastoma multiforme cells.
Prostatic Neoplasms
Serum macrophage migration inhibitory factor is not elevated in patients with prostate cancer.
Proteinuria
Assessment of serum macrophage migration inhibitory factor (MIF), adiponectin, and other adipokines as potential markers of proteinuria and renal dysfunction in lupus nephritis: a cross-sectional study.
Protozoan Infections
Macrophage migration inhibitory factor (MIF): a key player in protozoan infections.
Pruritus
Berberine induces anti-atopic dermatitis effects through the downregulation of cutaneous EIF3F and MALT1 in NC/Nga mice with atopy-like dermatitis.
Pruritus
Measurement of serum macrophage migration inhibitory factor (MIF) and correlation with severity and pruritus scores in client owned dogs with atopic dermatitis.
Psoriasis
Dimethylfumarate inhibits MIF-induced proliferation of keratinocytes by inhibiting MSK1 and RSK1 activation and by inducing nuclear p-c-Jun (S63) and p-p53 (S15) expression.
Psoriasis
High macrophage migration inhibitory factor (MIF) serum levels associated with extended psoriasis.
Psoriasis
Histochemical analysis of macrophage migration inhibitory factor in psoriasis vulgaris.
Psoriasis
Macrophage migration inhibitory factor gene polymorphism is associated with psoriasis.
Psoriasis
Macrophage migration inhibitory factor gene polymorphisms (SNP -173 G>C and STR-794 CATT5-8) confer risk of plaque psoriasis: A case-control study.
Psoriasis
Protein phosphatase 2C?/Wip1 regulates phospho-p90RSK2 activity in lesional psoriatic skin.
Psoriasis
Single-nucleotide polymorphism and haplotype analysis of macrophage migration inhibitory factor gene and its correlation with serum macrophage migration inhibitory factor levels in North Indian psoriatic patients with moderate disease severity: A cross-sectional study.
Psoriasis
Synthesis and bio-evaluation of human macrophage migration inhibitory factor inhibitor to develop anti-inflammatory agent.
Pulmonary Arterial Hypertension
Complexity of macrophage migration inhibitory factor (MIF) and other angiogenic biomarkers profiling in pulmonary arterial hypertension.
Pulmonary Arterial Hypertension
Design, Synthesis, and Biological Activity of New N-(Phenylmethyl)-benzoxazol-2-thiones as Macrophage Migration Inhibitory Factor (MIF) Antagonists: Efficacies in Experimental Pulmonary Hypertension.
Pulmonary Arterial Hypertension
Elevated serum levels of macrophage migration inhibitory factor and stem cell growth factor ? in patients with idiopathic and systemic sclerosis associated pulmonary arterial hypertension.
Pulmonary Arterial Hypertension
Macrophage migration inhibitory factor (MIF) in the development and progression of pulmonary arterial hypertension.
Pulmonary Arterial Hypertension
Macrophage Migration Inhibitory Factor in Clinical Kidney Disease.
Pulmonary Disease, Chronic Obstructive
A functional macrophage migration inhibitory factor promoter polymorphism is associated with reduced diffusing capacity.
Pulmonary Disease, Chronic Obstructive
Effect of infliximab on local and systemic inflammation in chronic obstructive pulmonary disease: a pilot study.
Pulmonary Disease, Chronic Obstructive
Genetic regulation of gene expression of MIF family members in lung tissue.
Pulmonary Disease, Chronic Obstructive
Macrophage migration inhibitory factor deficiency in chronic obstructive pulmonary disease.
Pulmonary Disease, Chronic Obstructive
Macrophage migration inhibitory factor, a role in COPD.
Pulmonary Disease, Chronic Obstructive
Macrophage Migration Inhibitory Factor: A Novel Inhibitor of Apoptosis Signal-Regulating Kinase 1-p38-Xanthine Oxidoreductase-Dependent Cigarette Smoke-Induced Apoptosis.
Pulmonary Disease, Chronic Obstructive
Non-small cell lung cancer is characterised by a distinct inflammatory signature in serum compared with chronic obstructive pulmonary disease.
Pulmonary Disease, Chronic Obstructive
Prediction of sarcopenia using a battery of circulating biomarkers.
Pulmonary Disease, Chronic Obstructive
Progress in the mechanism and targeted drug therapy for COPD.
Pulmonary Disease, Chronic Obstructive
Role of macrophage migration inhibitory factor (MIF) in allergic and endotoxin-induced airway inflammation in mice.
Pulmonary Disease, Chronic Obstructive
[Electroacupuncture Improves Pulmonary Function of Rats with Chronic Obstructive Pulmonary Disease by Down-regulating Inflammatory Reaction and Expression of Macrophage Migration Inhibitory Factor/CD 74-CD 44/p 38 MAPK Signaling in Lung Tissues].
Pulmonary Fibrosis
Inhibition of macrophage migration inhibitory factor (MIF) as a therapeutic target in bleomycin-induced pulmonary fibrosis rats.
Pulmonary Fibrosis
Macrophage Migration Inhibitory Factor (MIF) Inhibition in a Murine Model of Bleomycin-Induced Pulmonary Fibrosis.
Purpura
Lack of association between macrophage migration inhibitory factor gene (-173 G/C) polymorphism and cutaneous vasculitis.
Purpura
Lack of association between macrophage migration inhibitory factor gene promoter (-173 G/C) polymorphism and childhood Henoch-Schönlein purpura in Turkish patients.
Purpura
Urinary Macrophage Migration Inhibitory Factor as a Noninvasive Biomarker in Pediatric Henoch-Schönlein Purpura Nephritis.
Purpura
[Renal expression of macrophage migration inhibitory factor in children with Henoch-Sch-nlein purpura nephritis]
Purpura, Thrombocytopenic, Idiopathic
Polymorphism and expression of macrophage migration inhibitory factor does not contribute to glucocorticoid resistance in idiopathic thrombocytopenic purpura.
Pyelonephritis
Urinary macrophage migration inhibitory factor serves as a potential biomarker for acute kidney injury in patients with acute pyelonephritis.
Pyelonephritis
Urine macrophage migration inhibitory factor (MIF) in children with urinary tract infection: a possible predictor of acute pyelonephritis.
Renal Insufficiency, Chronic
Elevated serum macrophage migration inhibitory factor (MIF) concentrations in chronic kidney disease (CKD) are associated with markers of oxidative stress and endothelial activation.
Renal Insufficiency, Chronic
Expressions of macrophage migration inhibitory factor in patients with chronic kidney disease.
Reperfusion Injury
Deletion of macrophage migration inhibitory factor protects the heart from severe ischemia-reperfusion injury: A predominant role of anti-inflammation.
Reperfusion Injury
Early release of macrophage migration inhibitory factor after liver ischemia and reperfusion injury in rats.
Reperfusion Injury
Effects of macrophage migration inhibitory factor on cardiac reperfusion injury in mice with depression induced by constant-darkness.
Reperfusion Injury
The protective role of macrophage migration inhibitory factor in acute kidney injury after cardiac surgery.
Respiratory Distress Syndrome
Direct link between cytokine activity and a catalytic site for macrophage migration inhibitory factor.
Respiratory Distress Syndrome
Human circulating eosinophils secrete macrophage migration inhibitory factor (MIF). Potential role in asthma.
Respiratory Distress Syndrome
Macrophage Migration Inhibitory Factor (MIF) Plasma Concentration in Critically Ill COVID-19 Patients: A Prospective Observational Study.
Respiratory Distress Syndrome
Macrophage migration inhibitory factor within the alveolar spaces induces changes in the heart during late experimental sepsis.
Respiratory Distress Syndrome
Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome.
Respiratory Distress Syndrome
Role for macrophage migration inhibitory factor in acute respiratory distress syndrome.
Respiratory Distress Syndrome
[Effects of macrophage migration inhibitory factor in pathogenesis of acute respiratory distress syndrome in children]
Respiratory Distress Syndrome
[The pathogenic role of macrophage migration inhibitory factor in acute respiratory distress syndrome]
Respiratory Distress Syndrome, Newborn
A role for macrophage migration inhibitory factor in the neonatal respiratory distress syndrome.
Respiratory Distress Syndrome, Newborn
Umbilical cord levels of macrophage migration inhibitory factor in neonatal respiratory distress syndrome
Respiratory Syncytial Virus Infections
Macrophage migration inhibitory factor (MIF) controls cytokine release during respiratory syncytial virus infection in macrophages.
Rhabdomyosarcoma
Macrophage migration inhibitory factor (MIF) is induced by cytotoxic drugs and is involved in immune escape and migration in childhood rhabdomyosarcoma.
Rhabdomyosarcoma
Macrophage Migration Inhibitory Factor Is Secreted by Rhabdomyosarcoma Cells, Modulates Tumor Metastasis by Binding to CXCR4 and CXCR7 Receptors and Inhibits Recruitment of Cancer-Associated Fibroblasts.
Rheumatic Diseases
Macrophage migration inhibitory factor: a multifunctional cytokine in rheumatic diseases.
Rheumatic Fever
Association of macrophage migration inhibitory factor and mannose-binding lectin-2 gene polymorphisms in acute rheumatic fever.
Rheumatic Heart Disease
Impact of MIF Gene Promoter Variations on Risk of Rheumatic Heart Disease and Its Age of Onset in Saudi Arabian Patients.
Rheumatoid Nodule
Detection of sarcolectin-specific receptors like the cytokine macrophage migration inhibitory factor in rheumatoid nodules.
Rheumatoid Vasculitis
Elevated serum levels of macrophage migration inhibitory factor and their significant correlation with rheumatoid vasculitis disease activity.
Rhinitis, Allergic
Circulating MIF Associated With Disease Severity and Clinical Response of Sublingual Immunotherapy in House Dust Mite-Induced Allergic Rhinitis.
Rhinitis, Allergic
Macrophage migration inhibitory factor (MIF) contributes to the development of allergic rhinitis.
Rhinitis, Allergic
Macrophage migration inhibitory factor in allergic rhinitis: its identification in eosinophils at the site of inflammation.
Sarcoidosis
Macrophage migration inhibitory factor gene polymorphism is associated with sarcoidosis in biopsy proven erythema nodosum.
Sarcoidosis
Macrophage Migration Inhibitory Factor is not Associated with Sarcoidosis Susceptibility or Severity in Whites or Blacks.
Sarcoidosis
Protein levels of CC chemokine ligand (CCL)15, CCL16 and macrophage stimulating protein in patients with sarcoidosis.
Sarcoidosis
Sarcoidosis and MIF gene polymorphism: a case-control study in an Irish population.
Sarcoma
Macrophage migration inhibitory factor and stearoyl-CoA desaturase 1: potential prognostic markers for soft tissue sarcomas based on bioinformatics analyses.
Schistosomiasis mansoni
Macrophage migration inhibitory factor is critical to interleukin-5-driven eosinophilopoiesis and tissue eosinophilia triggered by Schistosoma mansoni infection.
Scleroderma, Diffuse
Expression of macrophage migration inhibitory factor in diffuse systemic sclerosis.
Scleroderma, Diffuse
Serum levels, tissue expression and cellular secretion of macrophage migration inhibitory factor in limited and diffuse systemic sclerosis.
Scleroderma, Systemic
Analysis of serum macrophage migration inhibitory factor and D-dopachrome tautomerase in systemic sclerosis.
Scleroderma, Systemic
Confirmation of association of the macrophage migration inhibitory factor gene with systemic sclerosis in a large European population.
Scleroderma, Systemic
Elevated serum levels of macrophage migration inhibitory factor and stem cell growth factor ? in patients with idiopathic and systemic sclerosis associated pulmonary arterial hypertension.
Scleroderma, Systemic
Expression of macrophage migration inhibitory factor in diffuse systemic sclerosis.
Scleroderma, Systemic
Macrophage migration inhibitory factor may contribute to vasculopathy in systemic sclerosis.
Scleroderma, Systemic
Macrophage migration inhibitory factor polymorphisms are a potential susceptibility marker in systemic sclerosis from southern Mexican population: association with MIF mRNA expression and cytokine profile.
Scleroderma, Systemic
Macrophage migration inhibitory factor promoter polymorphisms and the clinical expression of scleroderma.
Scleroderma, Systemic
Serum levels, tissue expression and cellular secretion of macrophage migration inhibitory factor in limited and diffuse systemic sclerosis.
Scleroderma, Systemic
Up-regulated macrophage migration inhibitory factor protects apoptosis of dermal fibroblasts in patients with systemic sclerosis.
Seizures
Macrophage migration inhibitory factor mediates the antidepressant actions of voluntary exercise.
Sepsis
A functional microsatellite of the macrophage migration inhibitory factor gene associated with meningococcal disease.
Sepsis
A MIF haplotype is associated with the outcome of patients with severe sepsis: a case control study.
Sepsis
A novel DNA vaccine-targeting macrophage migration inhibitory factor improves the survival of mice with sepsis.
Sepsis
Alternative chemical modifications reverse the binding orientation of a pharmacophore scaffold in the active site of macrophage migration inhibitory factor.
Sepsis
Association between high levels of blood macrophage migration inhibitory factor, inappropriate adrenal response, and early death in patients with severe sepsis.
Sepsis
Characterization, epitope identification and mechanisms of the anti-septic capacity of monoclonal antibodies against macrophage migration inhibitory factor.
Sepsis
Current advances in sepsis and septic shock with particular emphasis on the role of insulin.
Sepsis
Deletion of macrophage migration inhibitory factor ameliorates inflammation in mice model severe acute pancreatitis.
Sepsis
Direct link between cytokine activity and a catalytic site for macrophage migration inhibitory factor.
Sepsis
Effects of dexamethasone on macrophage migration inhibitory factor production in sepsis.
Sepsis
Expression and function of macrophage migration inhibitory factor (MIF) in melioidosis.
Sepsis
Functional and prognostic relevance of -173 G/C gene polymorphism of macrophage migration inhibitory factor in sepsis patients in Egyptian intensive care units.
Sepsis
High levels of serum macrophage migration inhibitory factor and interleukin 10 are associated with a rapidly fatal outcome in patients with severe sepsis.
Sepsis
High macrophage migration inhibitory factor levels in disseminated intravascular coagulation patients with systemic inflammation.
Sepsis
Increased plasma thioredoxin levels in patients with sepsis: positive association with macrophage migration inhibitory factor.
Sepsis
Increased susceptibility to septic and endotoxic shock in monocyte chemoattractant protein 1/cc chemokine ligand 2-deficient mice correlates with reduced interleukin 10 and enhanced macrophage migration inhibitory factor production.
Sepsis
Increases in serum macrophage migration inhibitory factor in patients with severe sepsis predict early mortality.
Sepsis
Interaction of macrophage migration inhibitory factor with ceruloplasmin: role of labile copper ions.
Sepsis
Lung-derived macrophage migration inhibitory factor in sepsis induces cardio-circulatory depression.
Sepsis
Macrophage migration inhibitory factor (MIF) and manganese superoxide dismutase (MnSOD) as early predictors for survival in patients with severe sepsis or septic shock.
Sepsis
Macrophage migration inhibitory factor and host innate immune defenses against bacterial sepsis.
Sepsis
Macrophage migration inhibitory factor and innate immune responses to bacterial infections.
Sepsis
Macrophage migration inhibitory factor as a diagnostic and predictive biomarker in sepsis: meta-analysis of clinical trials.
Sepsis
Macrophage migration inhibitory factor deficiency is associated with impaired killing of gram-negative bacteria by macrophages and increased susceptibility to Klebsiella pneumoniae sepsis.
Sepsis
Macrophage migration inhibitory factor is a critical mediator of severe acute pancreatitis.
Sepsis
Macrophage migration inhibitory factor is associated with positive cultures in patients with sepsis after cardiac surgery.
Sepsis
Macrophage migration inhibitory factor levels correlate with fatal outcome in sepsis.
Sepsis
Macrophage migration inhibitory factor regulates interleukin-6 production by facilitating nuclear factor-kappa B activation during Vibrio vulnificus infection.
Sepsis
Macrophage migration inhibitory factor within the alveolar spaces induces changes in the heart during late experimental sepsis.
Sepsis
MIF, a controversial cytokine: a review of structural features, challenges, and opportunities for drug development.
Sepsis
Novel arylazoarylmethane as potential inhibitor of macrophage migration inhibitory factor.
Sepsis
Oxidoreductase Macrophage Migration Inhibitory Factor is simultaneously increased in leukocyte subsets of patients with severe sepsis.
Sepsis
Pathogenic bacteria and TNF do not induce production of macrophage migration inhibitory factor (MIF) by human monocytes.
Sepsis
Phenolic hydrazones are potent inhibitors of macrophage migration inhibitory factor proinflammatory activity and survival improving agents in sepsis.
Sepsis
Plasma levels of macrophage migration inhibitory factor are elevated in patients with severe sepsis.
Sepsis
Redox responses in patients with sepsis: high correlation of thioredoxin-1 and macrophage migration inhibitory factor plasma levels.
Sepsis
Regulation of IL-1 and TNF Receptor Expression and Function by Endogenous Macrophage Migration Inhibitory Factor.
Sepsis
Regulatory role of C5a on macrophage migration inhibitory factor release from neutrophils.
Sepsis
Ribosomal protein S19 interacts with macrophage migration inhibitory factor and attenuates its pro-inflammatory function.
Sepsis
Role of macrophage migration inhibitory factor in glucocorticoid release and glucocorticoid receptor function in rats.
Sepsis
Structural and kinetic analyses of macrophage migration inhibitory factor active site interactions.
Sepsis
Synthesis and bio-evaluation of human macrophage migration inhibitory factor inhibitor to develop anti-inflammatory agent.
Sepsis
The cardioprotective effect of hypertonic saline is associated with inhibitory effect on macrophage migration inhibitory factor in sepsis.
Sepsis
The microsatellite, macrophage migration inhibitory factor -794, may influence gene expression in human mononuclear cells stimulated with E. coli or S. pneumoniae.
Sepsis
Thyroxine is a potential endogenous antagonist of macrophage migration inhibitory factor (MIF) activity.
Sepsis
[Role of macrophage migration inhibitory factor in mice with sepsis and after effect of its intervention.]
Sepsis
[Role of macrophage migration inhibitory factor in systemic inflammatory response and development of sepsis]
Shock, Septic
Activated protein C inhibits tumor necrosis factor and macrophage migration inhibitory factor production in monocytes.
Shock, Septic
Corticoids normalize leukocyte production of macrophage migration inhibitory factor in septic shock.
Shock, Septic
Endotoxin-induced myocardial dysfunction: effects of macrophage migration inhibitory factor neutralization.
Shock, Septic
Glucan phosphate attenuates cardiac dysfunction and inhibits cardiac MIF expression and apoptosis in septic mice.
Shock, Septic
Improved resistance to bacterial superinfection in mice by treatment with macrophage migration inhibitory factor.
Shock, Septic
Inhibition of macrophage migration inhibitory factor (MIF) tautomerase and biological activities by acetaminophen metabolites.
Shock, Septic
Macrophage migration inhibitory factor (MIF) and manganese superoxide dismutase (MnSOD) as early predictors for survival in patients with severe sepsis or septic shock.
Shock, Septic
Macrophage migration inhibitory factor (MIF) in meningococcal septic shock and experimental human endotoxemia.
Shock, Septic
Macrophage migration inhibitory factor (MIF): mechanisms of action and role in disease.
Shock, Septic
Macrophage migration inhibitory factor and innate immune responses to bacterial infections.
Shock, Septic
Macrophage migration inhibitory factor in cerebrospinal fluid from patients with central nervous system infection.
Shock, Septic
Macrophage migration inhibitory factor in patients with preterm parturition and microbial invasion of the amniotic cavity.
Shock, Septic
Macrophage migration inhibitory factor: a counter-regulator of glucocorticoid action and critical mediator of septic shock.
Shock, Septic
Novel half-life extended anti-MIF nanobodies protect against endotoxic shock.
Shock, Septic
Phylogeny and evolution of plant macrophage migration inhibitory factor/D-dopachrome tautomerase-like proteins.
Shock, Septic
Protection from septic shock by neutralization of macrophage migration inhibitory factor.
Shock, Septic
Response of serum macrophage migration inhibitory factor levels to stimulation or suppression of the hypothalamo-pituitary-adrenal axis in normal subjects and patients with Cushing's disease.
Skin Diseases
Assessment of macrophage migration inhibitory factor in patients with verruca vulgaris.
Skin Diseases
Evidence for a role of macrophage migration inhibitory factor in psoriatic skin disease.
Skin Diseases
Macrophage migration inhibitory factor as an incriminating agent in vitiligo.
Skin Diseases
Relationship of macrophage migration inhibitory factor levels in PBMCs, lesional skin and serum with disease severity and activity in vitiligo vulgaris.
Skin Neoplasms
Expression and Function of Macrophage Migration Inhibitory Factor in the Pathogenesis of UV-Induced Cutaneous Nonmelanoma Skin Cancer().
Skin Neoplasms
Macrophage migration inhibitory factor (MIF) plays a critical role in pathogenesis of ultraviolet-B (UVB) -induced nonmelanoma skin cancer (NMSC).
Sleep Apnea, Obstructive
Macrophage migration inhibitory factor gene polymorphisms and plasma levels in children with obstructive sleep apnea.
Sleep Apnea, Obstructive
[The expression of macrophage migration inhibitory factor in obstructive sleep apnea hypopnea syndrome and its injury to endothelial cells].
Spinal Cord Injuries
Deletion of macrophage migration inhibitory factor attenuates neuronal death and promotes functional recovery after compression-induced spinal cord injury in mice.
Spinal Cord Injuries
Elevated Circulating Levels of the Pro-Inflammatory Cytokine Macrophage Migration Inhibitory Factor in Individuals With Acute Spinal Cord Injury.
Spinal Cord Injuries
Glucocorticoids and macrophage migration inhibitory factor (MIF) are neuroendocrine modulators of inflammation and neuropathic pain after spinal cord injury.
Spinal Cord Injuries
Macrophage migration inhibitory factor as a therapeutic target after traumatic spinal cord injury: a systematic review.
Spinal Cord Injuries
Macrophage migration inhibitory factor facilitates production of CCL5 in astrocytes following rat spinal cord injury.
Spinal Cord Injuries
Macrophage migration inhibitory factor facilitates prostaglandin E2 production of astrocytes to tune inflammatory milieu following spinal cord injury.
Spinal Cord Injuries
Macrophage migration inhibitory factor induces cell death and decreases neuronal nitric oxide expression in spinal cord neurons.
Spinal Cord Injuries
Macrophage Migration Inhibitory Factor Promotes Chemotaxis of Astrocytes through Regulation of Cholesterol 25-Hydroxylase Following Rat Spinal Cord Injury.
Spinal Cord Injuries
Nanocarrier-mediated inhibition of macrophage migration inhibitory factor attenuates secondary injury after spinal cord injury.
Spinal Cord Injuries
Pilot study: elevated circulating levels of the proinflammatory cytokine macrophage migration inhibitory factor in patients with chronic spinal cord injury.
Spinal Cord Injuries
[Effect of tetramethylpyrazine on the expression of macrophage migration inhibitory factor in acute spinal cord injury in rats].
Spinal Cord Injuries
[Identification of macrophage migration inhibitory factor (MIF) in rat spinal cord and its kinetics on experimental spinal cord injury]
Spondylitis, Ankylosing
Association of CD14 and macrophage migration inhibitory factor gene polymorphisms with inflammatory microRNAs expression levels in ankylosing spondylitis and polyarthralgia.
Spondylitis, Ankylosing
Evaluation of inflammation and oxidative stress in ankylosing spondylitis: a role for macrophage migration inhibitory factor.
Spondylitis, Ankylosing
Macrophage Migration Inhibitory Factor Induces Inflammation and Predicts Spinal Progression in Ankylosing Spondylitis.
Spondylitis, Ankylosing
Macrophage migration inhibitory factor may play a protective role in osteoarthritis.
Spondylitis, Ankylosing
MiR-451 suppresses inflammatory responses in ankylosing spondylitis by targeting macrophage migration inhibitory factor.
Squamous Cell Carcinoma of Head and Neck
HIF-?/MIF and NF-?B/IL-6 Axes Contribute to the Recruitment of CD11b+Gr-1+ Myeloid Cells in Hypoxic Microenvironment of HNSCC.
Squamous Cell Carcinoma of Head and Neck
Increased expression of macrophage migration inhibitory factor during progression to hypopharyngeal squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Involvement of HPV Infection in the Release of Macrophage Migration Inhibitory Factor in Head and Neck Squamous Cell Carcinoma.
Squamous Cell Carcinoma of Head and Neck
Macrophage migration inhibitory factor in head and neck squamous cell carcinoma: clinical and experimental studies.
Squamous Cell Carcinoma of Head and Neck
Macrophage migration inhibitory factor is a novel prognostic marker for human oral squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Macrophage migration inhibitory factor promotes the invasion and metastasis of oral squamous cell carcinoma through matrix metalloprotein-2/9.
Squamous Cell Carcinoma of Head and Neck
Macrophage migration inhibitory factor: a potential driver and biomarker for head and neck squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Macrophage migration inhibitory factor: A promising oncogenic serological biomarker for oral squamous cell carcinoma.
Squamous Cell Carcinoma of Head and Neck
Pharmacological inhibition of macrophage migration inhibitory factor interferes with the proliferation and invasiveness of squamous carcinoma cells.
Squamous Cell Carcinoma of Head and Neck
Serum and salivary macrophage migration inhibitory factor in patients with oral squamous cell carcinoma.
Starvation
Macrophage migration inhibitory factor plays a permissive role in the maintenance of cardiac contractile function under starvation through regulation of autophagy.
Still's Disease, Adult-Onset
A genetic role for macrophage migration inhibitory factor (MIF) in adult-onset Still's disease.
Still's Disease, Adult-Onset
Potential role of macrophage migration inhibitory factor in adult-onset Still's disease.
Still's Disease, Adult-Onset
The levels of macrophage migration inhibitory factor as an indicator of disease activity and severity in adult-onset Still's disease.
Stomach Diseases
Identification of macrophage migration inhibitory factor and human neutrophil peptides 1-3 as potential biomarkers for gastric cancer.
Stomach Neoplasms
CD74 and macrophage migration inhibitory factor as therapeutic targets in gastric cancer.
Stomach Neoplasms
Clinicopathological Significance of Macrophage Migration Inhibitory Factor and its Relation with P53 in Gastric Cancer.
Stomach Neoplasms
Correlation between macrophage migration inhibitory factor and autophagy in Helicobacter pylori-associated gastric carcinogenesis.
Stomach Neoplasms
Gastric cancer susceptibility in gastric cancer relatives: Attributable risks of Macrophage migration inhibitory factor promoter polymorphism and Helicobacter pylori.
Stomach Neoplasms
Identification of macrophage migration inhibitory factor and human neutrophil peptides 1-3 as potential biomarkers for gastric cancer.
Stomach Neoplasms
Increased epithelial and serum expression of macrophage migration inhibitory factor (MIF) in gastric cancer: potential role of MIF in gastric carcinogenesis.
Stomach Neoplasms
Macrophage migration inhibitory factor and DJ-1 in gastric cancer: differences between high-incidence and low-incidence areas.
Stomach Neoplasms
Macrophage migration inhibitory factor as a potential prognostic factor in gastric cancer.
Stomach Neoplasms
Macrophage migration inhibitory factor regulates proliferation of gastric cancer cells via the PI3K/Akt pathway.
Stomach Neoplasms
microRNA-1228(?) impairs the pro-angiogenic activity of gastric cancer cells by targeting macrophage migration inhibitory factor.
Stomach Neoplasms
P115 promotes growth of gastric cancer through interaction with macrophage migration inhibitory factor.
Stomach Neoplasms
The diagnostic value of macrophage migration inhibitory factor (MIF) in gastric cancer.
Stomach Ulcer
Gastric epithelial expression of macrophage migration inhibitory factor is not altered by Helicobacter pylori infection in humans.
Stomatitis
Salivary alpha-1-antitrypsin and macrophage migration inhibitory factor may be potential prognostic biomarkers for oncologic treatment-induced severe oral mucositis.
Stroke
Deletion of macrophage migration inhibitory factor worsens stroke outcome in female mice.
Stroke
Enriched environment downregulates macrophage migration inhibitory factor and increases parvalbumin in the brain following experimental stroke.
Stroke
Hypoxia Signaling Regulates Macrophage Migration Inhibitory Factor (MIF) Expression in Stroke.
Stroke
Lack of macrophage migration inhibitory factor in mice does not affect hallmarks of the inflammatory/immune response during the first week after stroke.
Stroke
Macrophage migration inhibitory factor and the risk of myocardial infarction or death due to coronary artery disease in adults without prior myocardial infarction or stroke: the EPIC-Norfolk Prospective Population study.
Stroke
Macrophage Migration Inhibitory Factor Levels Correlate with Stroke Recurrence in Patients with Ischemic Stroke.
Stroke
Macrophage migration inhibitory factor promotes cell death and aggravates neurologic deficits after experimental stroke.
Stroke
Proinflammatory Cytokines, Adiponectin, and Increased Risk of Primary Cardiovascular Events in Diabetes Patients With or Without Renal Dysfunction: Results from the ESTHER study.
Stroke
Upregulation of CD74 and its potential association with disease severity in subjects with ischemic stroke.
Stroke, Lacunar
Increased VEGF and Decreased SDF-1? in Patients with Silent Brain Infarction Are Associated with Better Prognosis after First-Ever Acute Lacunar Stroke.
Subarachnoid Hemorrhage
Cerebrospinal fluid macrophage migration inhibitory factor: a potential predictor of cerebral vasospasm and clinical outcome after aneurysmal subarachnoid hemorrhage.
Subarachnoid Hemorrhage
Macrophage migration inhibitory factor as a serum prognostic marker in patients with aneurysmal subarachnoid hemorrhage.
Subarachnoid Hemorrhage
The Association Between Serum Macrophage Migration Inhibitory Factor and Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage.
Superinfection
Improved resistance to bacterial superinfection in mice by treatment with macrophage migration inhibitory factor.
Systemic Vasculitis
Increased serum levels of macrophage migration inhibitory factor (MIF) in patients with microscopic polyangiitis.
Teratoma
MIF produced by bone marrow-derived macrophages contributes to teratoma progression after embryonic stem cell transplantation.
Thrombosis
Association between MIF gene promoter rs755622 and susceptibility to coronary artery disease and inflammatory cytokines in the Chinese Han population.
Thrombosis
Impact of counterbalance between macrophage migration inhibitory factor and its inhibitor Gremlin-1 in patients with coronary artery disease.
Thyroiditis
Macrophage migration inhibitory factor interacting with Th17 cells may be involved in the pathogenesis of autoimmune damage in Hashimoto's thyroiditis.
Thyroiditis
Serum macrophage migration inhibitory factor levels in Hashimoto's thyroiditis; a case control study.
Tonsillitis
Induction of macrophage migration inhibitory factor precedes the onset of acute tonsillitis.
Toxoplasmosis
Macrophage migration inhibitory factor (MIF) and pregnancy may impact the balance of intestinal cytokines and the development of intestinal pathology caused by Toxoplasma gondii infection.
Toxoplasmosis
MIF participates in Toxoplasma gondii-induced pathology following oral infection.
Toxoplasmosis
MIF Promotes Classical Activation and Conversion of Inflammatory Ly6C(high) Monocytes into TipDCs during Murine Toxoplasmosis.
Toxoplasmosis
NADPH oxidase 4 is required for the generation of macrophage migration inhibitory factor and host defense against Toxoplasma gondii infection.
Toxoplasmosis
Protective Effect Against Toxoplasmosis in BALB/c Mice Vaccinated With Toxoplasma gondii Macrophage Migration Inhibitory Factor.
Toxoplasmosis
WITHDRAWN: Macrophage migration inhibitory factor (MIF) and pregnancy may impact the balance of intestinal cytokines and the development of intestinal pathology caused by Toxoplasma gondii infection.
Toxoplasmosis, Congenital
Macrophage Migration Inhibitory Factor (MIF) Prevents Maternal Death, but Contributes to Poor Fetal Outcome During Congenital Toxoplasmosis.
Trichinellosis
[Serum Levels of Macrophage Migration Inhibitory Factor and Leptin in Patients with Acute Trichinellosis.]
Triple Negative Breast Neoplasms
Autophagy inhibition in breast cancer cells induces ROS-mediated MIF expression and M1 macrophage polarization.
Triple Negative Breast Neoplasms
Macrophage migration inhibitory factor inhibition as a novel therapeutic approach against triple-negative breast cancer.
Tuberculosis
Association of tuberculosis and polymorphisms in the promoter region of macrophage migration inhibitory factor (MIF) in a Southwestern China Han population.
Tuberculosis
CATT polymorphism in MIF gene promoter is closely related to human pulmonary tuberculosis in a southwestern China population.
Tuberculosis
Correlation between genetic susceptibility of tuberculosis and macrophage migration inhibitory factor.
Tuberculosis
Increased density of macrophage migration inhibitory factor (MIF) in tuberculosis granuloma.
Tuberculosis
Low expression Macrophage Migration Inhibitory Factor (MIF) alleles and tuberculosis in HIV infected South Africans.
Tuberculosis
Macrophage migration inhibitory factor (MIF) is a critical mediator of the innate immune response to Mycobacterium tuberculosis.
Tuberculosis
Macrophage migration inhibitory factor -173 G > C polymorphism and risk of tuberculosis: A meta-analysis.
Tuberculosis
Macrophage migration inhibitory factor -?794 CATT5-8 microsatellite polymorphism and susceptibility of tuberculosis.
Tuberculosis
Macrophage migration inhibitory factor gene influences the risk of developing tuberculosis in northwestern Colombian population.
Tuberculosis
Macrophage migration inhibitory factor reduces the growth of virulent Mycobacterium tuberculosis in human macrophages.
Tuberculosis
MIF -173 G?>?C (rs755622) Gene Polymorphism Modulates Tuberculosis Risk: Evidence from a Meta-analysis and Trial Sequential Analysis.
Tuberculosis
Single nucleotide polymorphisms in cytokine MIF gene promoter region are closely associated with human susceptibility to tuberculosis in a southwestern province of China.
Tuberculosis
Usefulness of the IgA and IgG Responses to Macrophage Migration Inhibitory Factor for the Diagnosis of Tuberculosis.
Tuberculosis, Pulmonary
Analysis of MIF, FCGR2A and FCGR3A gene polymorphisms with susceptibility to pulmonary tuberculosis in Moroccan population.
Tuberculosis, Pulmonary
Association between the MIF-173G/C Polymorphism and Serum MIF levels with Pulmonary Tuberculosis: A Meta-analysis.
Tuberculosis, Pulmonary
Elevated levels of serum macrophage migration inhibitory factor in patients with pulmonary tuberculosis.
Tuberculosis, Pulmonary
Functional polymorphisms in the gene encoding macrophage migration inhibitory factor (MIF) are associated with active pulmonary tuberculosis.
Tuberculosis, Pulmonary
Macrophage migration inhibitory factor -173 G/C polymorphism is associated with an increased risk of pulmonary tuberculosis in Zahedan, Southeast Iran.
Tuberculosis, Pulmonary
Macrophage migration inhibitory factor -173 G>C single nucleotide polymorphism and its association with active pulmonary tuberculosis.
Tuberculosis, Pulmonary
Prognostic value of serum macrophage migration inhibitory factor levels in pulmonary tuberculosis.
Tuberculosis, Pulmonary
Serum and BAL macrophage migration inhibitory factor levels in HIV infected Tanzanians with pulmonary tuberculosis or other lung diseases.
Tuberculosis, Pulmonary
Serum Macrophage Migration Inhibitory Factor as a Biomarker of Active Pulmonary Tuberculosis.
Urinary Bladder Neck Obstruction
Null mutation in macrophage migration inhibitory factor prevents muscle cell loss and fibrosis in partial bladder outlet obstruction.
Urinary Bladder Neoplasms
Inhibition of macrophage migration inhibitory factor decreases proliferation and cytokine expression in bladder cancer cells.
Urinary Bladder Neoplasms
Macrophage migration inhibitory factor anti-thrombin III complexes are decreased in bladder cancer patient serum: Complex formation as a mechanism of inactivation.
Urinary Bladder Neoplasms
Macrophage migration inhibitory factor gene -173G>C polymorphism and risk of bladder cancer in southeast China: a case-control analysis.
Urinary Bladder Neoplasms
Null mutation for macrophage migration inhibitory factor (MIF) is associated with less aggressive bladder cancer in mice.
Urinary Tract Infections
Macrophage Migration Inhibitory Factor is Increased in the Urine of Patients With Urinary Tract Infection: Macrophage Migration Inhibitory Factor-Protein Complexes in Human Urine.
Urinary Tract Infections
Urinary macrophage migration inhibitory factor in children with urinary tract infection.
Urinary Tract Infections
Urine macrophage migration inhibitory factor (MIF) in children with urinary tract infection: a possible predictor of acute pyelonephritis.
Uterine Cervical Neoplasms
Correlation of macrophage migration inhibitory factor gene polymorphism with the risk of early-stage cervical cancer and lymphatic metastasis.
Uterine Cervical Neoplasms
KSHV co-infection regulates HPV16+ cervical cancer cells pathogenesis in vitro and in vivo.
Uterine Cervical Neoplasms
Loss of macrophage migration inhibitory factor impairs the growth properties of human HeLa cervical cancer cells.
Uterine Cervical Neoplasms
Macrophage migration inhibitory factor expression in cervical cancer.
Uterine Cervical Neoplasms
Macrophage migration inhibitory factor promoter polymorphisms (-794CATT5-7 ) as potential biomarker for early-stage cervical cancer.
Uterine Cervical Neoplasms
[Expression of MIF, VEGF and p16 proteins and their correlation with clinicopathological features in cervical cancer]
Uveitis
Modulating of ocular inflammation with macrophage migration inhibitory factor is associated with Notch signaling in experimental autoimmune uveitis.
Uveitis
Prominent increase of macrophage migration inhibitory factor in the sera of patients with uveitis.
Vaccinia
The immune response to infection with vaccinia virus in mice. II. Appearance of hypersensitivity, production of macrophage migration inhibitory factor and transformation of spleen cells in response to virus antigens.
Vascular Diseases
Evidence for a role of macrophage migration inhibitory factor in vascular disease.
Vascular System Injuries
Stabilization of atherosclerotic plaques by blockade of macrophage migration inhibitory factor after vascular injury in apolipoprotein E-deficient mice.
Vasculitis
Elevated serum levels of macrophage migration inhibitory factor and their significant correlation with rheumatoid vasculitis disease activity.
Vasculitis
Lack of association between macrophage migration inhibitory factor gene (-173 G/C) polymorphism and cutaneous vasculitis.
Vasculitis
Macrophage migration inhibitory factor (MIF) and thyroid hormone alterations in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV).
Vasculitis
Relationship between serum levels of macrophage migration inhibitory factor and the activity of antineutrophil cytoplasmic antibody-associated vasculitides.
Vasculitis
Role of macrophage migration inhibitory factor in granulomatosis with polyangiitis.
Vasculitis, Leukocytoclastic, Cutaneous
Lack of association between macrophage migration inhibitory factor gene (-173 G/C) polymorphism and cutaneous vasculitis.
Vasospasm, Intracranial
Cerebrospinal fluid macrophage migration inhibitory factor: a potential predictor of cerebral vasospasm and clinical outcome after aneurysmal subarachnoid hemorrhage.
Vertigo
Elevated serum macrophage migration inhibitory factor levels correlate with benign paroxysmal positional vertigo and recurrence events.
Virus Diseases
Contribution of macrophage migration inhibitory factor to the pathogenesis of dengue virus infection.
Virus Diseases
Influence of Epstein-Barr virus and human papillomavirus infection on macrophage migration inhibitory factor and macrophage polarization in nasopharyngeal carcinoma.
Virus Diseases
Macrophage migration inhibitory factor (MIF) controls cytokine release during respiratory syncytial virus infection in macrophages.
Virus Diseases
Macrophage migration inhibitory factor enhances influenza-associated mortality in mice.
Virus Diseases
Macrophage migration inhibitory factor induced by dengue virus infection increases vascular permeability.
Virus Diseases
Macrophage Migration Inhibitory Factor Triggers Inflammatory Responses During Very Virulent Infectious Bursal Disease Virus Infection.
Virus Diseases
Pathogenic roles of macrophage migration inhibitory factor during dengue virus infection.
Virus Diseases
Release of macrophage migration inhibitory factor and CXCL8/interleukin-8 from lung epithelial cells rendered necrotic by influenza A virus infection.
Vitiligo
Macrophage Migration Inhibitory Factor in Alopecia Areata and Vitiligo: A Case-Controlled Serological Study.
Vitiligo
Macrophage migration inhibitory factor in patients with vitiligo and relationship between duration and clinical type of disease.
Vitiligo
Relationship of macrophage migration inhibitory factor levels in PBMCs, lesional skin and serum with disease severity and activity in vitiligo vulgaris.
Vitiligo
Soluble CD27 and MIF as possible serum biomarkers of vitiligo activity in Egyptian patients in Sharkia Governorate.
Vitreoretinopathy, Proliferative
Macrophage migration inhibitory factor levels in the vitreous of patients with proliferative vitreoretinopathy.
Vitreoretinopathy, Proliferative
Monocyte chemotactic protein-1 levels in the vitreous of patients with proliferative vitreoretinopathy.
Warts
Assessment of macrophage migration inhibitory factor in patients with verruca vulgaris.
Warts
Possible role of interleukin-17 and macrophage migration inhibitory factor in cutaneous warts.
Wiskott-Aldrich Syndrome
Production of macrophage migration inhibitory factor and lymphotoxin by leukocytes from normal and Wiskott-Aldrich syndrome patients.
Zika Virus Infection
An hPSC-Derived Tissue-Resident Macrophage Model Reveals Differential Responses of Macrophages to ZIKV and DENV Infection.
html completed